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Zusammenfassung 
Trotz seit nunmehr als dreißig Jahren Forschung an epidermalen Stammzellen ist noch nicht 
verstanden wie die Gewebshomöostase der interfollikulären Epidermis (IFE) reguliert wird. 
Dies ist hauptsächlich dem Fehlen von eindeutigen Markern für die Identifikation von 
humanen epidermalen Stammzellen geschuldet. In dem Haarfollikel und Follikel-armer Haut, 
wie der Epidermis des Mäuseohres, wurden langsam-teilende oder auch label-retaining 
Zellen (LRZ) als Stammzellen beschrieben. Es wird angenommen, dass diese LRZs für die  
Aufrechterhaltung der Gewebshomöostase verantwortlich sind. Um diese Frage zu 
beantworten, müssen jedoch Stammzellen in der Haut eindeutig identifiziert werden. Das Ziel 
dieser Studie war die Isolierung  und Charakterisierung von LRZs unter der Annahme, dass 
das langsame Teilen ein Charakteristikum von epidermalen Stammzellen ist. Da 
Untersuchungen an der Haut restriktiv sind wurde für diese Studie ein in vitro 3D 
organotypisches Hautmodell  verwendet. Für den Nachweis von LRZs wurde ein 
induzierbarer Tet-Off-H2B-GFP lentiviraler Reporter Vektor verwendet. Dadurch wurde eine 
Methode entwickelt normale adulte humane Keratinozyten (NHEK) mit diesem lentiviralen 
Vektor erfolgreich zu infizieren und transduzierte NHEK in Langzeit organotypischen 
Kulturen (OTK) zu kultivieren. Mit Pulse-Chase Experimenten (2 Wochen pulse, 6 Wochen 
chase) war es möglich vitale LRZs aus der IFE funktionell als langsam-teilende Zellen zu 
identifizieren und als GFP-positive Zellen aus OTKs zu isolieren. Zur weiteren 
Charakterisierung dieser Zellen wurden Microarray-Analysen von den isolierten label-
retaining basalen Zellen und den entsprechenden unmarkierten basalen Zellen durchgeführt. 
Die Analyse ergab, dass 102 Gene differentiell in LRZs reguliert sind. Wir konnten zeigen, 
dass eine hohe Anzahl von Genen der extrazellulären Matrix (EZM) oder EZM 
modulierenden Gene in LRZs hoch reguliert waren. Dies konnte mittels qRT-PCR verifiziert 
werden.  Um die differentielle Proteinexpression zu bestimmen sind weitere Versuche in 
Vorbereitung. Anhand dieses Profils nehmen wir jedoch an, dass LRZs imstande sind ihre 
lokale Umgebung, auch als Nische bezeichnet, aktiv durch die Sekretion von EZM 
Komponenten zu beeinflussen. Diese besondere EZM kann zur besseren Anhaftung der 
LRZs in der Nische dienen, sowie als Reservoir für Wachstumsfaktoren, die Zellsignale 
regulieren können.  Die Analyse mit dem Programm Ingenuity Pathway Analyse ergab, dass 
TGFβ in die Regulierung involviert sein könnte. Stimulierungs-Experimente mit TGFβ 
ergaben dementsprechend, dass TGFβ-1 die Hochregulation von Genen stimuliert, die auch 
in LRZs im Gewebe-Kontext sehr hoch reguliert waren. Daher nehmen wir an, dass LRZs ein 
klar unterscheidbares molekulares Profil im Vergleich zu anderen basalen Zellen der IFE 
haben, welches ihnen erlaubt ihre Nische spezifisch zu regulieren. Für die funktionelle Rolle 
der LRZs als epidermale Stammzelle bleiben weitere Untersuchungen abzuwarten. 
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Summary 
Despite more than 30 years of epidermal stem cell research, it is not yet understood how 
tissue homeostasis is balanced in the interfollicular epidermis (IFE). This is mainly because 
of the lack of distinct markers to identify human epidermal stem cells. In the hair follicle and 
the follicle-poor mouse ear epidermis stem cells have been described as slow-cycling cells, 
also called label-retaining cells (LRCs) (Bickenbach, 1981; Braun et al., 2003; Cotsarelis et 
al., 1990). It is suggested that these LRCs are responsible for maintaining tissue 
homeostasis. To address this stem cells need to be identifiable which has yet to be 
accomplished. Suggesting, that slowly cycling is a characteristic also of epidermal stem cells 
in the IFE, the aim of this study was the isolation and characterization of LRCs. Since 
investigation on human skin is restricted, we employed a human in vitro 3D organotypic skin 
model (Muffler et al., 2008). For the detection of LRCs we utilized an inducible Tet-Off-H2B-
GFP lentiviral reporter vector. Thus, a method was developed to successfully infect normal 
human adult keratinocytes (NHEK) with the lentiviral vector and these keratinocytes were 
further propagated in organotypic cultures (OTC) to establish long-term skin equivalents. In 
pulse-chase approaches (2 weeks pulse, 6 weeks chase), viable LRCs of the IFE could be 
functionally identified as slow-cycling cells and isolated as GFP positive cells from OTCs. To 
further characterize these cells, microarray analysis was performed of the isolated basal 
LRCs and their respective non-labeled basal cell fraction. This analysis revealed 102 genes 
to be differentially regulated in the LRCs. We could show that a high fraction of upregulated 
genes in LRCs were ECM or ECM remodeling genes which could be verified by qRT-PCR. 
Further characterization on protein level is in progress. From this profile it is suggested, that 
LRCs actively modulate their local microenvironment, referred to as niche, by secreting 
unique ECM components. This distinct ECM may well serve for enhanced adhesion of LRCs 
to the niche as well as a reservoir for growth factors regulating cell signaling. Ingenuity 
pathway analysis further suggested a role for TGFβ signaling in this regulation. Accordingly, 
stimulation experiments provided first evidence that TGFβ-1 stimulates upregulation of those 
genes in NHEKs in 2D cultures that were highly upregulated in LRCs in their tissue context. 
Thus, we propose that LRCs exhibit a distinct molecular profile that compared to all other 
basal cells allows them to establish their specific regulatory niche. Their functional role as 
epidermal stem cells has now to await further investigations. 
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Abbreviations 
°C  Degree Celsius 
µg  Microgram 
µL  Microlitre 
µm  Micrometre 
AB  Antibody 
Asc. a. ph. Ascorbic acid phosphate 
bFGF   Basic fibroblast growth factor 
BM  Basement membrane 
BrdU   5’-Bromo-2’-deoxyuridine  
BSA   Bovine serum albumine  
cDNA   Complementary DNA  
cm  Centimetre 
CO2  Carbon dioxide 
COL1A1 collagen, type I, alpha 1 
Cy3  Indocarbocyanin  
D  Day(s) 
D10  DMEM with 10% FCS  
DAPI  4′,6-Diamidino-2-phenylindol  
Dest  de-ionized  
DMEM  Dulbecco´s modified Eagle´s 
medium  
DNA  Deoxyribonucleic acid  
dNTP  Deoxyribonucleotide 
triphosphates  
ECM  Extracellular matrix 
EDTA  Ethylendiamintetraacetate  
EGF  Epidermal growth factor  
et al.  et alii/aliae, and others   
EtOH  Ethanol 
FA  Formaldehyde 
FCS  Fetal calf serum 
fdm  Fibroblast-derived matrix  
Fig  Figure 
g  Gram(s) 
G  Gravity constant  
GAPDH Glyceraldehyde-3-phosphate- 
dehydrogenase 
GFP  green fluorescent protein 
GO  Gene Ontology 
h  Hour(s)  
H&E  Hämatoxylin & Eosin 
HaCaT  Human adult Calcium 
Temperature  
HBSS  Hank´s balanced salt solution  
HCl  Chlorhydric acid 
HIST1H2BG Histone Cluster 1, H2bg 
HIST1H4H Histone Cluster 1, H4h 
Hoechst Bisbenzimide  
IdU  Iododeoxyuridine 
IFE  Interfollicular epidermis 
IFF  Indirect Immunofluorescence 
IGFB4  insulin-like growth factor 
binding protein 4 
 
 
IGF  Insulin-like growth factor 
IL6  Interleukin 6 
Ki67  Nuclearprotein associated with  
proliferation 
L  Liter 
Lam-PCR Linear amplification-mediated  
Polymerase Chain Reaction 
LRC  Label-retaining cell 
Lrp6  Low-density lipoprotein 
receptor-related protein 6  
MeOH  Methanol 
mg  Milligramm 
min  Minute(s) 
ml  Millilitre 
mm  Millimetre 
MMP  Matrix metalloprotease  
mRNA  messenger RNA  
ms  Millisecond 
NaN3  Sodium azide 
NaCl  Sodium chloride  
nm  Nanometre 
NaOH  Sodium hydroxide  
NHEK  Normal human epidermal 
keratinocytes 
ON  Over night 
OTC  Organotypic coculture  
PBS-  Phosphate buffered saline  
PBS+  Phosphate buffered saline 
containing Magnesiochloride 
and Calciumchloride  
PCR  Polymerase Chain Reaction 
Pen/Strep Penicillin / Streptomycin 
PFA  Paraformaldehyde 
pH  pondus hydrogenii  
qRT-PCR Quantitative real-time  
Polymerase Chain Reaction 
RNA  Ribonucleic acid  
rpm  rounds per minute  
RT  Room temperature 
Sca OTC scaffold-based  
organotypic coculture 
Snai2  snail family zinc finger 2 
TGFβ  Transforming growth factor β 
TGFβR1 TGFβ receptor type 1 
TGFβR2 TGFβ receptor type 2 
TGFβR3 TGFβ receptor type 3 
THBS1  Thrombospondin-1 
TIMP2  metallopeptidase inhibitor 2 
V  Volt 
Wnt  int/Wingless family 
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1 Introduction 
1.1 The human skin 
The skin serves as a protective barrier of the human body and is with an expansion about 
1.7m2 and a proportion up to 16% of the total body weight the largest human organ (Jung, 
1995; Williams, 2003). The human skin has a lot of unique and important functions. It 
protects the human body from infection with pathogens and harmful substances from the 
environment, for example UV-radiation and exogenous substances. Furthermore the skin 
plays an important role in the regulation of heat and water, including regulating the electrolyte 
metabolism. Other functions are the regulation of the immune response through Langerhans 
cells and the sensation of touch, heat, and cold through Merkel- and nerve cells. The skin is 
made up of two major compartments, the dermis and the epidermis. Underneath is the 
deeper subcutaneous adipose and connective tissue (hypodermis). Epidermis and dermis 
are connected through the basement membrane which mainly contains collagen type IV and 
collagen type VII, proteoglycans like perlecan and different laminins. 
 
1.1.1 Dermis 
The dermis constitutes of a fibroblastic connective tissue and serves as the supporting base 
for the epidermis (Kanitakis, 2002). The main component of the dermis is a dense network of 
type I and type III collagen fibrils and elastic fibers embedded in different 
glycosaminoglycans, a family of water-binding macromolecules (Wilkes et al., 1973). This 
extracellular matrix (ECM), secreted by dermal fibroblasts, gives the skin high elasticity, and 
tensile strength as well as compressibility (Deutzmann R, 2007). Fibroblasts are the main cell 
type in the dermis, but there are also immune cells like macrophages, mast cells and 
dendrocytes (Fritsch, 2009; Sterry, 2005). Embedded in the dermis are skin appendages 
such as hair follicles, sebaceous glands and sweat glands. 
 
The dermis comprises two zones, the stratum reticulare and the stratum papillare. The 
uppermost layer, the stratum papillare is rich in vascular vessels and neuronal cells and 
contains crypts, the dermal papillae, which interlock with the epidermis (Moll, 2010). These 
dermal papillae increase the contact area with the epidermis, ensuring optimal nourishment 
of the epidermis by running blood vessels through the papillae (Kanitakis, 2002). The stratum 
reticulare forms the lower part of the dermis and passes continuously into the subcutis. It 
consists of a more compact and dense network of collagen fibers giving the skin a high 
stability (Fritsch, 2009). 
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1.1.2 Epidermis 
The epidermis is a multilayered, stratified, squamous epithelium with a thickness of 40 µm to 
0,2 mm depending on age, gender and location (Kanitakis, 2002). Histologically, the 
epidermis is divided into four different layers, the stratum basale, the stratum spinosum, the 
stratum granulosum and the stratum corneum (Burns, 2004) (Figure 1). The major cell 
population are keratinocytes (> 90%), but also melanocytes, Langerhans cells and Merkel 
cells can be found. The epidermis is continuously renewing. Keratinocytes undergo terminal 
differentiation as the cells migrate from the basal layer to the surface of the skin. Since there 
are no blood vessels in the epidermis present, the epidermis is supplied via diffusion through 
the underlying dermis. The downward projections of the epidermis, between the dermal 
papillae, are called epidermal rete ridges. Keratinocytes build up two independent networks, 
a network of keratin intermediate filaments and a network of actin filaments. The keratin 
filaments are connected to the desmosomes (Garrod et al., 2002; Kottke et al., 2006), 
whereas the actin filaments are part of the adherens junctions (Perez-Moreno et al., 2003; 
Young et al., 2003). Desmoglein is a typical marker for desmosomes and E-cadherin for 
adherens junctions, correspondingly. Moreover, there are gap junctions, which allow the 
exchange of water, ions, and small molecules between adjacent cells (Mese et al., 2007). In 
addition the basal keratinocytes are firmly anchored to the basement membrane by 
hemidesmosomes (Figure 1). These intracellular connections allow keratinocytes to 
communicate and function as a sheet and enable the formation of an epithelial cell polarity 
(Shin et al., 2006).  
 
The stratum basale (or basal cell layer), which is tightly connected to the subjacent basement 
membrane, is the epidermal regenerative layer. The next overlying layers are the stratum 
spinosum where the keratinocytes change their morphology to a more horizontal and 
polygonal flattened shape (Figure 1). Moreover, they form intercellular desmosomal 
connections which lead to a tight cell association providing resistance to physical stress 
(Kanitakis, 2002). In parallel to this differentiation process the keratinocytes also change their 
expression profile. While basal keratinocytes express mainly keratin 5 and keratin 14, the 
expression of keratin 1 and 10 specifies the suprabasal layers, starting at the stratum 
spinosum, and therefore represents the onset of epidermal differentiation. 
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Figure 1: The structure of the epidermis. The stratum basale contains proliferating keratinocytes, from 
there they detach from the basement membrane and undergo a well defined terminal differentiation 
program while morphological changes occur. Figure from (Denecker et al., 2008) 
 
The stratum granulosum consists of more flattened cells holding abundant keratohyalin 
granules in their cytoplasm (Chu, 2008). The deeply basophilic keratohyalin granules which 
contain precursors of the keratin matrix-like profillagrin dissolve and release their content as 
the cells of the granular layer undergo the terminal differentiation process to a cornified cell 
(Chu, 2008). 
 
In the most superficial layers, the stratum corneum, the cells lose their nuclei and are finally 
shed off (Figure 1). The cornified layers provide a barrier and protects the epidermis from 
dehydration (Jackson et al., 1993). The horny cells (corneocytes) form tight junctions and are 
surrounded by a cornified envelope which is made up of proteins crosslinked by 
transglutaminases (Moll, 2010). Involucrin, filaggrin, loricrin, small proline rich proteins 
(SPR), repetin and proteins of the S100-family are components of the cornified envelope and 
indicate the terminal epidermal differentiation (Steinert and Marekov, 1995; Steinert and 
Marekov, 1997) (Figure 1). 
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1.2 Epidermal stem cells 
In skin, there is a constant balance between cell proliferation and cell death, called tissue 
homeostasis. This epithelial balance is maintained by stem cells. Epidermal stem cells play a 
critical role in human skin homeostasis and wound repair. Adult stem cells in the skin are 
characterized by their capacity for self-renewal for an extended time period, and the ability to 
differentiate into multiple lineages derived from their tissue origin (Weissman and Baltimore, 
2001).  
 
There have been indentified three different populations of epidermal stem cells in mouse and 
human skin: in the permanent portion (the bulge region) of the hair follicle, in the sebaceous 
gland (SG) and in the interfollicular epidermis (Figure 2). Lineage tracing revealed that each 
compartment is maintained by their own, distinct stem cell population (Clayton et al., 2007; 
Ghazizadeh and Taichman, 2001; Ito et al., 2005; Levy et al., 2005; Levy et al., 2007). The 
interfollicular epidermis and the sebaceous glands are constantly self-renewing tissues, while 
hair follicles cycle between growth (anagen), involution and rest (telogen) (Hardy, 1992).  
 
1.2.1 Hair follicle and sebaceous gland 
Most of the knowledge on the regeneration potential of the epidermis comes from intensive 
research on murine hair follicles (HFs). The best characterized region for stem cells in the HF 
is the bulge region. Within this bulge region of the HF several suggested markers of stem 
cells exist including keratin 15 (K15) (Morris et al., 2004) and CD34 (Blanpain et al., 2004; 
Lyle et al., 1998; Trempus et al., 2003). There are three distinct populations of CD34. In the 
basal layer of the bulge are α6 integrin high-, K15- and CD34- expressing stem cells located 
(Figure 2). In the suprabasal layer above is a CD34 positive stem cell population with low 
levels of α6 integrin (Blanpain et al., 2004) (Figure 2).  Lgr5, a known marker for stem cells in 
the intestinal and gastric epithelium of mice (Barker et al., 2010; Barker et al., 2007), is 
expressed in the third CD34 positive stem cell population, which is located at the lower part 
of the bulge region (Figure 2). However, there is a dynamic change of the lgr5 expression 
during the hair cycle. While lgr5 expression overlaps with CD34 in the resting bulge 
(telogen), the lgr5 positive cells start proliferating and migrating to the outer root sheath 
(ORS) to contribute to anagen hair growth while losing their CD34 expression (Jaks et al., 
2008). Other markers for stem cell populations in the bulge region are Sox9 (Vidal et al., 
2005), Lhx2 (Rhee et al., 2006), and transcription factor 3 (tcf3) (DasGupta and Fuchs, 
1999). Furthermore, lineage-tracing demonstrated that there is an lgr6- expressing stem cell 
population of non dividing cells right above the bulge region located at the isthmus of the HF 
(Snippert et al., 2010) (Figure 2). This lgr6 stem cell pool can renew the sebaceous gland 
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and the upper follicle. Moreover, lgr6 lineage-tracing analyses during wound repair shows 
that this stem cell pool permanently contributes to the newly formed interfollicular epidermis 
(Snippert et al., 2010). Above the lgr6 positive cell population is a stem cell population 
located which lacks the expression of CD34 and K15, but is positive for MTS24 and α6 
integrin (Nijhof et al., 2006) (Figure 2). MTS24 was suggested as murine progenitor or stem 
cell marker due to their high clonogenic potential (Nijhof et al., 2006). In the upper part of the 
HF a quiescent population can be found, which express additionally lrig1. The sebaceous 
gland, belonging to the HF unit and also named as pilosebaceous tract, has his own stem 
cell compartment. Here stem cells were identified as CD34 negative, K14 positive and 
positive for the transcriptional repressor, Blimp1 (Ghazizadeh and Taichman, 2001; Horsley 
et al., 2006) (Figure 2). This shows that there are multiple stem cell populations in the HF, 
but it is still elusive if they act independently or if they are organized in a hierarchical manner.  
 
 
Figure 2: Schematic representation of stem cells in the murine hair follicle. Summary of suggested stem 
cell marker in the murine hair follicle. There are distinct stem cell populations and yet it has not been 
resolved if they act independently or in an organized hierarchical manner. Figure modified from (Boehnke 
et al., 2012).  
 
Importantly, the markers of the mouse HF stem cells could not be detected in the human HF. 
Instead CD200 was suggested as marker for stem cells in the human bulge, as well as 
follistatin and the frizzled homolog 1 (Ohyama et al., 2006). This demonstrates that marker 
characterizing stem cells are different in mouse and human, suggesting that also the 
regulation may be different. This is substantiated by obvious differences between the 
  Introduction 
 
6 
 
structure of mouse and human skin. Not only the HF density is higher in mouse skin, also the 
structure and the cycling time of the HF differs. For example are human scalp hair follicles 
significantly larger than hair follicle in mice. And the growth cycle of the human hair follicles 
takes years rather than weeks like in mice. Moreover, in mouse hair follicle growth cycling is 
continuously and hair follicles are highly synchronized for the first two cycles while in human 
hair follicle cycle independent of each other (Cotsarelis, 2006; Porter, 2003).  
 
1.2.2 The interfollicular epidermis 
Despite the fact that earliest studies of skin homeostasis were done in the mouse 
interfollicular epidermis (IFE), little is known about stem cells in the IFE. Lineage tracing 
revealed that there is a distinct reservoir of stem cells in the IFE, but after injury also bulge 
stem cells are able to contribute to the regeneration of the IFE (Ito et al., 2005; Levy et al., 
2005). However, also cells of the IFE contribute to the reepithelialized epidermis and bulge-
derived cells in the reepithelialized epidermis did not, or at least only very few cells, persist in 
the regenerated epidermis (Ito et al., 2005; Levy et al., 2005).  
 
Stem cells in the IFE are still difficult to identify. This is mainly because of the lack of 
definitive markers. Several studies suggested that 1-10% of the basal cells are stem cells 
(reviewed in (Kaur, 2006)). In mammals many adult stem cells are considered as rarely 
dividing or slowly cycling cells (Arai et al., 2004; Cotsarelis et al., 1990). Therefore, stem 
cells can be identified functionally as label-retaining cells (LRCs) (Bickenbach, 1981). This 
could be first shown in situ in the murine IFE; slow cycling cells were able to maintain a DNA 
label for prolonged periods (Bickenbach, 1981). Young mice were given a pulse with 
radioactive H3-thymidine or later with 5-bromo-20-deoxyuridine (BrdU), which is incorporated 
into their DNA during the high proliferation in this developmental phase of the epidermis. 
Subsequently, the chase period started and no label was administered for 4-6 weeks. During 
that time the DNA label is diluted in a proliferation-associated manner and only the 
infrequently dividing cells were able to keep the label over time (Bickenbach and Chism, 
1998; Cotsarelis et al., 1990; Morris and Potten, 1999). These slowly cycling cells were 
identified as LRCs and were shown to behave like clonogenic cells in vitro (Bickenbach, 
1981; Mackenzie and Bickenbach, 1982). Moreover, a higher colony forming ability for 
isolated LRCs of the mouse skin was demonstrated (Morris and Potten, 1994). Several 
studies could show that LRCs can be detected in the murine IFE and the hair follicle bulge 
(Bickenbach, 1981; Cotsarelis et al., 1990; Morris et al., 1985). There are hints that also in 
the human IFE heterogeneity in the proliferative activity can be found. Early studies showed, 
that there are differences in the colony forming potential of cultured keratinocytes isolated 
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from the skin. They can be divided in holoclones, which have a high proliferation potential, 
paraclones with differentiated colonies and meroclones with intermediate characteristics 
(Barrandon and Green, 1987). Importantly, clonal assays of cultured basal keratinocytes 
isolated from the human IFE showed that cells which had the highest self-renewal capacity in 
vitro were slow cycling in vivo (Jones et al., 1995). Since labeling methods cannot be applied 
to human skin, this approach was further developed in a human in vitro 3D- organotypic skin 
model (Muffler et al., 2008). Normal human keratinocytes are able to incorporate nucleotide 
analogues like iododesoxyuridine (IdU) and to be subsequently cultivated for long-term in 
OTCs. It was shown that LRCs could be identified in the epidermal basal layer in OTCs 
(Muffler et al., 2008) (Figure 3 A). However, using nucleotide analogues such as IdU, does 
not allow isolation of vital LRCs. This is hampered due to the necessary use of fixation 
methods to visualize the label. This problem could be bypassed by the generation of a 
tissue-specific Histone 2B-GFP (H2B-GFP)-fusion construct controlled by a tertracycline-
responsive regulatory element (Tet-Off) (Tumbar et al., 2004). Tumbar et al. engineered a 
transgenic mouse with an H2B-GFP tet-off controlled reporter under the control of a keratin 5 
(K5) promoter (Tumbar et al., 2004). In order to isolate and characterize LRCs from the 
mouse epidermis pulse-chase experiments were performed using Doxycycline (Dox) in the 
drinking water. After a chase period of 4 weeks, with the presence of Dox, <1% of the bulge 
cells could be detected as label-retaining cells (Tumbar et al., 2004).  
 
     
Figure 3: Detection of label-retaining cells (LRCs) in 3D organotypic cultures (OTCs). (A) Normal human 
keratinocytes after a pulse of 2 weeks with the nucleotide analogue IdU. All cells are labeled (in red). 
Figure from (Muffler et al., 2008)(B) LRCs could be detected in the basal layer of the epidermis after a 
chase period of 8 weeks (8w). Figure from (Muffler et al., 2008). (C) 3 week old OTC of HaCaT-ras II4 Tet-
Off-H2B-GFP cells under the absence of Dox. All cells remain GFP-positive (in green). Figure from 
(Falkowska-Hansen et al., 2010) (D) After a chase period of 3 weeks (3w) LRCs can be identified and 
localized in the basal layer. Figure from (Falkowska-Hansen et al., 2010). 
 
To apply this approach for human cells, a lentiviral-based vector harboring a bicistronic 
expression cassette was developed allowing transducing the whole regulatory Tet-Off-H2B-
A 
B
 
C 
D 
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GFP unit in a single step (Falkowska-Hansen et al., 2010). The vector was successfully 
introduced into human immortal and malignant keratinocytes (HaCaT and HaCaT-rasII4) by 
viral infection. 
 
Furthermore, it was shown that by using HaCaT-ras II4 Tet-Off-H2B-GFP cells on OTCs the 
H2B-GFP expression was sustained also under 3D conditions (Figure 3 C). Moreover, it was 
demonstrated that the cells remained responsive to Dox. The OTCs were cultivated for one 
week in the absence of Dox in the culture media, this allows the expression of GFP (pulse 
period). After the addition of Dox to the culture medium for the following weeks, the reporter 
is turned off and the H2B-GFP expression is declining in all proliferating cells and only slow-
cycling cells are able to keep the label (chase period) (Figure 3 D). These slowly cycling, 
H2B-GFP LRCs, could be successfully detected in the basal layer in OTCs of HaCaT-ras II4 
H2B-GFP cells (Falkowska-Hansen et al., 2010) (Figure 3 D).  
 
In the literature several markers for stem cells in the IFE are suggested. The expression of 
high levels of β1 integrin of human keratinocytes was one of the first marker characterized in 
vitro (Jones and Watt, 1993). These β1 integrinhigh expressing cells showed higher colony 
forming ability and better adherence to ECM proteins, like type IV collagen and fibronectin 
(Jones and Watt, 1993). Also in the human IFE in vivo β1 integrinhigh expressing 
keratinocytes could be detected at the tips of the dermal papilla from several body sites 
(Jensen et al., 1999). However, there are high numbers of integrin-bright basal cells, 
between 25– 50%, depending on body site (Jones et al., 1995). Therefore other markers 
need to be taken into account for the identification of stem cells. Another suggested marker, 
which was co-expressed with β1 integrinhigh, was the Notch ligand delta like 1 (DLL1) (Lowell 
et al., 2000). There was enhanced Delta1 expression above the dermal papillae. 
Interestingly, it was shown that if Delta1 was over-expressed in a population of keratinocytes, 
there was no change on the proportion of stem cells, but neighbouring keratinocytes were 
driven to entry into the transit amplifying compartment and to differentiate. Therefore Delta1 
expression of epidermal stem cells was suggested to block Notch signaling in order to 
prevent differentiation of themselves and to influence the fate of adjacent keratinocytes 
(Lowell et al., 2000). Another potential marker which is co-expressed with high levels of β1 
integrin was the melanoma chondroitin sulphate proteoglycan (MCSP). However, the 
combination of β1 integrinhigh and MCSP did not further increase the colony forming ability as 
with β1 integrinhigh alone. But the expression of MCSP was shown to be a marker for 
mitotically inactive cells and promoting cell-cell adhesion (Legg et al., 2003). On the basis of 
DLL1 and MCSP expression Watt et al. performed single-cell expression profiling of these 
cells. These studies suggested Lrig1 as potential stem cell marker, which is important for the 
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quiescent state of the stem cells. Over-expression of Lrig1 in keratinocytes showed a 
reduced capacity of proliferation, but did not influence the clonal growth capacity. It was 
suggested that Lrig1 acts through the downregulation of the EGF receptor responsiveness 
and a negative regulation of myc (Jensen and Watt, 2006). Lrig1 was also found to be 
expressed at the top of rete ridges which also express MCSP, DLL1 and β1 integrinhigh 
(Jensen and Watt, 2006). Further analysis on the basis of single cell expression 
discriminated by DLL1 expression suggested the transmembrane glycoprotein, CD46, as 
new epidermal stem cell marker (Tan et al., 2013). CD46 was also shown to colocalize with 
β1 integrin and restricted to basal keratinocytes in human skin (Tan et al., 2013). CD46 
knockdown experiments further showed a reduction in the growth rate and adhesiveness of 
these cells as well as an impaired spreading of the cells (Tan et al., 2013). Therefore CD46 
could increase the adhesion of the stem cells to basement membrane in the IFE (Tan et al., 
2013). Notably, single cell expression profiling of human keratinocytes did not always show 
an overlap of expression of DLL1, Lrig1, MCSP and β1 integrinhigh (Jensen and Watt, 2006). 
However, cells isolated on the basis of these markers had a greater colony forming efficiency 
in 2D (Tan et al., 2013). In addition, there are also other markers suggested for epidermal 
stem cells. Kaur et al. demonstrated that keratinocytes isolated from neonatal human and 
adult murine skin on the basis of high expression of α6 integrin and low expression of the 
transferring receptor CD71 represent a quiescent subpopulation (Li et al., 1998). 
Interestingly, cells with α6bri and CD71dim expression were detected at the bottom part of the 
rete ridges in human IFE. Thus these cells were located at the opposite site of the rete ridge 
as described for β1 integrinhigh expression (Muffler et al., 2008). Importantly, it was shown 
that α6bri and CD71dim expressing cells had the greatest intrinsic tissue-regenerative capacity 
when transplanted on de-epithelialized rat tracheas (Li et al., 2004; Schluter et al., 2011). 
Recently, also the Wnt inhibitor, WIF1, was reported as interfollicular stem cell marker and 
seems to inhibit cell cycle progression in the presence of Wnt ligands (Schluter et al., 2013). 
Moreover, LRCs in OTCs showed co-expression of WIF1 (Schluter et al., 2013). Taken 
together, a number of markers are described. It remains unclear which of these markers 
indeed refers to stem cells and accordingly where the stem cells are located within the IFE. 
Therefore, the obvious lack of a unifying model to describe the regulation of stem cells in the 
IFE underlines the need for further investigations in order to clarify the crucial parameters. 
 
1.3 Homeostasis of the skin 
Two different models have been proposed for epidermal regeneration. So far the prevailing 
model for epidermal maintenance was the hierarchical model. This model suggests that the 
tissue is organized in epidermal proliferative units (EPUs). These EPUs comprise a LRC, 
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which divides asymmetrically, giving rise to a new stem cell and a short-lived transit-
amplifying cell (TAC). The population of TACs leaves the basal layer after 4-6 cell cycles and 
pass through a differentiation program thereby generating columnar units (Potten, 1974). The 
number of cell divisions of TACs is thought to be limited due to an internal ‘‘memory’’ prior 
entering terminal differentiation (Potten, 1981; Strachan and Ghadially, 2008) (Figure 4 A). 
Nevertheless there are also data which are inconsistent with the hierarchical model. For 
instance, in various studies LRCs in the IFE could be detected rarely and not that often as 
expected by the hierarchical model (Allen and Potten, 1974; Braun et al., 2003; Potten, 
1974). Furthermore, up to now little is known about the contribution of LRCs to the 
homeostasis due to the lack of further characterization by transplantation assays. Therefore, 
in vivo lineage-tracing was chosen as a fundamental tool to investigate the fate of individual 
stem cell and its descendants. To mark a cell and its progeny inducible genetic labeling was 
applied (Alcolea and Jones, 2013; Clayton et al., 2007; Jones et al., 2007). These studies 
were interpreted that the basal cell layer of the IFE is composed of a single type of 
proliferative progenitors with random fate choice, termed as stochastic model (Figure 4 B). 
All basal cells can have three different outcomes with random choice upon cell division, 
either two differentiated daughters, two undifferentiated progenitors, which remain in the 
basal layer and continue to divide, or one of each (Clayton et al., 2007; Doupe et al., 2010; 
Lim et al., 2013) (Figure 4 B). Long-term homeostasis is ensured through balanced 
symmetrical cell divisions. Importantly, the stochastic model cannot exclude the existence of 
a LRC population, assuming that these stem cells make only minimal contribution to 
epidermal homeostasis and are mainly activated during epidermal wounding (Clayton et al., 
2007; Mascre et al., 2012).  
 
 
Figure 4: Two models for epidermal homeostasis. (A) In the hierarchical model the epidermis contains a 
stem cell which rarely divides and gives raise to the rapidly proliferating transit amplifying (TA) cells. 
They are believed to undergo a limited number of cell divisions before they terminal differentiate. (B) The 
stochastic model based on lineage tracing suggests that cycling basal keratinocytes can generate three 
different outcomes: both remain proliferating (in orange); both are differentiating (in purple) or one is 
differentiating and one remains proliferative.  Figure from (Hsu et al., 2014). 
A
 
B
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So far the stochastic model is only described in mouse skin (Clayton et al., 2007; Gomez et 
al., 2013; Lim et al., 2013; Mascre et al., 2012). Therefore, the question remains if also the 
human IFE is maintained by a single type of proliferating cells as suggested by the stochastic 
model. The situation could be different for the human IFE which has not only many more 
layers of keratinocytes, but also its basal layer is undulating and tightly connected with the 
dermis through rete ridges (RR) and dermal papillae (Kanitakis, 2002). Notably, there are 
also rete ridge-poor parts in human skin, like e.g. human breast skin. Moreover, the density 
of HF is greatly reduced making the IFE predominant in the human skin (Figure 5).  
 
 
Figure 5: Comparison of normal human and normal mouse skin. (A) Human epidermis is generally thicker 
and comprises 6–10 cell layers. Furthermore the IFE is predominant in human skin and contains less hair 
follicles. (No hair follicles are present in this image) (B) The mouse IFE has only three cell layers and has 
no rete ridges. Mouse epidermis contains only short interfollicular regions with much more hair follicles. 
Figure from (Gudjonsson and Elder, 2006).Scale bar: 100µm. 
 
1.4 Stem cell niche 
Studies on stem cells from diverse systems have shown that stem cells reside in a dynamic 
and specialized microenvironment often referred to as stem cell niche. The maintenance and 
survival of stem cells is controlled by extracellular cues from the surrounding 
microenvironment as well as by intrinsic genetic programs within the stem cell (Fuchs et al., 
2004; Jones and Wagers, 2008; Watt and Driskell, 2010). Obviously, epidermal stem cells 
need an appropriate environment and are dependent on a niche, since they are losing their 
“stemness” in culture and thus cannot be cultivated for long-term. Studies in OTCs also 
showed that without the supporting fibroblasts in the dermal part, long-term maintenance of 
the epithelium is not possible (Boehnke et al., 2007). There is growing evidence that 
especially the ECM may play an essential role in the stem cell niche, because it can directly 
or indirectly regulate the maintenance, proliferation, self-renewal and differentiation of cells 
(Lu et al., 2012). The expression of β1 integrinhigh expression, which is suggested as 
epidermal stem cell marker, (Jones et al., 1995; Jones and Watt, 1993; Webb et al., 2004) 
lead to a higher adhesiveness of stem cells to ECM proteins, e.g. fibronectin and type IV 
collagen (Jones et al., 1995). Integrins have also the ability to deliver signals into the cell or 
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from the cell to the ECM (Hynes, 2002) and can enhance the response to growth factors 
(Brizzi et al., 2012). In accordance with this, also HF bulge stem cells and mouse epidermal 
LRCs express higher levels of ECM genes, like different collagens, tenascin C and fibulin 1 
(Morris et al., 2004; Tumbar et al., 2004). The functional consequences of a distinct ECM 
protein expression are poorly understood. The ECM could not only serve as anchor for stem 
cells it could be important for the cell-cell communication and intrinsic regulatory 
mechanisms. For instance, reduction of Integrin expression drives the cells into 
differentiation (Grose et al., 2002; Watt, 2002). Furthermore, β1 integrin is essential for 
spindle orientation along with asymmetric cell division (Lechler and Fuchs, 2005).  
 
1.5 Studying epidermal stem cells 
For obvious ethical reasons human epidermal stem cell biology cannot be studied in vivo but 
requires appropriate in vitro experimental models. To investigate complex biological 
processes of the skin in vitro 3D organotypic culture systems were developed. Organotypic 
coculture systems are produced by seeding human keratinocytes onto a dermal equivalent 
which contains human fibroblasts. 3D organotypic cultures are also known as skin 
equivalents (Boehnke et al., 2007). The advantage of OTCs is the air exposed cultivation of 
the keratinocytes hence inducing the tissue specific differentiation process and the 
development of a terminal differentiated epithelium. First attempts of successful OTCs were 
described by Bell and colleagues (Bell et al., 1981). The dermal part, called dermal 
equivalent, can be prepared according to various principles. There are dermal equivalents 
made up of  e.g. collagen seeded with dermal fibroblasts (Bell et al., 1981; Fusenig et al., 
1980; Stark et al., 2004) or by de-epidermized dermis (DED) (Ponec et al., 1988; Prunieras 
et al., 1983). However one major drawback of skin equivalents based on e.g. type I collagen 
hydrogels is the early degeneration due to high shrinkage and decreased stability of the 
OTCs. These models are therefore not useful for long-term studies. To investigate epidermal 
stem cell biology, OTCs with an extended lifespan enabling long-term studies on skin 
regeneration and homeostasis are necessary. This was fulfilled by the development of DE´s 
which are reinforced with scaffold and colonized with human skin fibroblasts (Figure 6) (Stark 
et al., 2006; Stark et al., 2004). Also DEs based on a primary human fibroblast-derived 
dermal matrix are suitable for long-term studies. In this approach dermal equivalents are 
generated solely by fibroblasts.  
 
Since fibroblasts are able to synthesize, remodel and maintain all ECM components by 
themselves human fibroblasts were cultivated without any addition of collagen or a scaffold 
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and generate a complex extracellular matrix largely similar to the dermis in the human skin 
(Berning et al., 2015; El Ghalbzouri et al., 2009). 
 
 
Figure 6: Schematic illustration of a skin equivalent. The dermal equivalent is reinforced with a scaffold 
and suspended with fibroblasts. Keratinocytes are seeded on top and cultivated air-exposed. 
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1.6 Aim 
Despite more than 30 years of research on epidermal stem cells, stem cells in the human 
interfollicular epidermis have yet to be identified. This is mainly because of the lack of 
definitive markers. Stem cells play an essential role for maintaining homeostasis in the 
epidermis. Because stem cells rarely divide, they can be identified functionally as label-
retaining cells (LRCs). However, the role of LRCs for tissue homeostasis is still elusive. 
Therefore, there is a strong need to isolate and characterize LRCs from the human 
epidermis. 
 
Since investigations on human skin are very limited and LRC-detection with DNA labels 
cannot be applied to humans, pulse-chase experiments were further developed in a human 
in vitro 3D organotypic skin model (Muffler et al., 2008). Normal human keratinocytes are 
able to incorporate nucleotide analogues like IdU and can be subsequently cultivated in long-
term skin OTCs which mimics the human skin under controlled in vitro conditions. It was 
shown that LRCs could be identified in the epidermal basal layer of the epidermis (Muffler et 
al., 2008). However using nucleotide analogues such IdU, does not allow isolating vital 
LRCs. This is hampered due to the necessary use of fixation methods to visualize the label. 
 
To circumvent this problem and to detect viable LRCs in the epithelium, alternative methods 
were established. With the development of an inducible Tet-Off-H2B-GFP lentiviral reporter 
vector the detection and isolation of living label-retaining cells became possible (Tumbar et 
al., 2004). Falkowska-Hansen et al. were able to infect immortal and tumorigenic 
keratinocytes with an similar one-step vector system and to perform pulse-chase 
experiments to identify LRCs (Falkowska-Hansen et al., 2010). Up to now this approach was 
not used for human normal keratinocytes (NHEK) in order to detect LRCs. Therefore, the aim 
of this study was to establish the conditions to infect human adult keratinocytes with this 
H2B-GFP lentiviral vector, to perform pulse-chase experiments in long-term skin equivalents 
(OTCs) in order to generate and isolate label-retaining cells (LRCs). Moreover, the regulation 
of LRCs and new markers for the identification of LRCs, the potential stem cell, should be 
explored. In this respect the transcriptional analysis from isolated LRCs would promise 
deeper insight into their regulation and functionality. 
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2 Material and Methods 
2.1 Material 
2.1.1 Cells 
Normal human keratinocytes and dermal fibroblasts 
  
Primary keratinocytes and primary fibroblasts were routinely isolated in our laboratory from 
explant cultures of human skin. In this thesis keratinocytes from three different donors and 
fibroblasts from one donor were used. The internal name of the keratinocytes and fibroblasts 
is the date of isolation (Table1). The skin samples were kindly provided by Dr. Doebler 
(ATOS Klinik, Heidelberg) and the women's Hospital in Tübingen with the consent of the 
Ethics Committee. 
 
      
internal name age gender area 
Fib1 04.04.07 23 years female n/s 
KH1 04.04.07 23 years female n/s 
KH17.04.07 43 years female breast 
KH19.04.12 49 years female breast 
Table 1: Normal human keratinocytes (KH) and fibroblasts from primary human explants. 
 
HEK293T cells 
 
HEK293T cells were kindly provided by the group of Dr. Jörg Hoheisel. 
 
 
2.1.2 Cell culture supplements and media 
Cell culture supplements 
Article  Supplier  
Adenine  Sigma Aldrich, Steinheim, Germany  
Aprotinin (Trasylol®) (1000 I./E./ml)  Bayer Vital, Leverkusen, Germany 
Ascorbic acid stock: 50 mg/ml  
fdmSE medium: 50 μg/ml  
Sigma-Aldrich, Taufkirchen, 
Germany  
Choleratoxin Sigma Aldrich, Steinheim, Germany  
DermaLife LifeLine, CA, USA 
DMEM (Dulbecco´s Modified Eagle´s Medium)  Cambrex (Lonza), Verviers, Belgium  
EDTA (Ethylenediaminetetraactetate)  
(0.05% (w/v)) in PBS+ 1 μl/ml phenolred  
Serva Electrophoresis GmbH, 
Heidelberg, Germany  
EGF (Epidermal growth factor) 1 ng/ml, Sero-med, Wien, Austria  
F12 Cambrex (Lonza), Verviers, Belgium  
FCS (Fetal calf serum)  Invitrogen Gibco, Darmstadt, 
Germany  
FGF (Fibroblast growth factor) Invitrogen Gibco, Darmstadt, 
Germany  
Glycerol  Carl Roth, Karlsruhe, Germany  
Hydrocortisone Sigma Aldrich, Steinheim, Germany  
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Penicillin / Streptomycin (10U/ml; 10μg/ml)  Biochrom, Berlin, Germany  
Penicillin / Streptomycin / Amphotericin Cambrex (Lonza), Verviers, Belgium  
rhInsulin Sigma Aldrich, Steinheim, Germany  
TGF-β1 human recombinant  
10 μg/ml dissolved in 4mM HCl with 1mg/ml BSA, 
OTC medium: 1 ng/ml  
R&D Systems, Minneapolis, USA, 
240-B/CF  
Thrombin S lyophilized 10 I.E./ml in PBS + CaCl2 
(5,88 mg/ml)  
Baxter, Unterschleißheim, Germany  
Tissucol Fibrinogen 1.0 lyophilized, thermo inactivated Baxter, Unterschleißheim, Germany 
Trypsin 0.4% + 0.1% in PBS/1 μl/ml Phenolred  Roche Biochemica, Mannheim, 
Germany  
 
Cell culture media 
Article  Ingredients  
D10  DMEM + 10% FCS + 1% Penicillin (10U/ml)/Streptavidin (10μg/ml)  
FADcomplete 1:1 DMEM / F12, 5 % FCS, 1 % Pen / Strep,  
5mg / L Insulin, 10-10M Choleratoxin, 1μg / L rhEGF, 24μg / L Adenin, 0.4μg 
/ mL Hydrocortison  
fdm OTCs 
Medium 
1:1 DMEM / F12, 10 % FCS, 1 % Pen / Strep / Amph., 200 µg / mL Asc. 
Acid, 1 µg / mL TGFβ, 2.5 ng / mL EGF, 5 ng / mL  FGF, 5 µg / mL 
rhInsulin 
Sca OTC 
Medium 
1:1 DMEM / F12, 10 % FCS, 1 % Pen / Strep / Amph., 200 µg / mL Asc. 
Acid, 10-10M Choleratoxin, 1μg/l rhEGF, 250U/ml Aprotinin  
Freezing 
Medium  
DMEM containing 20% FCS and 10% (v/v) Glycerol  
rFAD 1:1 DMEM / F12, 10 % FCS, 1 % Pen / Strep, 200 µg / mL Asc. Acid, 0.4 
µg / mL Hydrocort., 10-10 M Choleratoxin 
Trypsin / 
EDTA  
0.05%Trypsin/ 0.025% (w/v) EDTA in PBS with Phenolred  
 
2.1.3 Antibodies, kits and primer 
Primary antibodies 
Epitope Species Dilution Supplier / Order no. 
Collagen VII rabbit 1:5000 L.Bruckner-Tudermann, Freiburg, 
Deutschland 
Decorin rabbit 1:200 H. Kresse,Münster 
Desmoglein 1+2  mouse 1:10 Progen 61002 
E-cadherin mouse 1:20 Progen 10028 
Fibronectin rabbit 1:200 Telios 
Filaggrin Mouse  1:100 Acris FLG01  
Involucrin Mouse 1:100 Sigma I9018 
Keratin 10 Mouse monoclonal 1:10 Progen 11414 
Keratin 14 mouse 1:100 Abcam 7800 
Ki67 Mouse monoclonal 1:20 Dako M724029-2 
Ki67 rabbit 1:400 Abcam 15580 
Integrin α6 rat 1:500 Progen 10709 
Integrin α6 mouse monoclonal 1:20 Millipore CBL458 
Integrin α6  
PE conjugated 
monoclonal 1:100 Millipore CBL458P 
phospho-Smad3  rabbit monoclonal 1:100 Abcam 52903 
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Thrombospondin mouse 1:20 Immunotech,Marseille,France 
0148 
Vimentin guinea pig 1:100 Progen GP53 
 
Secondary antibodies 
Host species Reactive species Conjugated with Dilution Supplier / Order no. 
donkey rabbit DyLight488 1:500 Invitrogen A21206 
goat rabbit Cy3 1:500 Jackson 111-165-003 
goat mouse Alexa488 1:500 Invitrogen A11029 
goat mouse Cy3 1:500 Jackson 115-165-068 
goat rat Alexa488 1:500 Jackson 112-545-003 
donkey guinea pig Cy3 1:500 Dianova 706166148 
 
Kits 
Kits Supplier  
Färbekit Hämatoxylin & Eosin (H&E) Morphisto, Frankfurt, Deutschland  
Mycoplasma Detection Kit Sigma-Aldrich, Taufkirchen, Germany  
QIAshredder Qiagen, Hilden, Germany 
RNA Isolation Kit ARCTURUS Pico Pure Lifetechnologies, Darmstadt, Germany 
RNase-free DNase Set Qiagen, Hilden, Germany 
RNeasy Mini Kit Qiagen, Hilden, Germany  
 
Primer 
Gene  
 
Primersequenz 
(left)  
 
Primersequenz  
(right) 
COL1A1 gaagagaaggccccgttg cggtagcctttaggtccgata 
Decorin gggctggcagagcataagta cctttttggtgttgtgtcca 
Fibronectin gaactatgatgccgaccagaa ggttgtgcagatttcctcgt 
Fibulin 1 gctggaggagctgcactg tccccagcagacagcaat 
Fibulin 2 caggtggcctctaacaccat gcttgcagggtccattgt 
GAPDH agccacatcgctcagacac gcccaatacgaccaaatcc 
HIST14H4 aggctggagtcgttggtg actttggtcctgcttcttgg 
HIST1H2BG cagtttggctaacgtggttaaa ccgagtctctgggatgacac 
IGFBP4 gagatcgaggccatccag cgaattttggcgaagtgc 
IL6 ccagagctgtgcagatgagt ctgcagccactggttctgt 
Keratin 14 cctctcctcctcccagttct atcgtgcacatccatgacc 
Lumican gaaagcagtgtcaagacagtaagg ggccactggtaccaccaa 
P21 aggtccccctggaaagaa catctgatccagggtttcca 
Smad3 gtctgcaagatcccaccag agccctggttgaccgact 
Smad7 cgatggattttctcaaaccaa aggggccagataattcgttc 
Snai2 tggttgcttcaaggacacat gcaaatgctctgttgcagtg 
Tenascin C  ggaatacacactgagaatctttgc aagtctcttggagaatcgaggtc 
TGFβ gcagcacgtggagctgta cagccggttgctgaggta 
TGFβR1 ctgctcctcctcgtgctg ggtggcagaaacactgtaacg 
TGFβR2 tggtgctctgggaaatgac caccttggaaccaaatggag 
TGFβR3 cagatggatgccagcaca tgatgttgtgtccttgctttg 
THBS1 gctccggtacacacagcaa agggtcagagatcagctaggc 
TIMP2 gaagagcctgaaccacaggt cggggaggagatgtagcac 
Vimentin aaagtgtggctgccaagaac agcctcagagaggtcagcaa 
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2.1.4 Technical equipment and consumables 
Name Supplier  
CASY® cell counter with TTC analysis 
system 
Schärfe System, Reutlingen, Germany  
Cell culture incubator HeraCell 240 and 240i ThermoScientific, Schwerte, Germany 
Cell Freezing machine Kryo 10 Series III Planer, Sunbry-on-thames, UK 
Centrifuge 5417 R (for Eppendorf tubes)  Eppendorf, Wesseling-Berzdorf, Germany  
Centrifuge Heraeus Laborfuge 400  Thermo Scientific, Fermont, USA  
Cryo boxes  Nunc, Wiesbaden, Germany  
Cryostat CM3050S Cryotome  Leica, Wetzlar, Germany  
Digital Timer, Neolab 2-2002 neoLab, Heidelberg, Germany 
Dispensette  Brand, Wertheim, Germany 
ELISA Reader Multiskan FC Thermo Scientific, Schwerte, Germany 
Foreceps Dumont Dumont, Montignez, Switzerland 
Gammacell 1000 (137Cs) Atomic Energy of Canada Limited, Ontario, 
Canada 
Gasprofi 1 micro WLD-Tec neoLab, Heidelberg, Germany 
Laboratory Scale Delta Range PC440 Mettler-Toledo, Gießen, Germany 
Lab pipettes, Gilson Pipetman, 10-1000µL Gilson, Mannheim, Germany 
Light Cycler 480 II Roche Mannheim, Germany 
Liquid nitrogen dewar KGW Isotherm, Karlsruhe, Germany 
Micro scales Sartorius, Göttingen, Germany 
Microscope AX-70 (fluorescence) 
F-View II CCD-camera 
Olympus, Hamburg, Germany  
Microscope IX-70 (cell culture)  
AxioCam ERc 5s 
Olympus, Hamburg, Germany 
Microscope BX-51 (Histology) 
Color-View I camera 
Olympus, Hamburg, Germany 
Minifuge RF Heraeus Intruments, Osterode, Germany 
Microcentrifuge II, GMC-060 Daihan Labtech, Corea 
NanoDrop 1000 Thermo Scientific, Dreieich, Germany 
Nitrogen tank CHRONOS Messer, Griesheim, Germany 
PCR machine DNA Engine Dyad Peltier 
Thermal Cycler 
BioRad, Munich, Germany 
pH Meter ph522 WTW, Weinheim, Germany 
Pipetboy acu IBS Integra Biosciences, Zizers, Switzerland 
Pipetboy Comfort IBS Integra Biosciences, Zizers, Switzerland 
Pipettes mline Biohit, Göttingen, Germany 
Serological pipettes Stripette, 10-50ml Corning, Amsterdam, Netherlands 
Shaker KS250 basic IKA Labortechnik, Staufen, Germany 
Sliding microtome Leica SM2010 R Leica Biosystems, Nussloch, Germany 
Sterile tissue culture hood, HeraSafe HS18 Heraeus Instruments, Hanau, Germany 
Thermomixer 5436 Eppendorf, Hamburg, Germany 
Tissue-Tek TEC Tissue Embedding Console Sakura Finetek, Zoeterwoude, Netherlands 
Tissue-Tek VIP 5 Jr. Vacuum Infiltration 
Processor 
Sakura Finetek, Zoeterwoude, Netherlands 
Vacuboy and VACUSAFE system Integra Biosciences, Fernwald, Germany 
Vortexer REAX 200 Heidolph Instruments, Schwabach, Germany 
Water bath Köttermann, Hänigsen, Germany 
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Consumables 
Consumables Supplier 
6-well deep-well plates BioCoatTM  
(Scaffold -OTCs)  
BD Biosciences, Heidelberg, Germany 
6-well Falcon inserts 0.4µm, translucent, 
High pore density 
BD Biosciences, Heidelberg, Germany 
12-well deep-well ThinCert-plates  
(fdm OTCs) 
Greiner Bio-One,Frickenhausen, Germany 
12-well ThinCert 0.4µm, translucent Greiner Bio-One,Frickenhausen, Germany 
Cell culture dishes and plates, various sizes BD Biosciences, Heidelberg, Germany  
Cell culture tubes CELLSTAR 15ml-50ml Greiner Bio-One, Frickenhausen, Germany 
Cell Strainer 40 and 70µm BD Bioscience, Heidelberg, Germany 
Cover glasses, various sizes Menzel, Braunschweig, Germany 
Cryomold, various sizes Sakura Tissue-Tek, Zoertewonde, 
Netherlands 
Cryo tube TM Vials  Nunc, Wiesbaden, Germany  
Filter tips, various volumina Nerbe-Plus, Winsen/Luhe, Germany 
Filter tips, Tip-One, various volumina Starlab, Hamburg, Germany 
Immersion Oil Immersol 518N  Zeiss, Jena, Germany 
Liquid Blocker Pen Daido, Sangyo, Tokyo, Japan 
Microscope slides (Histobond®)  Marienfeld, Lauda-Königshofen, Germany  
Microscope slides (uncoated)  Langenbrinck, Teningen, Germany  
Object glasses  (76x26mm) Menzel, Braunschweig, Germany 
Parafilm M Bemis Plastic Packaging, Neenah, USA 
Paraffin Vogel, Gießen, Germany 
PCR tube, 0.5ml Eppendorf, Hamburg, Germany 
Pipette tips, various sizes Starlab, Hamburg, Germany 
quadriPERM dishes Greiner Bio-One, Frickenhausen, Germany 
Safe-Lock tubes, 1.5ml Eppendorf, Hamburg, Germany  
Superfrost Plus slides Menzel, Braunschweig, Germany 
Syringe Luer Lock tip (5, 10, 30, 50ml) Terumo, Leuven, Belgium 
 
2.1.5 Buffer, solutions, chemicals and enzymes 
Buffer and Turnkey Solutions 
Buffer Ingredients 
Antibodybuffer 3% BSA/PBS- 
Blockingbuffer (IIF and FACS) 3% BSA/PBS- 
FACS Buffer 2%FCS/PBS- 
Turnkey Solutions Company 
Aquaguard-1 and -2 PromoCell, Heidelberg, Germany 
CASY® clean Innovatis AG, Reutlingen, Germany 
CASY® ton Innovatis AG, Reutlingen, Germany 
Dako Fluorescent Mounting Medium DAKO, Glostrup, Denmark 
dNTPs Fermentas, St. Leon-Rot, Germany 
Eukitt® O.Kindler, FREIBURG, Germany 
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Chemicals 
Name Supplier 
2-Propanol Sigma Aldrich, Steinheim, Germany 
Acetone Sigma Aldrich, Steinheim, Germany 
ß-mercaptoethanol Sigma Aldrich, Steinheim, Germany 
DAPI Sigma Aldrich, Steinheim, Germany 
Ethanol, absolute Sigma Aldrich, Steinheim, Germany 
Ethanol, denaturated Berkel AHK Alkoholhandel, Berlin, Germany 
Formaldehyde solution wt. 37% Sigma Aldrich, Steinheim, Germany 
Glycerol Carl Roth, Karlsruhe, Germany 
Hematoxylin/Eosin (H/E)  Carl Roth, Karlsruhe, Germany  
Methanol Sigma Aldrich, Steinheim, Germany 
Normal goat serum Dianova, Hamburg, Germany 
Nuclease free water Qiagen, Hilden Germany 
PBS (Phosphate Buffered Saline)  Serva Electrophoresis, Heidelberg, Germany  
PBS+ (PBS with MgCl2, CaCl2)  Serva Electrophoresis, Heidelberg, Germany  
Polybrene Santa Cruz, Heidelberg, Germany 
Polyethylenimine Polysciences, Eppelheim, Germany 
Sodium butyrate Sigma Aldrich, Steinheim, Germany 
SYBR®Green  Invitrogen, Karlsruhe, Germany  
Triton®X-100 Sigma Aldrich, Steinheim, Germany 
 
Enzymes 
Name Company 
DNA Polymerase I Invitrogen, Karlsruhe, Germany 
Reverse transcriptase Quiagen, Hilden, Germany 
Hot Start Taq Polymerase,Fermentas St.Leon-Rot, Germany 
RNase Roche Applied Sciences, Mannheim, 
Germany 
DNase Roche Applied Sciences, Mannheim, 
Germany 
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2.1.6 Software 
Software 
Article  Company  
Adobe CS5  Adobe Systems Incorporated  
AxioVision Version 40V 4.8  Carl Zeiss Micro Imaging, Göttingen, 
Deutschland  
Cell^D, Cell^F  Olympus, Hamburg, Deutschland  
Chipster Version 3.1.1 Sourceforge.net  
GraphPad Prism V 4.0 Statcon, Witzenhausen, Germany 
ImageJ Version 1.4  Wayne Rasband, National Institute of Health, 
USA  
Ingenuity IPA  Qiagen, Redwood, USA 
LightCycler® 480 1.5.0. SP4 Roche Applied Sciences, Mannheim, 
Deutschland  
Microsoft Excel 2010  Microsoft Corp., USA  
Microsoft Power Point 2010  Microsoft Corp., USA  
GraphPad Prism Version 4.0  Statcon, Witzenhausen, Deutschland  
GenomeStudio  Illumina, Inc., San Diego, USA  
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2.2 Methods 
2.2.1 Cellculture methods 
2.2.1.1 Cultivation and maintenance of human fibroblasts 
The cultivation of human dermal fibroblasts was in Dulbecco's modified Eagle's medium 
(DMEM) with 10% FCS and 1% Penicillin/Streptavidin (D10). The medium was exchanged 
three times per weeks. The cells were split at confluency (approx. every 10 days). For 
passaging the cells the medium was removed, the culture dish was rinsed with 5ml EDTA 
(0.05%) and incubated for 3 min with 0.1 % Trypsin / EDTA at 37°C. Finally to stop the 
trypsin-activity 2 volumes D10 was added to the cell suspension. Subsequently the cell 
suspension was counted with the CASY®-cell counter. The cells were seeded at a density of 
6400 - 9500 cells per cm2.  
 
2.2.1.2 Feeder cells for the cocultivation with keratinocytes 
To prepare feeder cells human dermal fibroblasts were cultivated and after trypsinization 
irradiated with 55Gy (Gammacell 1000). In this way they are mitotically inactivated and 
overgrowth of the fibroblasts is prevented. However the irradiated fibroblasts still have 
growth-promoting activity through the secretion of factors for keratinocytes. Feeder cells 
were seeded in FAD medium at a density of 3200 cells per cm2. For optimal medium 
precondition keratinocytes were seeded earliest 24 hours after preparation of the feeder 
cells. 
 
2.2.1.3 Isolation, cultivation and maintenance of human keratinocytes 
Human adult keratinocytes were obtained from human skin biopsies. The biopsies were 
placed for 30 min in an antiseptic Betaisodona solution and then washed with PBS+. The 
epidermis is separated from the dermis by incubating the minced skin biopsie (0,5cm thick 
and 4cm long) in 0,5mg/ml Thermolysin over night at 4°C. To achieve a single cell 
suspension the epidermis was subsequently incubated in a 0.8% trypsin-EDTA mixture for 
10 min at 37°C and then separated with the help of active pipetting. The reaction was 
stopped with FAD medium (2x times) before the cell suspension was filtered through a 70µm 
cell strainer. The cell strainer was washed several times with medium. Cells were counted 
with the CASY®-cell counter and seeded on feeder culture dishes (35000cells/cm2). The 
keratinocytes were trypsinized and frozen in freezing medium at 80% confluency (2x106 
cells/ml per tube, passage 1). After thawing keratinocytes were cultivated in tissue culture-
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treated dishes either with feeder cells and FAD medium or without feeder cells in DermaLife 
medium. Keratinocytes were grown up to 80% confluency and then trypsinized. The cells 
were washed in EDTA (0.05%) followed by the incubation with EDTA (0.05%) for 3 min at 
37°C. Feeder cells were detached by washing the plate with the preincubated EDTA solution, 
while the keratinocytes remain sticking on the culture dish. Subsequently the dish with EDTA 
was incubated for another 7 min at 37°C. In contrast to keratinocytes cultivated with feeder 
cells, the incubation step with EDTA to lose cell-cell contacts by the binding of calcium ions 
was not necessary when cultivating keratinocytes in DermaLife medium, since the medium 
contains low amounts of calcium and the cells are not tightly connected. To detach the 
keratinocytes the culture dish was incubated for 3 min with 0.4 % Trypsin / EDTA at 37°C. 
The separation of the cells was achieved by active pipetting. For the inhibition of trypsin twice 
the amount of FCS-containing medium was added. Cells were counted with the CASY®-cell 
counter. Confluency and appearance of the cells was determined with a phase contrast 
Olympus IX70 Inverted Microscope. Images were taken using an Axiocam ERc 5s (Zeiss) 
and computer processed using AxioVision (Zeiss MicroImaging).  
 
2.2.1.4 Stimulation of cells with TGFβ-1 
NHEKs were seeded in low-calcium medium (DermaLife) in a 6cm petridish. After 24h the 
medium was changed and the stimulation started with TGFβ. Therefore, the cells were 
supplied with DermaLife medium with 10pg/ml – 10ng/ml TGFβ-1. Samples were taken after 
8 h, 24hrs, 48hrs, 3 d and 4d and the medium was replaced every 48h. As controls served 
unstimulated cells harvested at the same time points. 
 
2.2.1.5 Treatment of cells with Y-27632 
NHEKs were seeded either in low-calcium medium (DermaLife) or in calcium-containing FAD 
medium with 5% FCS and feeder fibroblasts in a 10cm petridish. NHEKs were supplied with 
medium containing 10µM Y-27632. Keratinocytes were grown up to 80% confluency and 
then seeded into a new dish.  
 
2.2.1.6 Proliferation Assay 
To examine the proliferation kinetics of keratinocytes proliferation assays were performed. 
The different treated cells were seeded on 24 well plate at a density of 2x104 per well, then 
cultivated for 12 h until the first plate for the standard curve was harvested. Therefore the 
medium was removed and washed with PBS before stored at -20°C. The plates were 
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harvested 48 h, 72 h, 96 h. Every group was analysed in octuplicates. To measure the 
proliferation of the cells at each time point the DNA of the cells was stained. Therefore a lyse 
buffer (PBS + 0,1% TritonX-100) with SyBr-Green (1:2500) was prepared and 1ml was 
added into each well and incubated for 1 hour (in the dark at RT). The measurement was 
done with the Ascent 2.4 Flouroscan with the filter 485-538nm. The total cell number was 
calculated using the standard plate as reference, where a given fluorescent intensity is 
correlated with a defined cell number. To determine the proliferation rate in OTCs 
cryosections of the OTCs were stained with Ki67, a cellular marker for proliferation (staining 
protocol see 2.2.4.1.). For each sample, five representative images were captured with 20x 
magnification. The total cell number of basal cells and the number of Ki67-positive cells was 
determined. The result was expressed as mean ratio in percentage. 
 
2.2.1.7 Freezing and thawing of cells 
In order to prepare frozen cell stocks the cells are frozen in liquid nitrogen. After 
trypsinization the cells were counted with the CASY®-cell counter and then centrifuged for 
5min at 1000rpm. The cell pellet was resuspended in freezing medium with a final cell 
concentration of 2x106 cells per ml. The cryotubes were filled with 1ml of the cell suspension 
and after 30 min incubation at RT, placed in isopropanol filled cryoboxes and incubated for 
1h at 4°C. This ensures a slow and gentle cooling process. Subsequently the cryoboxes 
were transferred to a -80°C freezer over night before they were long term stored in liquid 
nitrogen. For thawing a new cell stock, the cryotube was taken out of the liquid nitrogen and 
thawed in the water bath at 37°C. The thawed cell pellet was either resuspended in 5 ml of 
fresh medium (D10, FAD or DermaLife) and then transferred into a culture dish containing 
pre-warmed medium or directly transferred into the culture dish. The medium was exchanged 
one day after thawing. 
 
2.2.1.8 Mycoplasmtest 
For the rapid and reliable detection of mycoplasma a highly-sensitive PCR technology, the 
mycoplasma Detection Kit Venor®GeM, was used. For the detection of mycoplasma 1ml of 
the cell culture medium was taken. After a centrifugation step for 6 min with 12000rpm 900µL 
of the supernatant was removed. 100µl of the sample supernatant was incubated at 95°C for 
10 min, followed by a briefly centrifugation for a few seconds to remove cellular debris. Per 
sample which was testet 2µL of the sample supernatant was added to the PCR reaction 
tube. The PCR was performed according to manufacturer’s instructions. The PCR products 
were separated by electrophoresis in a 1,5% standard agarose gel. To visualise the DNA 
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fragments SYBR® Safe DNA Gel Stain was added. If the sample is positive for mycoplasma 
a distinct 265-278 bp band appeared. All cells used were regularly tested for mycoplasma. 
 
 
2.2.1.9 Cell pellets  
For the isolation of RNA the cells were trypsinized and then centrifuged for 5 min at 
1000rpm. The cell pellet was resupended in 1ml PBS- and transferred into a 1.5ml 
Eppendorf tube. After another centrifugation step at 1000rpm for 5 min the supernatant was 
removed and the pellet was frozen in liquid nitrogen and stored at -80°C.   
 
2.2.1.10 Scaffold Based Long Term Organotypic cocultures (sca OTCs) 
For scaffold based dermal equivalents 6 well plates with cell culture inserts (0.4µm pore size, 
high pore density) were used. As scaffold served M3 saffold with a diameter of 21cm which 
was placed into the cell culture filter. To produce the DE fibroblasts were trypsinized and 
1x106 cells were used per DE. The fibroblasts were resuspended in FCS and the same 
amount of thrombin solution (10I.E./ml) was added. Subsequently 850µL of the 
thrombin/fibroblast mixture was seeded on top of the scaffold. Then 850µL of 
fibrinogen/PBS+ (1:1) was added to the thrombin/fibroblast solution and carefully mixed. The 
final concentration of fibrinogen was 2mg/ml and 2,5 I.E./ml Thrombin. For Polymerisation 
the DEs were placed to the incubator (5%CO2, 37°C) for 30 min.  Finally D10 medium 
containing ascorbic acid phosphate (1:1500) and 1ng/ml recombinant human TGF-β1 was 
added to the bottom well and on top of the DE. The DEs were cultivated for 4-7 days. Before 
the keratinocytes were seeded sterile glass rings were placed on top of the DEs and cultures 
were transferred into 6 well deep well plates. Additionally the medium was shifted to rFAD 
with ascorbic acid phosphate (1:1500) and aprotinin (Trasylol, 1:20). The keratinocytes were 
trypsinized as described and 1x106 cells per culture in 1ml were seeded inside the ring on 
top of the DE. The cultures were kept submers for 48 hours until the rings were removed with 
sterile forceps and the air exposed cultivation started (day 1 of the cultures). The cultures 
were supplied with rFAD with ascorbic acid phosphate (1:1500) and a reduced aprotinin 
concentration (1:40). The medium was changed three times per week. For pulse-chase 
experiments Doxycycline (Dox, 1ng/ml, 1: 1000) was added to the culture medium after 14 
days of cultivation for another 6-11weeks. Subsequently, the cultures were harvested or 
single- cell suspension of the OTCs was performed. 
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2.2.1.11 Fibroblast-derived matrix Organotypic cocultures (fdm OTCs) 
Cell dervived matrices DEs were also prepared in 6 well or 12 well deep well plates with cell 
culture inserts (0.4µm pore size, high pore density). To achieve a cell derived matrices 
fibroblast are seeded multiple times and cultivated for 4 weeks in fdmDE medium (see 2.1.2). 
During this precultivation fibroblasts can synthesize, remodel and maintain ECM components 
and thereby create a cell derived matrix DE. First, fibroblasts are trypsinized as described 
and seeded with a density of 0,5x106 cells (for 12 well cultures) or 1,5x106 cells (for 6 well 
cultures) in one ml per insert. Multiple seeding occurred within one week, in total three times. 
Each insert has a final amount of 1,5x106 (12 well plate) or 6x106 (6 well plate) of fibroblasts. 
After the precultivation period in fdmDE medium (see 2.1.2) keratinocytes are seeded on top 
of the DEs. Therefore keratinocytes are trypsinized as describes above and the cell pellet 
with 0,25x106 (12 well plate) or 1 x106 (6 well plate) is resuspended in 1ml of rFAD with 
ascorbic acid phosphate (AscP, 1:1500). The cultivation is without aprotinin, since the cell 
derived matrix prevents the invasion of the keratinocytes. The medium of the cmd DEs is 
shiftet directly before seeding of the keratinocytes. The skin equivalents are cultivated in 
rFAD with AscP (1:1500). Pulse-chase experiments were performed as described in 2.2.1.9. 
 
2.2.1.12 Single cell suspensions of OTCs 
To obtain a single cell suspension of the OTCs first the epidermis needed to be separated 
from the dermis. Therefore each culture was cut into small pieces and incubated with a 
freshly prepared Disapse II solution (1mg/ml) for 2 hours at 37°C. Subsequently the 
epidermis was peeled of the dermis with the help of sterile tweezers. The epidermis was cut 
into smaller pieces and transferred into a 50ml Falcon tube with prewarmed 0.4 % Trypsin / 
EDTA solution. The Falcon was incubated for 3 min at 37°C. To separate the cells properly 
active trypsination by pipetting the solution and chipping the Falcon was necessary. To stop 
the trypsin activity twice of the amount of D10 Medium was added to the cell/trypsin 
suspension and filtered through a 70µL cell strainer into a new 50ml Falcon tube. After 
washing the filter, the cell suspension was counted with the CASY®-cell counter. 
 
2.2.1.13 FACS Analysis or Sorting  
For FACS analysis the single cell suspensions of the OTCs (see 2.2.1.11) or cell 
suspensions of cell from culture dishes (for trypsination see 2.2.1.3) were spun down for 5 
min at 1000rpm and resuspended in 1ml of PBS (up to 10x106 cells/1ml) and then analysed. 
For FACS sorting the cells were resuspended in 500µL blocking solution (PBS with 3% BSA) 
and incubated for 15 min on ice, followed by the incubation of the conjugated antibody for 30 
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min on ice. Finally the suspension was centrifuged for 5 min at 1000rpm and the pellet was 
resuspended in 1ml FACS Buffer (PBS with 0,5% FCS). All samples were analyzed by flow 
cytometry (FACSCalibur) and FlowJo Software. For FACS sorting the samples were sorted 
by the FACS Core Facility of the Universitätsklinikum Heidelberg. The sorting was performed 
by the BD FACSAria™ III cell sorter. Cell suspension was mixed with 1 μL 7AAD or 
Propidium iodide (PI) for live staining of the cells. The cells were collected in 15ml Falcon 
tubes (up to 5x106 cells) or in a 1.5ml Eppendorf tube (for small samples, below 5x104 cells).  
 
2.2.1.14 Isolation of LRCs 
To isolate LRCs from OTCs the single cell suspension of the OTCs (see 2.2.11) was counted 
with the Casy cell counter and centrifuged for 5min at 1000rpm. The cells were resuspended 
in 500µL blocking solution (PBS with 3% BSA) and incubated for 15 min on ice, followed by 
the incubation with an anti-CD49f Phycoerythrin (PE) conjugated Antibody, clone 4F10 
(Millipore), for 30 min on ice. Finally the suspension was centrifuged for 5 min at 1000rpm 
and the pellet was resuspended in 1ml FACS Buffer (PBS with 0,5% FCS). LRCs were 
sorted for PE (α6 integrin) and GFP- positive cells. Basal cells were sorted for PE (α6 
integrin) positive and GFP- negative cells. Suprabasal cells were sorted for PE (α6 integrin) 
negative and GFP- negative cells. 
 
2.2.2 Processing of tissue 
2.2.2.1 Preservation of OTCs 
To further analyse the OTCs one half of the cultures was analysed histologically and the 
other half was analysed with immunofluorescence stainings. For the histological analysis the 
OTCs were fixed for at least 24h in a ready to use solution “special fixative for anatomy and 
histology” (Mephisto). Afterwards the OTCs were dehydrated in increasing concentrations of 
ethanol (70, 80, 90 and 96%) and then transferred into xylene. Finally the cultures were 
embedded in paraffin wax and stored at room temperature. The paraffin embedded samples 
were cut with a sledge microtome with a thickness of 4µm. 
For immunofluorescence analysis the cultures were embedded in Tissue Tek and frozen in 
the gas phase of liquid nitrogen.  Frozen tissue sections with a thickness of 6-8µm were 
made by using a Cryotome. The sections were stored at -20°C. 
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2.2.2.2 Cells on cytospins 
From single cell suspension or trypsinized cells cytospins were prepared. A cell number up to 
30.000 cells per Cytospin was taken up in 100 μL of medium and transferred into a cytospin 
funnel. The samples were centrifuged at 1.200 rpm for 5 minutes to attach the cells through a 
cytofunnel to a glass slide. The glass slides can be then processed for IIF. 
2.2.3 Tet-Off-H2B-GFP reporter 
2.2.3.1 Bacterial transformation and plasmid purification 
To produce competent bacteria 3ml of LB media were inoculated with 30µL of the bacteria 
HB101 and grew overnight at 37oC in a roller drum. The next day 500µL of the overnight 
culture were inoculated into a sterile Erlenmeyer flask containing 50ml of fresh LB medium. 
The culture was placed on a shaker and after 2 hours the cell density reached mid-log 
growth phase. The growth rate of the culture was determined by taking 1ml of the cultures 
and reading the optical density at 550 nm wavelength using a spectrophotometer. The 
optimal OD550 is 0.5. The cell suspension was centrifuged at 5000rpm for 5 min at 4°C. The 
cell pellet was resuspended with 20µL ice-cold sterile 50 mM CaCl2 (Solution A). The cell 
suspension was placed on ice for 15 min. Then the cells were centrifuged at 5000rpm for 5 
min. at 4°C. The cell pellet was resuspended in 2,8 ml of sterile ice-cold 100mMCaCl2 
(Solution B). For long-term storage 100µL were stored at -80oC until needed. For 
transformation to 100µL of the bacterial culture 2µL plasmid (0,5ng/µL) was added. The 
mixture was incubated for 30 min on ice until 900µL of SOC medium was added and 
incubated at 37oC for 1 hour in a roller drum (250 rpm). 200µL of the cells were plated on 
selective LB agar containing ampicillin (Amp).  The plates were incubated over night at 37°C. 
6 single colonies were picked and incubated over night at 37°C in fresh LB medium 
containing Amp. For the purification of the plasmids the Quiagen EndoFree Plasmid 
Purification Kit was used. All steps were performed according to manufacturer’s instructions. 
 
2.2.3.2 Virus production 
To produce the viral particles approx. 57.000 HEK293T cells per cm2 were seeded in a 175 
cm2 cell culture flask and cultivated with DMEM with 10% heat inactivated FCS. The cells 
had to be even distributed across the substrate surface. The cells were incubated for 24h at 
37°C under 5% CO2. For the transient transfection of the cells with the expression constructs 
the transfection solutions A and B solution were prepared according to Table 2. A vector map 
of the tet-off-H2B-GFP vector is shown below. 
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Vector map tet-off H2B-GFP lentiviral vector. 
 
The transfection solution A and B was mixed and the mixture was incubated for 25-30 min at 
room temperature. Subsequently the mixture was added to the HEK293T culture and 
incubated for 16-18h. To induce the expression of the transgenes 480 µL sodium butyrate 
(500mM) was added to 24 ml culture volume of the transiently transfected cells to reach a 
final concentration of 10mM. 
 
Transfection solution A psPAX stock sol. 12 µL (= 12 µg) 
pMD2.G stock sol. 4.8 µL (= 4.8 µg) 
pWPXLTTT-H2BGFP stock 
sol. 
16 µL (= 16 µg) 
Hanks´ balanced salt 
solution 
1967 µL 
  Σ  2000 µL 
Transfection solution B PEI stock sol. 90 µL (90 =µg) 
Hank´s balanced salt 
solution 
1910 µL 
  Σ  2000 µL 
 
 
After 8h the culture medium was exchanged for fresh DMEM with 30% heat inactivated FCS 
and incubated for 16-18h. Finally the culture supernatant was harvested at 48h and 72h post 
cells transfection. The culture supernatant was then filtrated through a 0.45µm filter and 
pooled and stored at -80°C or concentrated by ultracentrifugation. The producer cells were 
discarded. 
 
Table 2: Instructions to produce viral particles for one 175 cm2 culture flask. 
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2.2.3.3 Concentration by Ultracentrifugation 
For the preparation of highly concentrated viral stocks the supernatant is concentrated by 
ultracentrifugation. Therefore 4 ml sucrose (20%) was placed in an ultracentrifuge tube 
(Beckman Culture) before 30 ml of the supernatant is carefully laid over without disrupting 
the sucrose cushion. The ultracentrifuge tubes were equalized and placed into the 
ultracentrifuge buckets into the SW28 rotor. The tubes were centrifuged for 2 hours at 4°C at 
25.000rpm. After the centrifugation the supernatant is removed and the pellet is dissolved in 
DMEM (1:100). The lentiviral stocks were aliquoted in 50µL aliquots and stored at -80°C. 
 
2.2.3.4 Virus Titration 
The concentration of infectious virus was measured by limiting dilution whereas the viral 
proteins expressed by infected cells are detected by FACS. Therefore 4x105 keratinocytes 
where seeded with 2 ml DermaLife medium per well in a 6 well plate. After 5 hours 16µl 
polybrene/well (1µg/ml) is added into each well. After preparation of a serial dilutions of the 
virus (1/100-1/100000) the serial dilutions of the virus is added to the pre-plated cells. The 
plates are then centrifuged for 2500rpm at 37° C for 90 minutes before the virus is removed 
and replaced with fresh DermaLife Medium. After 48 hours all wells are trypsinized as 
described in XY and analyzed by FACS. The titer is calculated with the following formula: 
Titer (TU/µL) = GFP positive cells/100 x initial cell number x dilution of virus. 
 
2.2.3.5 Transduction of cells 
For the transduction of keratinocytes 4 x 105 keratinocytes were seeded per well in a 
collagen I coated 6-well plate. After 2 hours the virus supernatant and polybrene (8 µg/ml) is 
added into each well. Subsequently the plates are centrifuged for 90 min at 2500rpm at 
37°C. After this spinoculation the virus was removed and with fresh medium exchanged. The 
cells were trypsinized after 3 days of cultivation and seeded on OTCs or analyzed by FACS. 
 
2.2.4 Staining methods 
2.2.4.1 Indirect Immunofluorescence 
In indirect immunofluorescence the first antibody (primary) is unlabeled and in order to detect 
the antigen the second anti-immunoglobulin antibody is tagged with a fluorescent dye. 
Frozen cryosections were, after thawing, fixed in cold (4°C) 80% ethanol for 10 min and then 
transferred for another 2 min in 100% aceton (-20°C). The sections were briefly washed in 
PBS, air dried and staining areas were marked with a hydrophobic pen (PapPen) before 
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placed in the humidifier chamber. The sections were blocked with 3% BSA in PBS+ solution 
for 15 min at RT to avoid non-specific binding of the second antibody. Afterwards the first 
antibody, diluted in the block solution, was incubated for 1h at 37°C and then another 30 min 
at RT or at 4°C over night.  The sections were washed in PBS+ with 0,1% Triton X100 for 5 
min and then twice in PBS+ for 5 min. The secondary antibody was also diluted in the 
blocking solution and incubated for 30 min at 37°C and 30 min at RT. Subsequently the 
slides were washed as described above with an additional wash at the end for 1 min in 
ddH20. The sections were directly covered with a fluorescent mounting medium (DAKO) and 
a cover slip. The slides were dried for at least 1h at RT and then stored at 4°C.  
 
2.2.4.2 Hematoxylin and eosin (H&E) - stain 
The hematoxylin and eosin stain (H&E) is a common and most widely used staining in 
histology to evaluate the morphology of tissue. The hematoxylin is used to visualize the 
nuclear details (in blue) following by contrast counterstaining with eosin to stain proteins 
nonspecifically (in pink). The paraffin sections were deparaffinized by incubation in xylene for 
8 min twice and then rehydrated by passing the slides through a graded alcohol series 
(100% ethanol, 96% ethanol, 80% ethanol, 70% ethanol, each 4 min) and finally washed in 
ddH20 for 2 min. Subsequently the slides were incubated in hematoxylin for 6 min and then 
rinsed for 8 min with H20. The sections were then incubated with eosine for 6 min and again 
rinsed with H20 for 6 min. Following this the slides were dehydrated through a series of 
alcohol in ascending concentrations (70% ethanol, 80% ethanol and 90% ethanol, 100% 
ethanol) and a short incubation in isopropyl (2 min) and xylene for 2 x 5 min. Finally the 
slides were mounted with Eukitt mounting medium. The slides were analysed using a 
microscope (Olympus BX51), Images were taken using a Color view I camera and computer 
processed using the Olympus software Cell^D. 
 
2.2.5 Molecular biology techniques 
2.2.5.1 RNA Isolation 
To isolate the RNA from small samples the ARCTURUS Pico Pure RNA Isolation Kit (Life 
Technologies) or RNeasy Mini Kit was used. The protocol was performed according to the 
manufacturer´s instruction. Additionally all samples were treated with DNaseI for 15 min at 
RT (RNase-Free DNase Set, Qiagen). The concentration of the RNA was determined with an 
Agilent 2100 Bioanalyzer (Agilent Technologies GmbH). RNA samples were stored at -80°C. 
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2.2.5.2 DNA Isolation 
For the isolation of genomic DNA of cells the QIAamp DNA Mini Kit (Quiagen) was used. The 
protocol, DNA Purification from Tissues, was performed according to the manufacturer´s 
instruction. 
 
2.2.5.3 Reverse Transcriptase 
For the synthesis of cDNA for qRT-PCR the RevertAid H Minus first Strand cDNA Synthesis 
Kit was used. For each reaction 3μg of total RNA was transcribed according to the 
manufacturer’s instructions. First to the RNA were 2μl oligo (dT)18 primer (1 μg/μl) added and 
mixed with RNase free water to a final volume of 22 µL.  The mixture was incubated for 5 min 
at 70 °C and 5 min at 4 °C. Subsequently 8μl 5x reaction buffer, 2μl RiboLock RNase 
Inhibitor (20 U/μl), 2 μl of RevertAid H Minus M-MuLV Reverse Transcriptase (200 U/μl) and 
4μl dNTP mix (10mM) were added. The mixture was incubated for 60 min at 42 °C and 
terminated by heating to 70 °C for 10 min. The cDNA in a final volume of 40µL was stored at 
-20 °C for real-time PCR. For small RNA samples, the RNA samples were send to the 
microarray unit of the DKFZ “Genomics and Proteomics Core Facility” where the cDNA 
synthesis was performed with the NuGEN Ovation Pico WTA System. 
 
2.2.5.4 Real-time PCR 
Quantitative real-time PCR (qRT-PCR) was used for the relative quantification of mRNA 
expression of different selected genes. The qRT-PCR was performed in a thermal block 
LightCycler 480-II (Roche) according to the manufacturer’s instructions. Each reaction had a 
total volume of 15µL containing 10µL LC Master probe, 10mM forward/reverse primers and 
UPL-probe (0.1mM) and nuclease free water. All primers were designed with the Universal 
Probe Libary software. After pipetting the 15µL into a PCR 96 well plate, 50ng of cDNA 
dissolved in 5 µL RNase free water was added. For negative control 5µL water was added to 
the 15µL. The plate was then sealed properly with a LightCycler® 480 sealing foil by 
pressing it firmly to the plate surface using a sealing foil applicator and centrifuged for 1 min 
at 1000rpm. Every qRT-PCR was performed in duplicates and a house keeping gene, 
GAPDH, as an internal reference was measured. The mixture was pre-incubated for 10 min 
at 95 °C, then 45 cycles were carried out, each composed of 95°C for 10sec and annealing 
for 30 sec at 60 °C and 1 min at 72°C. After each cycle the fluorescence was measured at 
530nm. The reaction ended with a cooling step at 40°C for 10sec. Before beginning all real 
times experiments with a new set of primers an efficiency test was performed to verify the 
quality of the primer/probe combination. To obtain a standard curve the cDNA of the target 
  Material and Methods 
 
33 
 
cells was used in a dilution series of 100, 20, 4, 0.8 and 0.16ng. With the LightCycler® 480 
Software and the algorithm “Second Derivative Maximum” the crossing point (CP) of each 
gene of interest could be determined. This CP values allowed the calculation of the ratio of 
the relative mRNA expression of control (basal keratinocytes) vs. LRCs, normalized to the 
housekeeping gene, using the formula of Pfaffl (Pfaffl, 2001), whereas controls were set to 1. 
 
ratio = (Etarget)Δ CP target (control-sample) / (Eref) ΔCP ref (control-sample)  
 
Since for each test a standard curve of the cDNA was performed, the quality and the 
efficiency of the PCR reaction could be included into the calculation. 
 
2.2.6 Microarray 
For expression profiling microarrays were performed. Therefore RNA samples (small 
samples) were send to the microarray unit of the DKFZ “Genomics and Proteomics Core 
Facility”. For the analysis the BeadChip HumanHT-12 v4 was used. For the cDNA synthesis 
the NuGEN Ovation Pico WTA System was used. The protocols were performed according 
to the manufacturer´s instruction. For the analysis three replicates from independent 
experiments were used. From each experiment isolated LRCs were compared to isolated 
basal keratinocytes from OTCs after a chase period of 6-7 weeks. Data extraction was 
individual for each bead, whereas the data point was excluded if the median absolute 
deviation (MAD) was above 2.5.  
 
2.2.7 Analysis of microarray data 
The raw data were analysed with Chipster an open source platform (www.chipster.csc.fi). 
Normalisation was performed with the Illumina- lumi pipeline. Statistical analysis of the 
microarray data was performed after normalization. For quality control the genes were 
filtered on the basis of their coefficient of variation (CV), only genes with a CV above 0.95 
pass the filter. Statistics were performed by using the Empirical Bayes test with a p-value cut 
off of 0.05. The two samples Benjamini and Hochberg's (BH) correction was applied for p-
value adjustment. A p-value below 0.05 was considered as significant. Annotation was 
performed with Ingenuity pathway analysis software.  
 
2.2.8 Linear Amplification Mediated (LAM)-PCR 
150ng of DNA was used for integration site analysis by 3´LTR-LAM-PCR as described 
previously (Schmidt et al., 2001; Schmidt et al., 2007) and subsequent Illumina MySeq 
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sequencing was performed. For linker ligation during LAM PCR procedure, sample specific 
barcoded linker cassettes were used. LAM restriction digest was performed using MluCl. For 
sequencing, specific barcoded primers were added to both ends of the LAM-PCR. Analysis 
of sequenced integration sites was performed as described previously. The sequenced 
integration sites were valid if the lentiviral LTR was fully present at the vector-genome 
junction and the genomic DNA flanking the vector integration had a unique sequence match 
of ≥95% in alignment with the human genome employing Blat. A sequencing validity cut-off 
was set as described (Dieter et al., 2011). Based on sequencing of clones harboring known 
integration sites the cut-off was defined at a minimal level below 0.1% of the total sequence 
counts. Collisions below the cut-off were subsequently removed from the analysis.  
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3 Results 
3.1 Optimization of infection methods for human adult primary keratinocytes 
with the Tet-Off-H2B-GFP lentiviral vector 
Until now the identification of epidermal stem cells in the IFE is still difficult. In the hair 
follicles and mouse ear epidermis, which lack hair follicles, infrequently dividing, slow-cycling, 
cells have been described as stem cells (Bickenbach, 1981; Braun et al., 2003; Cotsarelis et 
al., 1990). For the detection of label-retaining cells (LRC) in the epidermis, the potential stem 
cells, and the isolation of a pure LRC population gene transfer is a promising tool. With the 
generation of Tet-off-controlled Histone 2B-GFP (TRE- H2BGFP/K5Tetoff) transgenic mice 
under the control of a keratin promoter it was possible to identify and isolate LRCs from 
mouse epidermis (Tumbar et al., 2004). Furthermore, with the development of a lentiviral-
based Tet-Off-H2B-GFP reporter harboring the Tet-Off regulatory elements and genes with 
the Histone 2B-GFP (H2BGFP) fusion construct allowed to transduce various cell types in a 
single step. Using this Tet-Off-H2B-GFP lentiviral reporter it was possible to successfully 
infect also epidermal cell lines (Falkowska-Hansen et al., 2010). Normal human adult 
keratinocytes (NHEK) are difficult to infect (Arcasoy et al., 1997; Grubb et al., 1994). 
Therefore an effective, but sensitive method had to be established to infect NHEKs. 
 
3.1.1 NHEKs can be efficiently infected with a tet-off-H2B-GFP lentiviral vector 
Since keratinocytes have a limited lifespan in culture expansion of H2B-GFP positive NHEKs 
is excluded. Therefore, a highly efficient gene transfer method, for transduction of the 
majority of keratinocytes without influencing the cell viability, is required. It was shown in 
other studies that centrifugation with the infectious supernatant, to concentrate the virus 
particles at the cell surface (spinoculation), can enhance infection rates from 40 to >90% for 
primary keratinocytes (Gagnoux-Palacios et al., 2005). Additionally, polybrene (Pb), a 
cationic polymer, was used to increase the efficiency of lentiviral infection of cells (Nead and 
McCance, 1995; Staedel et al., 1994; Toyoshima and Vogt, 1969). Accordingly, we 
compared the effect of spinoculation and Pb in our studies for the optimization of lentiviral 
transduction in NHEKs. Three different types of normal adult keratinocytes from sub-
confluent cultures in low-calcium medium were used for the transduction. NHEKs were either 
incubated over night or spinoculated for 90 min. with the infectious supernatant. FACS 
analysis of transduced NHEK 48 h after infection without spinoculation showed that the 
percentage of cells expressing GFP in NHEKs ranged between 0.5% and 15% according to 
the used virus dilution (Figure 7 A). We confirmed that to significant enhance the 
transduction efficiency spinoculation is necessary (Figure 7 B). The transduction efficiency 
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was about 45% increased with spinoculation in all three tested NHEKs with a virus dilution of 
1:500 (Figure 7 B). To investigate the effect of Pb, NHEKs were centrifuged in the presence 
or absence of 8µg/ml Pb during viral infection. As shown in Figure 7 A and B, addition of Pb 
increased the transduction efficiency in a range between 5% and 29% dependent on the type 
of NHEKs and used virus dilution (Figure 7 A and B). However, Pb enhances the viral 
infection rate less than spinoculation.  
 
 
Figure 7: Optimization of infection method for human adult primary keratinocytes with the Tet-Off-H2B-
GFP lentiviral vector. (A) Three different types of keratinocytes were tested. Cells were infected with three 
virus concentrations (1:500, 1:2000, 1:8000) and either spinoculated (spin) or incubated with the virus 
over night at 37°C (no spin). Polybrene (+Pb) was added to the culture medium (8µg/ml) of 2 groups (spin, 
+Pb and no spin +Pb). (B) NHEKs were infected with a virus dilution of 1:500 and spinoculated (spin) or 
infected over night at 37°C with the lentivirus. Cells were cultivated either in the presence or absence of 
Pb (8µg/ml) during infection. GFP positive cells were assessed by flow cytometric analysis 48 hours after 
infection. Statistical test: n=3, 1way-ANOVA, Bonferroni's Multiple Comparison Test, * p ≤ 0.05, ** p ≤ 0.01. 
Moreover it was shown, that keratinocytes are very sensitive to polybrene at concentrations 
higher than 5 μg/ml (Nanba et al., 2013). Phase contrast images of transduced NHEKs either 
in the presence or absence of Pb (8µg/ml) during the infection process showed no 
morphological differences compared to the non-transduced keratinocytes (Control) (Figure 8 
A and B). Therefore, we conclude that keratinocytes tolerate an amount of 8µg/ml (Figure 8 
A). This dose was used for all further studies.  
 
Collagen, type I represents a natural ECM component of the skin (Deutzmann R, 2007). 
Therefore, collagen coating of cell culture plates promotes the adhesion of NHEKs in 2D 
cultures. To enhance the attachment of NHEKs during the infection process we used 
collagen type I coated culture dishes. We observed that collagen coating of the cell culture 
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plates was increasing the rate of infection (Figure 8 C). Using these transduction conditions 
with higher virus concentrations, for example 1:100, transduction efficiencies up to almost 
100% were obtained without damaging the cells (Figure 8 B, lower panel). Both, the control 
group and the transduced keratinocytes, appeared to be healthy after the virus infection and 
the treatment with polybrene (Figure 8 A and B). 
 
Figure 8: Expression of Tet-Off-H2B-GFP in NHEK 2D cultures (A) Phase contrast images of NHEK non-
transduced (Control) or (B) transduced with Tet-Off-H2B-GFP reporter virus (1:100) assessed by 
fluorescence microscopy. Upper panel: cultivation without Pb, lower panel: cultivation with Pb (8µg/ml) 
during viral infection. (C) NHEK cultivated on a collagen coated (+ collagen coat) or non-coated (no 
collagen coat) cell culture dish during viral infection. Numbers of H2B-GFP positive NHEK were analyzed 
by flow cytometry 48hours after transduction.  
In summary we showed, that spinoculation markedly increased the transduction rate. 
Moreover, the addition of Pb (8µg/ml) and collagen type I coating of the cell culture plates 
further enhanced the rate of infection. Therefore, we used these conditions for all further 
studies.  
3.2 H2B-GFP expression of NHEKs can be tightly regulated by doxycycline 
For the detection of label-retaining cells GFP expression of the reporter has to be turned off 
in order to detect only slow cycling cells as GFP positive cells. Thus the responsiveness of 
the reporter plays an essential role to perform pulse-chase experiments. Since we used a 
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Tet-Off advanced inducible gene expression system, the gene of interest is turned off in the 
presence the antibiotic, doxycycline (Dox). To evaluate the responsiveness of the reporter 
construct NHEKs were cultivated under the presence of 1 ng/ml of Dox. The GFP expression 
was assessed by fluorescence microscopy and flow cytometry. Already one passage after 
the addition of Dox (Figure 9 A, first arrow) was a strong decline in the number of GFP 
positive NHEKs, only 5% of the cells were still GFP positive (Figure 9 A, passage 14). No 
GFP positive cells could be detected anymore two passages after addition of Dox (Figure 9 
A, passage 15). To determine the kinetics also for again switching on the H2B-GFP 
expression, Dox was removed (Figure 9 A, second arrow). Within one passage almost all 
cells turned on the GFP expression (Figure 9, passage 16). This showed that the H2B-GFP 
expression was tightly regulated by doxycycline. 
 
 
Figure 9: Tight regulation with Dox of the H2B-GFP reporter without influencing the cell viability. (A) 
NHEKs were cultivated for the indicated passages either in the presence or absence of Dox (1ng/ml) as 
indicated by the arrows. H2B-GFP positive NHEK were quantified by flow cytometry. (B) Calculation of the 
population doubling (PD) number of H2B-GFP positive NHEK cultivated with Dox (1ng/ml) or without Dox 
after each passage. NHEK were cultured for 5 passages. 
Moreover, we wanted to examine if Dox has an influence on the cell viability and cell cycle 
activity. Therefore NHEKs were cultured over several passages under specific conditions 
(see 2.2.1.5) in the presence or absence of Dox. The population doubling number was 
determined after each passage (Figure 9 B). The population doubling number of 
approximately 3.5 per passage was similar whether the cultures were treated with Dox or 
without Dox.  This showed no influence of Dox on the cellular growth. 
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3.3 Characterization of Tet-Off-H2B-GFP positive NHEKs in 3D OTCs 
3.3.1 H2B-GFP transduced NHEKs are able for long-term regeneration in OTCs 
For the detection of label-retaining cells in 3D organotypic cultures, long-term homeostasis of 
the cultures is necessary. The scaffold OTC (sca OTC) model system enables the cultivation 
of keratinocytes with a healthy and vital epithelium for more than 15 weeks (Muffler et al., 
2008). Thus, sca OTCs can establish a microenvironment providing human epidermal stem 
cells with the ability for epidermal long-term regeneration. In this study, as a second type of 
organotypic cultures, fdm OTCs were used (Berning et al., 2015). In this setting normal 
human dermal fibroblasts (NHDF) produce a fibroblast-derived matrix as dermal equivalent 
to establish long-term homeostasis which provides a similar microenvironment for NHEKs 
(Berning et al., 2015). Sca OTCs and fdm OTCs were used in this study in order to test if 
there are any differences between the different 3D models grown with H2B-GFP 
keratinocytes. 
 
To determine if transduced NHEKs were able to establish regenerative capacity and long-
term maintenance, H2B-GFP NHEKs were seeded on dermal equivalents and cultivated air-
exposed for 8 weeks. The transduced keratinocytes developed a well organized, stratified 
and differentiated epithelium after 2 weeks (Figure 10 B, C). Importantly, these cultures were 
also suitable for long-term regeneration (Figure 10 B, C, 8 weeks). The histological analysis 
revealed no visible differences between the control groups, the non-transduced keratinocytes 
and the transduced keratinocytes, irrespective of the treatment with Dox (Figure 10 A, B, C). 
Also in comparison no differences were seen between fdm OTCs and sca OTCs after 2 and 
8 weeks (Figure 10, upper panel vs. lower panel). Taken together, the results demonstrated 
that neither the tet-off-H2B-GFP vector nor Dox influenced NHEKs in their long-term 
regeneration ability in 3D tissue cultures.  
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Figure 10: Influence of H2B-GFP expression and Dox on long-term regeneration in OTCs. Paraffin 
sections of 2-week-old (2w) and 8-week-old (8w) OTCs stained with hematoxylin/eosin to analyze the 
histological structure. OTCs were either grown from non-transduced NHEK (A) or H2B-GFP transduced 
NHEK (B+C) and cultivated in the absence (A+B) or presence (C) of Dox. 
 
3.3.2 No influence on the proliferation capacity of transduced NHEKs in OTCs 
The histology was very similar between OTCs grown from H2B-GFP NHEKs and non-
transduced NHEKs, suggesting that the proliferation was not altered by gene transduction. 
To test this, the proliferation rate was determined by staining sections of 3D cultures with the 
proliferation marker Ki67 (Figure 11 A.). There was no difference in the proliferation rate 
between the control group and OTCs made up from transduced keratinocytes. Proliferation 
of keratinocytes in 4 week-old epithelia was restricted to the basal cell layer and was about 
25% of the basal cells. The addition of Dox into the culture medium had also no effect on cell 
  Results 
 
41 
 
proliferation (Figure 11 C.). Furthermore the proliferation rate was similar between fdm OTCs 
(Figure 11 B) and sca OTCs (Figure 11 C) independent of transduced keratinocytes or non 
transduced keratinocytes. 
   
 
Figure 11: Proliferation of H2B-GFP NHEK compared to non-transduced NHEK in OTCs. (A) Cryosections 
of fdm OTCs and sca OTCs were stained for the proliferation marker, Ki67 (red) and α6 integrin (green). 
The nuclei were counterstained with Dapi (blue). Upper picture: fdm OTCs, non-transduced NHEK, lower 
picture: fdm OTCs, H2B-GFP NHEK. The percentage of Ki67-positive cells compared to the total basal cell 
number was quantified by microscopy. Two cultures per condition were analyzed either of (B) fdm OTCs 
or (C) sca OTCs, cultivated in the absence or presence of Dox, grown with transduced or non-transduced 
NHEK for 4weeks. Images of 4 representative regions per culture were taken using a 20x objective in 
order to calculate the percentage of Ki67-positive cells normalized to the corresponding number of basal 
keratinocytes.  
3.3.3 Regular epidermal differentiation of transduced keratinocytes in OTCs 
For studies on epidermal stem cells, tissue homeostasis including the regular epidermal 
differentiation and the development of a proper stem cell microenvironment in vitro is crucial. 
To evaluate tissue homeostasis, the regular epidermal differentiation and establishment of a 
basement membrane as well as intracellular junctions as marker for tissue integrity and 
stability, were analyzed. Therefore, we seeded H2B-GFP NHEKs on sca OTCs or fdm OTCs 
and cultivated them air-exposed for 4 weeks. The expression of different markers in the skin 
were examined in OTCs of transduced keratinocytes (GFP) compared to non-transduced 
keratinocytes (control), either treated with Dox (GFP, +Dox) or untreated (GFP, no Dox). 
Desmoglein 1, a typical marker for desmosomes in the epidermis, showing the tight 
connection between the cells of all vital suprabasal cell layers, was regularly expressed in all 
transduced and non transduced cultures (Figure 12 A) and independent of the treatment with 
Dox (Figure 12 A). There was also no difference between sca OTCs and fdm OTCs (Figure 
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12 A, upper 3 panels vs. lower 3 panels). As a marker of the basement membrane the 
expression of collagen VII was analyzed. Collagen VII is part of the anchoring fibrils in the 
sublamina densa and a sign of a mature basement membrane. In all epithelia regular 
Collagen VII expression could be detected in the basement membrane (Figure 12 B) 
confirmed therefore the development of a proper basement membrane associated with tissue 
homeostasis. Notably, in sca OTCs, without Dox treatment, the expression of collagen VII 
was partly fragmented, this was not the case for sca OTCs + Dox treatment. There was also 
no difference in the expression of keratin 14 in all epithelia (Figure 12 C). Keratin 14 could be 
detected in the basal layer, slightly lowered within the more apically located layers 
specifically in the stratum spinosum and stratum granulosum. An early differentiation marker 
is involucrin, a component of the cornified envelope, first visible in the upper layers of the 
stratum spinosum (Rice and Green, 1979). The expression displayed proper differentiation in 
all cultures (Figure 12 D). The expression of E-cadherin in cultures with transduced and non 
transduced keratinocytes (Figure 13 A) displayed the development of adherens junctions, 
important cell-cell contacts in the skin and critical for tissue integrity. 
 
Also differentiation markers like filaggrin which are indicating terminal differentiation (Candi et 
al., 2005), were observed regularly expressed in all GFP and control groups (Figure 13 B). 
 
Integrins, receptors for cell adhesion to extracellular matrix proteins, play an important role in 
cell-cell adhesions and act as key player in tissue homeostasis (Hynes, 2002). Moreover, 
there are also involved in niche formation (Lowell and Mayadas, 2012). In keratinocytes α6 
integrin is detected at the basal pole of the basal cell layer and the main component of 
hemidesmosomes. Irrespective of the H2B-GFP expression the typical distribution for in the 
basal cell layer could be detected in all cultures (Figure 13 C) and therefore displays a 
homeostatic epidermis (Hertle et al., 1991).  
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Figure 12: Influence of H2B-GFP expressing NHEK in comparison to non-transduced NHEK on the 
epidermal differentiation. Cryosections of 6-week-old OTCs (fdm OTCs and sca OTCs) grown from H2B-
GFP NHEK and non-transduced NHEK were fixed and then analyzed by immunofluorescence staining for 
the expression of the epidermal adhesion molecule desmoglein1 (red) (A), the basement membrane 
marker Collagen VII (red) (B), Keratin 14 (green) (C) and the early differentiation marker Involucrin (D), 
shown in red. Nuclei were counterstained with Dapi (blue). GFP expression in green. Upper three panels: 
sca OTCs. Lower three panels: fdmOTCs. Tet-Off-H2B-GFP NHEK were cultivated in the presence or 
absence of Dox as indicated. 
 
Taken together the immunostaining analysis of typical epidermal marker proteins displayed 
regular expression and localization of all markers. This reflects a normal epidermal tissue 
architecture developed by transduced NHEK OTCs. Neither the vector nor Dox seems to 
influence tissue development in 3D OTCs. Thus, the cultures made with transduced 
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keratinocytes were suitable to be used for pulse-chase experiments to study epidermal stem 
cells. Furthermore both dermal equivalents, scaffold-based and fdm-based, are suitable for 
long-term experiments with H2B-GFP NHEK.  
 
Figure 13: 6 week-old OTCs either fdm OTCs (A) or sca OTCs (B, C) grown with H2B-GFP NHEK or non-
transduced NHEKs in the presence or absence of Dox as indicated. Fixed cryosections were stained with 
specific antibodies in combination with Dapi (blue) as DNA staining. GFP expression is shown in green. 
Sections were analyzed for the expression of the adhesion molecule E-Cadherin (A), the late 
differentiation marker Fillagrin (B). Stainings all shown in red. (C) Expression of α6 integrin, a marker for 
basal cells, is shown in green. 
 
3.3.4 Tight regulation of the Tet-Off-H2B-GFP lentiviral reporter with Dox in OTCs 
To ensure the responsiveness of the Tet-Off-H2B-GFP lentiviral reporter the Dox regulation 
was also tested in OTCs. This is required to avoid false positive cells which could be 
identified incorrectly as LRCs. Therefore, H2B-GFP expressing NHEKs were seeded on 
OTCs. The cultures were cultivated for 2 weeks with Dox in the culture medium. After 2 
weeks of Dox treatment all cells had turned off the GFP (Figure 14 A), subsequently Dox was 
removed in order to turn on again the GFP. After a cultivation period of 1 week without Dox 
the keratinocytes were still GFP negative (Figure 14 B). The GFP signal could be detected in 
all cells after 4 weeks of cultivation without Dox (Figure 14 C). Taken together, the vector 
remained responsive to Dox and is also tightly regulated in OTCs. 
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Figure 14: Tight regulation of the H2B-GFP reporter in 3D. Cryosections of OTCs with H2B-GFP 
transduced NHEK were analyzed for GFP expression and α6 integrin (red) as basal cell marker by 
immunofluorescence staining. Nuclei were counterstained with Dapi (blue). (A) Tet-Off-H2B-GFP NHEK 
were cultivated in OTCs in the presence of Dox (1ng/ml) for the first 2 weeks.  (B) Thereafter, Dox was 
removed for one week. (C) Tet-Off-H2B-GFP NHEK cultivated for the first two weeks with Dox followed by 
the cultivation in the absence of Dox for 4 weeks.  
 
3.3.5 Gene silencing of H2B-GFP positive cells in OTCs 
For pulse-chase experiments, H2B-GFP NHEKs were sorted for their GFP expression and 
seeded on OTCs. Subsequently, the cultures were cultivated in the absence of Dox for the 
first two weeks (expression of H2B-GFP, pulse period). Analysis of OTCs grown with sorted 
H2B-GFP NHEKs showed a decline in the GFP signal (10-40%) after 2 weeks cultivation 
under the absence of Dox (Figure 15) although we sorted the cells for the GFP expression 
before seeding them on the dermal equivalent. This might be due to gene silencing of the 
Tet-Off-H2B-GFP reporter. To circumvent this loss of GFP positive cells we conclude to 
resort the H2B-GFP NHEKs in order to obtain a stable H2B-GFP expressing cell population.  
Due to the short lifespan of keratinocytes in culture such approaches are under normal 
cultivation conditions difficult to approach. Therefore we investigated the effect of a Rho-
associated protein kinase (ROCK) inhibitor Y-27632, which had been shown to improve the 
survival of dissociated human embryonic stem cells (Watanabe et al., 2007) as well as the 
cloning efficiency (Terunuma et al., 2010) and long-term proliferation of human keratinocytes 
(Chapman et al., 2010). Moreover, it was suggested that the ROCK inhibitor Y-27632 
enabled keratinocytes to efficiently bypass senescence and become immortal without 
detectable cell crisis (Chapman et al., 2010).  
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Figure 15: Analysis of cryosection from transduced, FACSorted, H2B-GFP NHEKs grown on OTCs after 2 
weeks in the absence of Dox.  Scale bar:100µm. 
 
3.4 Long-term cultivation of NHEKs with Rho kinase inhibitor Y-27632  
To explore the effect of Rho kinase inhibition on the long-term growth of keratinocytes 
isolated from adult skin, NHEKs were cultivated in the absence (Control) or presence of 
10µM Y-27632 (+Y-27632) in 2D cultures. To bypass senescence it was shown that the 
presence of feeder cells is required in concert with Y-27632 for foreskin keratinocytes 
(Chapman et al., 2010).  Therefore we also tested whether the co-cultivation with feeder is 
prerequisite for long-term cultivation of NHEKs in the presence of Y-27632. Already in 
passage 1, directly after the addition of the Rho kinase inhibitor, the treated cells were 
growing faster irrespective of being cocultivated with feeder in calcium-containing medium 
(FAD) or being cultivated in low-calcium, serum-free medium (DermaLife) without feeder cells 
(Figure 16, passage 1 A-D). In passage 4 the growth of the control cultures slowed down 
remarkably compared to the Y-27632 treated cultures (Figure 16, passage 4 A-D). In 
passage 5 signs of senescence, like the enlargement of cells, and increased differentiation in 
both control cultures, could be observed while the morphology of the Y-27632 treated 
cultures still resembled undifferentiated early passage NHEKs (Figure 16 B, D). In passage 6 
both control cultures cell death occurred (Figure 16, passage 6, A and C, indicated by the 
cross). Also the Y-27632 treated group cultivated in low-calcium medium without feeder 
(Figure 16 B, passage 6) showed first morphological signs of senescence, like bigger nuclei 
(Figure 16 B, passage 6). Beyond passage 6, only NHEKs grown in co-culture with feeder 
and FAD medium, containing Y-27632, continued to proliferate (Figure 16, D). In passage 22 
Y-27632 treated NHEKs still showed the morphology of early passages of NHEKs (Figure 16 
D, passage 1 and passage 22). These results demonstrated that NHEKs can be passaged 
for long-term in 2D by addition of Y-27632 to the culture medium in co-cultivation with feeder. 
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Figure 16: Long-term cultivation of NHEKs with Y-27632 required the co-cultivation with feeder cells. (A) – 
(D) Phase contrast images of keratinocytes cultivated in low-calcium medium (DermaLife, without feeder) 
are shown in the first two columns, whereas NHEKs cultivated in feeder co-culture with calcium-
containing medium are shown in the last two columns. Passage of NHEKs and treatment with Y-27632 
(10μM) as indicated. Cell death is indicated as cross. The magnification in passage 6 shows the 
enlargement of the cells with bigger nuclei. 
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3.4.1 Increased proliferation of NHEKs in the presence of Y-27632 
To determine whether the proliferation ability of Y-27632 treated NHEKs is higher compared 
to the control cultures, proliferation assays were performed with Y-27632 treated and non- 
treated cells. The total cell number was analyzed via SYBR Green staining. The proliferation 
assay was performed in DermaLife medium without feeder in passage 2. We could confirm 
that Y-27632 treated NHEKs have a higher proliferation ability compared to the untreated 
control (Figure 17 A) as it was also shown for neonatal foreskin keratinocytes, for human 
ectocervical keratinocytes and human vaginal keratinocytes (Chapman et al., 2010). 
 
 
Figure 17: (A) In orders to perform a SYBR Green proliferation assay, defined numbers of NHEK were 
seeded in 24-well plates. Cells in passage 2 were cultured in the absence or presence of Y-27636 in low-
calcium medium (without feeder). Plates were harvested at the indicated time points and the resulting 
number of cells was quantified by SYBR Green incorporation, compared to a well plate with defined cell 
numbers. Each measurement was performed in triplicates per time point. (B) Quantification of adherent 
NHEK in the presence or absence of Y-27632 following plating on collagen for 30 minutes. Cell number 
was determined via SYBR Green staining. (C) Growth rate of NHEK cultivated in the presence or absence 
of 10µM Y-27632 cultivated with feeder. The growth rate is measured as population doubling each 
passage. The proliferation assay was performed twice and one representative experiment is shown. 
 
 
To support that increased cell numbers in Y-27632 treated cells are due to higher 
proliferation and not caused by increased attachment to the culture dish after seeding, we 
performed adhesion assays. Therefore plates were coated with collagen type I, subsequently 
NHEKs were seeded in DermaLife in the presence or absence of Y-27632, incubated for 30 
minutes and washed with PBS.  
 
To examine the total cell number SYBR Green staining was performed. The analysis showed 
that there was no difference in adhesion (Figure 17 B). Taken together, our results indicate 
that in the presence of Y-27632 proliferation of NHEKs is increased rather than increased 
attachment of the cells. 
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3.4.2 Rho kinase inhibitor suitable to expand H2B-GFP positive NHEKs 
The cultivation of NHEKs in the presence of the Rho kinase inhibitor Y-27632 enables the 
cells for long-term cultivation over several passages. Consequently, the addition of Y-27632 
to the culture medium could be used to expand H2B-GFP NHEKs. Therefore transduced 
H2B-GFP NHEKs, with a transduction efficiency of 90-96%, were sorted 48 hours after 
transduction for their GFP expression and cultivated in FAD medium with feeder cells in the 
presence of Y-27632 (1st sort). At a confluence of 80% H2B-GFP NHEKs were trypsinized 
and resorted for their GFP expression. The second FACSort showed that 90% of the cells 
were still positive for GFP expression, whereas about 10% of the H2B-GFP positive NHEKs 
have lost the GFP expression (Figure 18 A, 2nd sort). The resorted H2B-GFP NHEKs were 
cultivated again in the presence of Y-27632 and harvested at 80% confluency. The third sort 
revealed that the H2B-GFP expressing cells sustained GFP expression (Figure 18 A, 3rd 
sort). Furthermore, phase contrast images showed no morphological difference between 
transduced NHEKs in passage 4 in the presence of Y-27632 (Figure 18 C) compared to the 
control cells in passage 4 in the presence of Y-27632 (Figure 18 B, non transduced, + Y-
27632). The morphology of transduced NHEKs in passage 4 with Y-27632 appeared as 
homogenous monolayers of small polygonal cells, resembling early passage NHEKs (Figure 
18 C). As shown in Figure 4 D, all transduced NHEK, in passage 4, sustained H2B-GFP 
expression after resorting. Taken together, the expansion of a stable H2B-GFP expressing 
NHEK population after two times of FACSorting was feasible. 
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Figure 18: Stable Expression of GFP after second sort in presence of Y-27632. (A) Flow cytometric 
analysis of H2B-GFP positive population. 2nd sort: 90% of the H2B-GFP positive NHEK were sorted and 
cultivated in the presence of Dox, trypsinized at confluence and resorted for their GFP expression (3rd 
sort). Phase contrast images of Y-27632 treated NHEK (B) and Y-27632 treated transduced NHEK (C) in 
passage 4. (D) Y-27632 treated H2B-GFP positive NHEKs in passage 4 after two times of sorting. Overlay 
of phase contrast image and GFP expression (green, FITCS/GFP channel). GFP was assessed by 
fluorescence microscopy. Scale bar: 100µm. The experiment was performed in duplicates. 
 
3.4.3 Rho kinase inhibitor does not support growth of transduced keratinocytes in 
OTCs 
Next we wanted to determine whether H2B-GFP NHEKs in later passages, propagated in the 
presence of Y-27632, retained their capacity to form a stratified epithelium in OTCs. It was 
reported that foreskin keratinocytes treated for 18 passages with Y-27632 were able to 
establish a well differentiated epithelium in organotypic raft cultures (Chapman et al., 2010). 
However, Chapman et al. showed that differentiation into a stratified tissue of Y-27632 
treated keratinocytes is only in the absence of Y-27632 possible (Chapman et al., 2010). 
Therefore H2B-GFP NHEKs, sorted twice by FACS, that had been cultured up to this point in 
the presence of Y-27632 were seeded on sca OTCs and cultured air exposed for 8 weeks 
without Y-27632 in the OTC media. As control cells, non-transduced NHEKs also in passage 
4, cultivated in Y-27632 and resorted for two times, were used. As second control, NHEK in 
passage 2, non- treated with Y-27632, were seeded on sca OTCs. The histological analysis 
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was done in three independent experiments. There was no remarkable difference in the 
differentiation capacity between the control group in passage 2 (Figure 19 A) and NHEKs in 
passage 4, precultivated with Y-27632 and FASorted twice (Figure 19 B). However, H2B-
GFP transduced keratinocytes, also in passage 4, previously expanded in the presence of Y-
72632 and FACSorted twice, did not grow on OTCs (Figure 19 C). We could exclude that the 
H2B-GFP transduced NHEKs did not grow because of the sorting process, since the 
untransduced group pass through the same procedure and was also sorted twice. In 
summary, the Rho kinase inhibitor (Y-72632) is a valuable tool to expand transduced NHEKs 
and extend the lifespan of the cells in monoculture. Nevertheless, this method was not 
suitable to cultivate these cells in OTCs as they did not allow long-term growth in OTCs. 
Therefore, we performed OTCs with non-sorted transduced NHEKs in an early passage in 
further experiments. 
 
 
Figure 19: Histological Analysis of NHEKs precultivated with Y-27632 in passage 4 on sca OTCs after 8 
weeks. Paraffin sections of these OTCs were fixed and stained with hematoxylin/eosin to visualize the 
morphology. (A) Control NHEK in passage 2, precultivation was in the absence of Y-27632. (B) NHEK 
precultivated in 10µM Y-27632 and seeded in passage 4 on OTCs. (C) H2B-GFP positive NHEK 
precultivated in 10µM Y-27632 and seeded in passage 4 on OTCs. Cultivation medium of OTCs was in all 
cultures in the absence of Y-27632. Scale bar: 100µm. Three independent experiments were performed 
and one representative experiment is shown. 
 
3.5 Detection of LRCs in H2B-GFP OTCs 
For pulse-chase experiments H2B-GFP keratinocytes were seeded on OTCs. The cultures 
were cultivated for the first two weeks without Dox (pulse period). This allowed the 
establishment of a homeostatic epithelium and the maturation of the stem cell niche while 
H2B-GFP is turned on. Subsequently, after 2 weeks, Dox is added to the culture medium in 
order to turn off the H2B-GFP (chase period). The H2B-GFP is declining in all cells in a 
proliferative associated manner; only slow cycling cells (LRCs) are able to keep the H2B-
GFP label over time. At the end of the pulse period we detected, as already described under 
chapter 3.3.5, a decline in H2B-GFP positive cells in OTCs (Figure 20 A). However, after 6 
weeks of chase, in the presence of Dox, we were able to detect basal LRCs in OTCs grown 
from H2B-GFP NHEKs (Figure 20 D, white arrow). Furthermore cluster of LRCs could be 
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observed after a chase period of 8 weeks (Figure 20 E) as well as after a chase period of 11 
weeks (Figure 20 F). Moreover, analysis of OTCs grown with H2B-GFP transduced NHEKs, 
cultivated in the absence of Dox (expression of H2B-GFP), showed, that most of the cells 
were labeled in an 8 and 12 week old epithelium (Figure 20 B and C), hence demonstrating 
that expression was sustained also under 3D conditions.  
 
 
Figure 20: Detection of LRCs in H2B-GFP NHEK cultures. (A) OTCs from H2B-GFP transduced NHEKs 
were cultivated for two weeks in absence of Dox (expression of H2B-GFP, pulse period). OTCs from H2B-
GFP transduced NHEK were cultivated for 8 weeks (8 wks) (B) or 12 weeks (12 wks) (C) in absence of Dox 
(expression of H2B-GFP). OTCs from H2B-GFP transduced NHEK were cultivated for two weeks in 
absence of Dox (pulse period) and then for 6 weeks (6 wks) (D) or 8 weeks (8wks) (E) or 11 weeks (11 wks) 
(F) in the presence of Dox in order to turn off the reporter (chase period) and to detect LRCs. White 
arrows: H2B-GFP positive LRCs. Cryosections were examined by immunofluorescence staining. Nuclei 
were stained with Dapi (blue). GFP expressed is shown in green. Basal cells were stained for α6 integrin 
(red) or the basement membrane is indicated by the dotted white line (E). Scale bar: 100µm. 5 
independent experiments were performed and one representative experiment is shown. 
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3.6 Isolation of basal NHEKs from OTCs 
To understand, characterize and assess the regenerative properties of the skin, the isolation 
of vital LRCs, the potential epidermal stem cells, is necessary. Therefore the aim of this 
study was to isolate LRCs after a chase period of minimum 6 weeks. It was shown that a 
chase period of 6 weeks is required to detect LRCs in OTCs (Muffler et al., 2008). The 
prerequisite to isolate vital LRCs is a single cell suspension of the epithelium. For this 
purpose a method was needed to obtain single cells from the epidermis of OTCs. To test the 
isolation method, 8 week-old OTCs grown from non-transduced NHEK were used. To 
separate the epidermis from the dermal part, OTCs were incubated with Dispase II (1mg/ml) 
for 2 hours at 37°C. Dispase II is an enzyme from Bacillus polymyxa and a gentle agent for 
the disruption of extracellular matrix of tissues and was shown to successfully separate 
epidermis from the dermis at the dermo-epidermal basement membrane (Kitano and Okada, 
1983). With this enzymatic digestion the epithelium is effectively removed from the dermal 
part without dissociation of keratinocytes (Figure 21 A). Subsequently, the epithelial sheets 
were dissociated into single cell suspensions by trypsinization similar to a protocol described 
by Longley et al. and Okada et al. (Kitano and Okada, 1983; Longley et al., 1991). Notably, 
we used higher trypsin concentrations (0.4%) and shorter incubation times (3 min., 37°C). To 
specifically select for basal keratinocytes of the epidermis the cell suspension was stained for 
α6 integrin, a surface marker for basal keratinocytes. Moreover, the cell suspension was 
analyzed for the expression of Keratin 10, a marker for early differentiation of keratinocytes. 
The analysis was performed by flow cytometry. Almost 60% of the isolated cells were α6 
integrin positive (Figure 21 B). Only 10% of the isolated cells were Keratin 10 positive (Figure 
21 B). Concomitantly, also IIF stainings of cytospin slides of the analyzed experiments 
showed that mainly basal keratinocytes were isolated, most of the cells were α6 integrin 
positive (Figure 21 B). Taken together, with this approach it was possible to obtain a single 
cell suspension from the epidermis of OTCs. This should be a suitable method to select for 
GFP-positive basal LRCs.  
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Figure 21: (A) Paraffin section of 8-week-old OTC grown from NHEK treated with Dispase II (1mg/ml) for 2 
hours at 37°C. First images displayed the dermal part, the second image the epidermis. Sections were 
fixed and stained with hematoxylin/eosin. (B) Single cell suspension of the dissociated epidermal sheet 
was analyzed by flow cytometry. Epidermal suspensions were labeled with antibodies to α6 integrin, a 
marker for basal cell (shown in red) and Keratin 10, a marker for differentiated cells (in green). (C) Single 
cell suspension of an 8 week-old Epithelium on a cytospin slide. For Cytospin slides, single cell 
suspensions are spun onto a microscope slide by use of a cytocentrifuge. Nuclei are stained with Dapi 
(blue), α6 integrin, a marker for basal cell, is shown in red and Keratin 10, a marker for differentiated cells 
in green. The experiment was performed three times. One representative experiment is shown. 
 
3.7 Isolation of vital LRCs  
Having demonstrated that we were able to successfully isolate basal epidermal cells from 
OTCs we next aimed at isolating LRCs from OTCs. For this purpose keratinocytes, 
transduced with H2B-GFP, were cultivated in OTCs 2 weeks under the absence of Dox 
(expression of H2B-GFP, pulse period). In order to turn the H2B-GFP reporter, Dox was 
added to the culture medium during the following 6–8 weeks of cultivation (chase period). 
Only slow cycling cells kept their H2B-GFP expression and could be detected as LRCs. The 
epidermis of these OTCs was separated from the dermal equivalent using Dispase II, 
followed by trypsination as described in chapter 3.6.  
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The separation was checked for every experiment by histological analysis. To select for 
basal keratinocytes and in particular for the GFP-positive basal LRCs, the cell suspension 
was stained for α6 integrin. For the purification of vital LRCs FACSorting was performed. The 
cell suspension was sorted for α6 integrin positive basal cells and α6 integrin- GFP double 
positive cells (LRCs). The FACS analysis showed three distinct populations; α6 integrin 
positive cells (basal cells), α6 integrin GFP double positive cells (basal LRCs) and α6 integrin 
negative cells (suprabasal cells) (Figure 22 A). The range of isolated LRCs compared to the 
cell number of isolated basal cells from 7 independent experiments was between 1%-7,4%, 
with an mean value of 5% (Figure 22 B). By this method LRCs could be isolated even after 
20 weeks of chase (Figure 22 B, experiment 7). Differences in the total amount of isolated 
basal cells and LRCs (Figure 22 B, 2nd and 3rd row) were due to different amounts of OTCs 
for the isolation (Figure 22 B, last row). Taken together, LRCs could successfully be purified 
from 7 independent preparations. 
 
 
Figure 22: (A) Ilustration of the flow cytometric fractionation of single cell suspension of H2B-GFP NHEKs 
grown for 8 weeks on sca OCTs with a chase period of 6 weeks. The epidermal suspension was stained 
for α6 integrin, a marker for basal keratinocytes. Three distinct populations could be detected by flow 
cytometry. Population 1 (LRCs): α6 integrin positive and GFP positive. Population 2 (basal cells): α6 
integrin positive and GFP negative. Population 3 (suprabasal): α6 integrin negative. (B) Overview about 
the fractionated isolations. LRCs making up between 1-7.4% of isolated basal cells. The isolated cell 
numbers of LRCs were between 563 cells and 52.000 cells. Cell numbers for basal cells were between 
0.054x106 and 4.6x106. Chase period is shown in the fifth column. The number of OTCs which were used 
for the experiment is shown in the last row. 
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3.8 Global gene expression analysis of isolated LRCs compared to isolated 
basal cells of OTCs 
To further characterize the isolated LRCs, a global gene expression analysis was performed. 
The expression profile of isolated LRCs, derived from OTCs after a chase period of 6-7 
weeks, was compared to isolated basal cells (α6 integrin positive and GFP-negative) of the 
same preparation. The microarray analysis were carried out by the DKFZ “Genomics and 
Proteomics Core Facility” using Ilumina BeadChip HumanHT-12 v4 which allows to analyze 
the expression level of 31.000 annotated genes. The analysis was run with biological 
triplicates. The raw data were analyzed with Chipster (software for high throughput data) and 
further analyzed with Ingenuity pathway analysis (IPA) software. The cut off for the p-value 
was 0.05. Non-metric multidimensional scaling (NMDS), a method to display a 
multidimensional data in fewer dimensions, calculates euclidean distances between the 
samples in the dataset. These distances are visualized using a 2D-plot. Therefore increasing 
distances between sample points equates to more dissimilarity. In Figure 23 A the NDMS 
showed that samples LRC #2 and #3 as well as the control #1, #2 and #3 were clustering 
whereas the sample LRC #1 was located at a different position (Figure 23 A). Therefore LRC 
#1 was excluded from further analysis. The analysis with chipster, considering the statistical 
tests (see method), revealed that 102 genes were significantly differentially regulated (Table 
5, appendix). The scatterplot in Figure 23 B is visualizing the differential analysis. Each dot 
represents the expression value of a gene, genes with equal expression values line up on 
the diagonal, whereas points below the diagonal represent genes with higher expression in 
the sample plotted on the x-axis (LRCs) and genes above have higher expression values in 
the sample plotted on the y-axis (control) (Figure 23 B). The further away the point is from 
the diagonal the larger is the expression difference. The scatter plot illustrated that there are 
more genes higher differentially expressed in LRCs than in basal cells (control) (Figure 23 
B). The heatmap image of the statistically processed data is another method to visualize 
grouping of samples and showing the differentially regulated genes. The gene is colored 
according to its expression level in the data, red is overexpressed and blue underexpressed. 
This clarified the similarities of expression levels within the groups (LRCs vs. Control) (Figure 
22 C).  
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Figure 23: (A) Non-metric multidimensional scaling (NMDS) comparison of the different samples. LRCs 
(triplicates) are depicted in green, basal cells (triplicates) in red. NMDS was performed by chipster. (B) 
Differential analysis of the gene expression profiles. Fold changes and p-values of LRCs against controls. 
Each dot represents a gene and is differentially expressed if it is not located on the diagonal. Scatter plot 
was created by chipster. (C) Chipster software was used to visualize the grouping of samples as a 
heatmap image.  Genes are colored according to their expression level in the dataset. Differentially 
overexpressed genes are colored in red or underexpressed genes in blue.  
Table 2 shows the 20 top upregulated genes and the top 6 downregulated genes with the 
highest foldchange. The complete list with all 102 differentially regulated genes can be found 
in the appendix. A selection of differentially regulated genes, which are classified in different 
clusters, is summarized in table 3. Clustering was performed with Chipster using Reactome 
which creates gene lists for over-represented pathways. Notably, the most over-represented 
pathways were pathways regarding the ECM composition, ECM interaction and cell adhesion 
(Table 3). 
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Table 2: (A) Overview about the genes with the highest fold change. A selection of 20 genes found to be 
most differentially upregulated in LRCs compared to basal cells. (B) Overview with the top 6 
downregulated genes. In bold are the genes which were validated by qRT-PCR. 
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Table 3: Functional classification of differentially regulated genes. Clustering was performed with 
chipster using Reactome which creates gene lists for over-represented pathways.  Shown are the top 10 
hits. 
Further analysis was done with Ingenuity pathway analysis (IPA) which is mapping data to 
biological processes and pathways as well as creating and modifying biological networks. 
The analysis showed a high involvement of genes associated with cellular assembly, 
organization and movement, cell death, survival, growth and proliferation (Table 4, Box A). 
Moreover the analysis predicted upstream regulators (Table 4, Box B). Particularly TGFβ 
was predicted to be upregulated and many upregulated genes from the dataset could be 
mapped to the TGFβ pathway (Table 4, Box C). 
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Table 4: (A) Summary of the Ingenuity pathway analysis (IPA) which is mapping data to biological 
processes and pathways as well as creating and modifying biological networks. (B) Top Upstream 
Regulators predicted by Ingenuity pathway analysis (IPA). (C) Genes in the dataset which could be 
mapped to the TGFβ pathway. TGFβ is predicted to be up- or downregulated or affected, calculated on the 
fold change of genes in the dataset compared to the data in the literature (Findings).  
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3.9 Validation of Gene Array data by Real-Time-quantitative-PCR 
From the genes that showed an increased expression level in basal LRCs compared to GFP-
negative basal cells, 12 candidates were selected (Table 2, in bold) and their expression was 
validated by Real-Time-quantitative-PCR (qRT-PCR) (Figure 24). For the validation, RNA 
from four experiments was used; LRCs and the GFP-negative basal cells (referred as 
control) were evaluated. Two were identical to those of the microarray analysis and two were 
achieved from two other independent experiments.  
3.9.1 Upregulation of ECM genes in LRCs 
The global gene expression analysis of fractionated LRCs revealed that the top upregulated 
genes and associated networks were ECM components, the assembly of ECM as well as 
adhesion to the ECM via the major class, integrins (Table 3). This was an unexpected result, 
since those genes are generally expressed in fibroblasts in the dermal part. However, 
regarding the stem cell niche the ECM plays an essential role and can profoundly influence 
cell fate and the maintenance of stem cell homeostasis (Brizzi et al., 2012; Hall, 1989; Lu et 
al., 2012). Decorin, an important member of the ECM in the skin, was shown to be most 
highly upregulated (22.4 fold change) in the LRCs analyzed by the microarray. This could be 
also confirmed by qRT-PCR, in all tested samples the relative mRNA expression was highly 
increased (3300 fold) (Figure 24 A, third bar), however there was a high variance between 
the expression levels within the analyzed groups (between 36 fold and 5600 fold increased 
expression).  Also other components of the ECM, like fibronectin, different collagens, fibulin 1 
and fibulin 2 had elevated gene expression in LRCs analyzed by the mircroarray. The 
verification with qRT-PCR for collagen, type I, alpha 1 (COL1A1), confirmed enriched mRNA 
levels (700 fold) (Figure 24 A, second bar). Validation by qRT-PCR for fibulin 1 expression 
showed a 1000 fold upregulation.  Likewise here we detected high variances between the 
expression levels within the analyzed groups (between 150 fold and 3200 fold increased 
expression). Fibronectin was about 40 fold increased (Figure 24 A), except of one group 
were the upregulation was only 2.4 fold. The relative mRNA expression of fibulin 2 in the 
analyzed LRCs was 7800 fold upregulated (Figure 24 A). Also here the expression levels 
had a high variance within the samples and were from 4 to 23.400. Lumican, a class II small 
leucine-rich proteoglycan, which also plays a key role in ECM organization (Schaefer and 
Iozzo, 2008), was shown to be 1.100 fold upregulated in LRCs (Figure 24 B) with expression 
levels between 11 and 4.230 fold within the analyzed groups.  
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Figure 24: qRT-PCR confirmed microarray data. Two LRCs and basal cells from OTCs analyzed in the 
BeadChip HumanHT-12 v4 gene expression array and two independent LRCs and basal cells from OTCs 
not analyzed in the BeadChip HumanHT-12 v4 gene expression array were used. The relative mRNA 
expression of selected genes, which were upregulated in the mircroarray, were validated with qRT-PCR. 
The mRNA expression of the tested genes were normalized to the control and the housekeeping gene 
GAPDH, as described (Pfaffl, 2001). Controls were set to 1 (dashed line). Results are the mean of the four 
experiments. 
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Surprisingly, vimentin, an intermediate filament protein, which is primarily found in 
mesenchymal cells and a marker for fibroblasts (Franke et al., 1979b) was also upregulated 
in LRCs. The mRNA expression of vimentin was 90 fold upregulated confirmed by qRT-PCR, 
whereas also here in one group the upregulation was only 2.4 fold (Figure 24 B). 
 
Thrombospondin-1 (THBS1) is a glycoprotein in the ECM that takes part in the cell-to-matrix 
communication through different pathways (Bornstein, 2001; Lawler, 2000; Sage and 
Bornstein, 1991; Taraboletti et al., 1990; Taraboletti et al., 1987) and is able to bind to 
fibronectin, laminins, collagens and other ECM proteins (Lahav et al., 1982). The microarray 
analysis revealed THBS1 as a 6 fold upregulated LRC transcript (Table 2). However, 
verification by qRT-PCR could not confirm the upregulation, since in two analyzed groups 
THBS1 expression was downregulated (0.06 fold and 0.002 fold). The mean value of THBS1 
expression was 6.000 fold increased (Figure 24 B) because the expression was in the two 
other LRCs between 212 fold and 24.200 fold increased.  
 
IGFB4 was shown to be highly upregulated (9 fold) in the microarray analysis (Table 2). 
IGFBP4 is an interesting target gene, since it binds and sequesters insulin growth factors 
and is thereby an inhibitor of the insulin pathway. The overexpression in LRCs may ensure 
that LRCs do not respond to IGF, a potent stimulant of epithelial proliferation (Bennett et al., 
2003; Sadagurski et al., 2006; Vasioukhin et al., 2001) and therefore regulate the quiescent 
replicative arrest. This assumption is supported by the fact that IGFBPs were also found to 
be upregulated in quiescent fibroblasts (Goldstein et al., 1991), mouse hair follicle stem cells 
(Morris et al., 2004) and quiescent human foreskin keratinocytes (Schluter et al., 2011). 
Particularly IGFBP4 can also bind to the canconcial Wnt receptors, frizzled and LRP6, 
thereby block signal transduction by Wnt (Cruciat and Niehrs, 2013). Therefore, also the 
inhibition of Wnt could play a role in LRCs. However, the analysis by qRT-PCR could not 
confirm increased transcription in all LRCs, in two groups we detected an upregulation 
(between 22 and 220 fold), while in two groups we detected no regulation or a 
downregulation (0.7 fold) (Figure 24 B).  
 
Tenascin c, also a member of ECM proteins and enriched in hair follicle stem cells (Morris et 
al., 2004) and bulge LRCs (Tumbar et al., 2004), was confirmed to be upregulated in LRCs 
(9 fold) determined by qRT-PCR (Figure 23 B).  
 
In summary, we could confirm the upregulation of COL1A1, decorin, fibulin 1, fibulin 2, 
fibronectin, lumican, tenascin C and vimentin. Whereas, the upregulation of IGFBP4 and 
THBS1 was not confirmed by qRT-PCR. 
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3.9.2 Degradation of ECM possibly inhibited in LRCs 
The microarray analysis revealed that LRCs expressed higher levels of TIMP2, a tissue 
inhibitor of metalloproteases (MMPs). MMPs are enzymes which are able to degrade all 
kinds of extracellular matrix proteins. Interestingly, TIMP2 was also upregulated in mouse 
hair follicle stem cells (Morris et al., 2004). The verification by qRT-PCR showed that the 
mean expression value of TIMP2 was 6.600 fold increased (Figure 24 B). Notably, also here 
the analyzed LRCs had a high variance in the mRNA expression levels, TIMP 2 was 
compared to the control cells between 9 and 26.500 fold upregulated. Our results indicate, 
that the upregulation of TIMP2 in LRCs could prevent the degradation of ECM proteins by 
MMPs.  
 
3.9.3 No EMT in LRCs 
Snai2 did not show up in the differentially regulated genes of the microarray, nevertheless 
there were hints that LRCs have phenotypic characteristics towards a more undifferentiated, 
mesenchymal phenotype e.g. the upregulation of vimentin (Figure 24 A). Since vimentin is 
also a marker for epithelial to mesenchymal transition (EMT) we wanted to exclude EMT of 
the LRCs. Therefore we tested the expression of Snai2 an inducer of EMT (De Craene and 
Berx, 2013). Interestingly, it was also shown that Snai2 can promote the transition of 
differentiated luminal cells to mammary stem cells (Mani et al., 2008). In addition Snai2 
expression was detected in the nucleus of basal cells in the human IFE and depletion of 
Snai2 leads to enhanced Keratin 10 expression, a differentiation marker. It was suggested 
that Snai2 can bind to differentiation promoting transcription factors and thereby regulate the 
undifferentiated state of basal keratinocytes (Mistry et al., 2014). Therefore, Snai2 was an 
interesting target and the expression of snai2 was analyzed. The mean gene expression of 
snai2 in LRCs was slightly upregulated (3 fold) (Figure 24 B). However, since in two groups 
of LRCs the expression was either not regulated (1.1 fold) or even downregulated (0.44 fold) 
we could not verify a specific upregulation of snai2 by qRT-PCR. Summarizing that we have 
no indication that snai2 does play a role in the state of LRCs nor we have EMT in the isolated 
LRCs. 
 
3.9.4 Upregulation of the cytokine IL6 in LRCs 
Interleukin 6, IL6, mRNA was the second highest upregulated gene in the analyzed LRCs (19 
fold) by the microarray (Table 2). IL6 acts as a multifunctional cytokine and regulates a broad 
range of inflammatory processes and stimulates immune responses (Kishimoto, 1989). 
Nonetheless, it was shown that IL6 expression in the skin has no direct prooinflammatory 
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activity (Turksen et al., 1992). Instead, it was demonstrated that IL6 expression did not 
enhance epidermal proliferation but was responsible for increased thickening of the stratum 
corneum (Turksen et al., 1992) and is an important regulator of the epidermal barrier (Wang 
et al., 2004). Moreover, it was proposed that IL6 regulates the survival and self-renewal in 
hematopoietic stem cells and early progenitors (Bernad et al., 1994). IL6 was confirmed to be 
upregulated by qRT-PCR with a mean fold change of 75 (Figure 24 B). Whereas the 
expression levels in the analyzed groups ranged from 11 to 189. However, the role of 
increased expression levels of IL6 in LRCs of the IFE is elusive and needs further 
investigations.  
 
3.9.5 Downregulation of Keratin 14 and histone clusters indicate reduced 
proliferation of LRCs 
Keratin 14, a marker of basal cells (Byrne et al., 1994; Coulombe et al., 1989), was 
downregulated in LRCs analyzed by the microarray. This result was verified by qRT-PCR, 
where Keratin 14 was downregulated with a fold change of 0.5 (Figure 24 C). It was 
suggested that downregulation of Keratin 14 results in reduced cell proliferation and that 
Keratin 14 expression plays a role in the maintenance of cell proliferation in the basal layer 
(Alam et al., 2011). Therefore, downregulation of Keratin 14 could also lead to a reduced 
proliferation of LRCs. 
 
Interestingly, mRNA transcripts for different histone clusters were also downregulated, 
revealed by the microarray analysis (table 2). It was shown that cells which progress from G1 
to S phase have an increased rate of histone gene transcription (Harris et al., 1991; Marzluff 
and Duronio, 2002). The Expression of the histone cluster 1, H4h (HIST1H4H) (0.4 fold 
change) and the histone cluster 1, H2bg (HIST1H2BG) (0.05 fold change) was 
downregulated confirmed by qRT-PCR (Figure 24 C) in LRCs. Therefore this could be a hint 
for a reduced cell proliferation in LRCs. 
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Figure 25: qRT-PCR revealed upregulated of TGFβ receptor 3. One sample of LRCs and basal cells from 
OTCs analyzed in the BeadChip HumanHT-12 v4 gene expression array and two independent LRCs and 
basal cells from OTCs, not analyzed in the microarray, were used. The relative mRNA expression of TGFβ, 
Smad3, Smad7, TGFβ receptor 1 (TGFβR1), TGFβR2 and TGFβR3 were validated with qRT-PCR. The 
mRNA expression of the tested genes were normalized to the control and the housekeeping gene GAPDH, 
as described (Pfaffl, 2001). Controls were set to 1 (dashed line). Results are the mean of the three 
experiments. 
 
3.10 Role of TGFβ in LRCs 
Although transforming growth factor-β (TGFβ) did not show up in the list of differentially 
regulated genes in the expression array analysis, the ingenuity pathway analysis (IAP) 
revealed TGFβ as one of the top upstream activators (Table 4). TGFβ signaling is known to 
be essential for the regulation of cell growth, development, and stem cell renewal and 
differentiation (Massagué and Chen, 2000; Patterson and Padgett, 2000; Ten Dijke et al., 
2002, 2009, Miyazono). Moreover it was shown that TGFβ signaling inhibits the proliferation 
of keratinocytes (Massague andWeinberg,1992). Thus, TGFβ may be an interesting target as 
it may regulate the slowly cycling of the LRCs. Accordingly, the expression of TGFβ, the 
TGFβ receptors and Smad3 and Smad7 was analyzed. Smad proteins, like Smad3, are 
mediating signals from the cell membrane to the nucleus (Derynck et al., 1998; Massagué, 
1998), whereas Smad7 acts as an endogenous Smad pathway inhibitor. We did not find 
differences in the expression level of TGFβ (Figure 25 A). Smad3 was slightly downregulated 
(0.4 fold change). Furthermore, the mean expression of Smad7 was upregulated (5 fold) 
(Figure 24 A), but was strongly downregulated (0,002 fold) in one group. Taken together, 
there were no differences in the expression of TGFβ or Smad3 and Smad7.  
 
The TGFβ receptor type I showed a slight down-regulation (0.6 fold change) whiles the TGFβ 
receptor type II was slightly upregulated (2.5 fold) in the LRCs (Figure 25 B). Interestingly, 
the TGFβ receptor type III (TGFβR3) was strongly upregulated (5.000 fold) (Figure 25 B). 
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TGFβR3, also named as betaglycan, is located at the cell surface and was shown to bind all 
three TGFβ isoforms with high affinity (Kaname and Ruoslahti, 1996). Betaglycan presents 
TGFβ to the TGFβR2 and promotes the binding of TGFβ, thereby regulating the availability 
of TGFβ to the cell. Betaglycan can serve as reservoir for TGFβ (Blobe et al., 2001; Lopez-
Casillas et al., 1991). However, betaglycan has no intrinsic TGFβ signaling activity (Andres et 
al., 1991; Cheifetz et al., 1987). Notably, there were observations that also other members of 
the TGFβ superfamily, like the bone morphogenetic proteins BMP-2 and BMP-7 are able to 
bind to betaglycan which is increasing the binding of BMPs to the their receptors (Kirkbride et 
al., 2008). Taken together, the qRT-PCR results do not support an upregulation of the TGFβ 
pathway, whereas increased betaglycan expression could indicate higher availability of 
TGFβ. 
 
3.11 No increased ECM protein expression of LRCs 
As a first attempt to investigate whether RNA upregulation was also effective for protein 
expression of selected target genes with elevated mRNA expression, indirect 
immunofluorescence (IIF) stainings were performed. For the staining, sections of OTCs from 
the analyzed isolated LRCs were used.  There was a strong expression of fibronectin in the 
dermal part and the basement membrane (Figure 26 A). However, with conventional 
detection methods no apparent difference of protein expression in LRCs (Figure 26 A, white 
arrows) and basal cells equally in the inherent underlying basement membrane was seen. 
This was also for thrombospondin-1, vimentin and decorin the case (Figure 26 B, C, D). 
Nevertheless, since this was only a first attempt to investigate the protein expression of ECM 
components in LRCs more effort has to be taken to explore this further.  
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Figure 26: Protein expression of ECM molecules and vimentin in LRCs vs. basal cells. Cryosections of 8-
week-old OTCs (sca OTCs with 6 weeks chase) grown from H2B-GFP NHEK used for the microarray were 
fixed and then analyzed by immunofluorescence staining for the expression of (A) Fibronectin and 
(B)Thrombospondin-1 (Thbs1) and (C) Vimentin as well as (D) Decorin. Stainings all shown in red. GFP is 
shown in green. Nuclei were counterstained with Dapi. LRCs: white arrows. Scale bar: 100µm. 
 
3.12 Induction of a LRC phenotype in vitro by TGFβ stimulation 
The ingenuity pathway analysis (IAP) associated many genes, which were upregulated in the 
microarray analysis, to the TGFβ pathway (Table 4 C). Moreover, our results showed an 
increased TGFβR3 (betaglycan) expression (Figure 25 B), which was shown to enhance the 
TGFβ dependent signaling by increasing the affinity of the ligand to TGFβR2 (Lopez-Casillas 
et al., 1993; Sankar et al., 1995). Therefore, we wanted to test if TGFβ can induce the 
expression of target genes, found in the microarray, in NHEKs in 2D cultures. It was already 
shown that TGFβ can induce a more mesenchymal phenotype with higher vimentin and 
fibronectin expression (Miettinen et al., 1994). NHEKs were cultivated in low-calcium medium 
(DermaLife) and treated either with 1ng/ml or 5ng/ml TGFβ-1 for up to 7 days. Gene 
expression was analyzed after 8 and 48 hours as well as 3 and 4 days. First results showed, 
that there was an early induction of vimentin (2.2 fold), thrombospondin-1 (THBS1) (2.3 fold), 
fibronectin (3.4 fold), Interleukin 6 (IL6) (2.6 fold), collagen, type I, alpha 1 (COL1A1) (3 fold) 
and tenascin C (3.3 fold) 8 hours after TGFβ treatment (Figure 27). After 2 days the relative 
mRNA expression of vimentin, THBS1, fibronection and IL6 decreased slightly, whereas the 
expression of COL1A1 (fold change 1.1) was not regulated or for tenascin C even slightly 
downregulated (0.9 fold, Figure 27). After 4 days of treatment with 1ng/ml TGFβ-1 vimentin 
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was 3 fold increased, also fibronectin, IL6 and COL1A1 were slightly upregulated while there 
was no difference in the expression levels of THBS1 and tenascin C between 48 hours and 4 
days (Figure 27). However, there was increased expression of vimentin (5.4 fold), THBS1 
(2.8 fold), fibronectin (20.5 fold), Il6 (22.6 fold), COL1A1 (4.3 fold) and Tenascin c (3.3 fold) 
in NHEKs after treatment with 5ng/ml after 3 days (Figure 27). There was no difference in the 
expression level of fibulin 1 independent of the time and concentration of TGFβ treatment 
(Figure 27). Even though there were indications that for instance in human airway smooth 
muscle cells TGFβ induced Fibulin1C mRNA expression (Lau et al., 2010). Taken together, it 
was possible to slightly induce genes, which had elevated expression levels in LRCs, by 
TGFβ stimulation, whereas treatment with higher TGFβ-1 concentrations (5ng/ml) seems to 
be required.  
 
To determine if TGFβ-1 stimulation also causes a downregulation of the histone clusters, as 
seen in LRCs, we also analyzed the expression of histone Cluster 1, H2bg (HIST1H2BG) in 
TGFβ treated NHEKs. We could determine a slight upregulation of HIST1H2BG (1.8 fold) in 
NHEKs stimulated with 5ng/ml TGFβ for 3days (Figure 27). Therefore, stimulation with 
TGFβ-1 did not lead to a decrease in histone cluster expression. 
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Figure 27: To characterize the effect of TGFβ stimulation NHEKs were cultivated in DermaLife without 
feeder for 8h, 48h and 4days with 1ng/ml TGFβ-1 or for 4days in 5ng/ml TGFβ-1 in 2D. Cells were 
harvested for total RNA-isolation and were subjected to qRT-PCR using primers specific for Vimentin, 
Fibulin 1, Thrombospondin-1 (THBS1), Fibronectin, Interleukin 6 (IL6), collagen, type I, alpha 1 (COL1A1), 
Tenascin C, Histone Cluster 1, H2bg (HIST1H2BG), SMAD3, SMAD7 and Cyclin-Dependent Kinase 
Inhibitor 1A (P21) to quantify relative mRNA expression. The mRNA expression of TGFβ stimulated 
samples was normalized to the unstimulated control and the housekeeping gene GAPDH, as described by 
(Pfaffl, 2001). Controls were set to 1 (dashed line). 
 
3.13 TGFβ pathway is activated upon stimulation with high concentrations of 
TGFβ in NHEKs cultivated in low-calcium medium 
In order to analyze if the TGFβ pathway is activated in NHEKs treated with different TGFβ 
concentrations in 2D, we looked for the expression of Smad3, Smad7 and the cell cycle 
inhibitor P21 by qRT-PCR. TGFβ was shown to induce the expression of cell cycle inhibitors, 
like Cyclin-Dependent Kinase Inhibitor 1A (P21) and cyclin-dependent kinase inhibitor 2B 
(P15) (Buschke et al., 2011; Datto et al., 1995; Hannon and Beach, 1994; Massague, 2000; 
Reynisdottir et al., 1995). We detected only a slight increase of P21 expression (2 fold) after 
treatment with 5ng/ml TGFβ for 3days (Figure 27). Furthermore there was no upregulation of 
SMAD3 in stimulated NHEKs (Figure 27). The expression of the endogenous Smad pathway 
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inhibitor, SMAD7, is induced by TGFβ (Buschke et al., 2011; Itoh et al., 2000; Massague and 
Chen, 2000; Moustakas et al., 2001). Smad7 was slightly upregulated (2.2 fold) after TGFβ 
stimulation for 3 days with 5ng/ml (Figure 27). In summary, these data do not support an 
activation of the TGFβ pathway in NHEKs treated with TGFβ-1 in monoculture. 
 
Therefore, we determined the phosphorylation status of the intracellular mediators of TGFβ 
signaling, Smad3, in response to TGFβ treatment in NHEKs by IIF. Expression of phospho-
Smad3 was detected partially in NHEKs in response to 5ng/ml TGFβ (for 48 hours) whereas 
upon treatment with 10ng/ml (for 48 hours) a strong phosphorylation of Smad3 was observed 
compared to the untreated control cells (Figure 28 A). This demonstrated that upon treatment 
with 5ng/ml TGFβ-1, the TGFβ pathway was not activated in all cells, whereas this was the 
case upon treatment with 10ng/ml TGFβ-1.  
 
  
Figure 28 (A) Single cell suspension of NHEKs treated for 48h with 5ng/ml or 10ng/ml TGFβ or the 
unstimulated Control on a cytospin slide. Nuclei are stained with Dapi (blue), Phospho-Smad3 staining is 
shown in red. (B) Phase contrast images of NHEKs in passage 2 treated with 5ng/ml or 10ng/ml TGFβ for 
3days compared to the unstimulated Control. Scale bar: 100µm.  
 
3.14 Influence of TGFβ on the proliferation of NHEKs in low-calcium medium 
TGFβ is known for the inhibition of the proliferation of keratinocytes in 2D cultures 
(Massague and Weinberg, 1992). To confirm that also NHEKs used for our 3D experiments 
are sensitive to TGFβ-dependent growth inhibition, NHEKs were supplied with 10pg to 
1ng/ml TGFβ-1 in monolayer cultures for up to 7 days. Counting cell numbers showed that 
the presence of TGFβ in a concentration up to 1ng/ml had no influence on the proliferation of 
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keratinocytes in low-calcium medium (Figure 29 A). Only treatment with a concentration of 
5ng/ml led to decreased proliferation (30%) already after 24 hours (Figure 29 B). NHEKs 
treated from passage 2 over several passages with low concentrations (1ng to 1pg/ml) 
showed decreased proliferation (Figure 29 C), this effect became even more pronounced in 
the presence of 1ng/ml (Figure 28 C).  
 
 
Figure 29: (A) NHEK in passage 2 cultivated in low-calcium medium (without feeder) were stimulated for 
8h, 24h, 48h, 4days and 7days either with 10pg/ml, 100pg/ml or 1ng/ml TGFβ and compared to the 
unstimulated Control. Cells were trypsinized and counted at each timepoint. (B) NHEK in passage 2 
cultivated in low-calcium medium (without feeder) were stimulated for 1, 2 and 3days with 5ng/ml TGFβ 
and compared to the unstimulated Control. Cells were trypsinized and counted at each timepoint. Cell 
counting was performed in duplicates per time point. (C) NHEK in passage 3 (p3), p4, p5 and p6 were 
cultivated in low-calcium medium (without feeder) and were stimulated from passage 2 continuously 
either with 10pg/ml or 1ng/ml TGFβ and compared to the unstimulated Control. Cells were trypsinized and 
counted at each timepoint 
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Phase contrast images of NHEKs treated with 5ng/ml or 10ng/ml showed upon treatment of 
5ng/ml only a slight effect on the proliferation (Figure 28 A), whereas treatment with 10ng/ml 
of TGFβ-1 had an enhanced inhibiting effect on the proliferation of NEHK (Figure 28 B). 
These data clearly demonstrated that TGFβ-1 stimulation with low concentrations (1ng to 
1pg/ml) for up to 7 days did not influence the proliferation of NHEKs. Inhibition of proliferation 
is achieved only upon stimulation over several passages with low concentration or treatment 
with higher TGFβ-1 concentrations (5-10ng/ml) in low-calcium medium.  
 
3.15 TGFβ stimulation increased ECM protein expression in 2D cultures 
To analyze protein expression of target genes which are involved in TGFβ signaling and 
were shown to be upregulated after stimulation with TGFβ-1 in NHEKs (Figure 27), indirect 
immunofluorescence (IIF) staining was performed. Therefore, NHEKs were harvested after 3 
days of treatment with 5ng/ml TGFβ-1. Single cell suspensions of these NHEKs are spun 
onto a microscope slide and IIF stainings were performed. There was a strong upregulation 
in protein expression of decorin after treatment with TGFβ for 3 days with 5ng/ml (Figure 30 
A). Furthermore increased expression of fibronectin and vimentin was observed after 
stimulation with TGFβ-1 (Figure 30 B, C). These data confirmed increased protein 
expression in NHEKs after stimulation with TGFβ-1 of target genes shown in the microarray. 
 
 
Figure 30: Single cell suspension of NHEK treated for 3days with 5ng/ml TGFβ (lower panel) or the 
unstimulated Control (upper panel) on a cytospin slide. Nuclei are stained with Dapi (blue), Decorin and 
Fibronectin staining is shown in red. Vimentin staining is shown in green. Scale bar: 100µm. 
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3.16 Clonal Analysis in OTCs 
Several studies suggested that 1-10% of the basal cells are stem cells (reviewed in (Kaur, 
2006) ). We wanted to investigate how many stem cells in OTCs are required to maintain the 
epidermis long-term. Linear amplification-mediated PCR (LAM-PCR) is a powerful tool to 
study cell kinetics in OTCs. With LAM-PCR it is possible to identify the integration site of 
lentiviral vectors in the cellular genome (Schmidt et al., 2007; Schmidt et al., 2009). This 
integration site serves as a unique molecular marker for each transduced cell and its clonal 
progeny. Using H2B-GFP transduced NHEKs allows tracking of individual vector integration 
sites and studying the clonal distribution in OTCs. For the analysis, H2B-GFP NHEKs were 
FACSorted for their GFP expression, expanded in 2D and seeded on fdm OTC. After 2, 6, 9 
and 12 weeks, respectively, the epidermis was separated from the dermis and the DNA of 
the epidermis was isolated. LAM-PCR was performed by the group of Prof. Hanno Glimm 
(DKFZ, Heidelberg). After 2 weeks of cultivation 186 individual clones could be detected 
(Figure 31). After 6 weeks, we saw a strong decline of the number of detected clones, only 
22 clones could be found. After 9 weeks 4 clones could be detected on average which 
maintain the entire epithelium of the OTCs. After a cultivation period of 12 weeks, only a 
single clone is responsible for maintaining the epidermis of the OTC. Although this approach 
did not provide any information about the average size of the clones during the cultivation in 
OTCs, these studies revealed that the number of clones progressively decreased in OTCs 
over time which confirmed studies in the mouse tail skin epidermis (Clayton et al., 2007). 
Moreover, our data suggest that only a single stem cell is able to maintain epidermal 
regeneration of the entire OTC. 
 
Figure 31: Clonal analysis of OTCs. LAM-PCR performed of fdm OTCs grown from H2B-GFP NHEK after 2, 
6, 9 and 12 weeks. DNA was isolated from the epithelium of the OTCs and then analyzed by LAM-PCR for 
the individual integration sites of the viral vector. n= 2. A sequencing validity cut-off was set as described 
(Dieter et al., 2011). Collisions below the cut-off were removed from the analysis. Graph of the individual 
integrations site after the indicated timepoints. 
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4 Discussion 
The aim of this study was the isolation and characterization of label-retaining cells, the 
potential epidermal stem cells. The purification and molecular characterization of vital label-
retaining cells (LRCs) is a key feature to understand the role of LRCs in long-term 
regeneration of the epidermis. Since there are no distinct markers, the identification of stem 
cells in the human interfollicular epidermis is still difficult. Studies of the human IFE revealed 
heterogeneous proliferation of the keratinoctyes within the epidermis (Potten, 1974; Potten 
and Morris, 1988; Rowe and Dixon, 1972). Because it is thought that stem cells rarely divide, 
LRCs were designated as stem cells (Bickenbach, 1981). However, using DNA labels like 5´-
iodo-2´-deoxyuridine (IdU) or 5´-bromo-2´-deoxyuridine (BrdU) for the detection of LRCs 
does not allow the isolation of living slow-cycling cells due the required fixation methods. A 
new pulse-chase strategy based on the Tet-Off controlled expression of a Histone2B-GFP 
fusion protein was used by Tumbar et al. (Tumbar et al., 2004) to detect LRCs in living young 
mice and to isolate vital LRCs from mouse epidermis. A major benefit of this labeling method 
is the constant expression of H2B-GFP without affecting chromosomal structures (Kanda et 
al., 1998) and a slow turnover of the H2B-GFP fusion protein (Brennand et al., 2007; Tumbar 
et al., 2004). To study and isolate LRCs in the human system, we used organotypic cultures 
(OTCs). OTCs grown from human normal keratinocytes (NHEK) can be cultured for several 
weeks and thereby permit the development of a stem cell niche (Muffler et al., 2008). 
Moreover, the establishment of LRCs in the basal layer was shown (Muffler et al., 2008). 
Therefore, OTCs as a 3D in vitro model of the human skin, provide an excellent experimental 
tool to study epidermal stem cells (Muffler et al., 2008; Stark et al., 2006; Stark et al., 2004). 
 
4.1 H2B-GFP lentiviral reporter for the detection of LRCs 
The generation of a Tet-Off-H2B-GFP lentiviral reporter could be used to infect various cell 
types, like HeLa cells, murine pancreatic ductal adenocarcinoma (mPDAC) cells, 
Neuroblastoma cell lines, Medulloblastoma cell lines, Hepatocarcinoma cell lines and 
epidermal cell lines (Falkowska-Hansen et al., 2010). Moreover, it offers a new method for 
the detection of LRCs in 3D tissue culture systems (Falkowska-Hansen et al., 2010). The 
identification of LRCs in OTCs grown from H2B-GFP transduced human malignant 
keratinocytes was reported by Falkowska-Hansen et al.  Our first goal was to successfully 
infect normal human keratinocytes (NHEK) with the same lentiviral vector. Since epithelial 
cells, like primary keratinocytes, are difficult to infect with adenoviral or lentiviral vector 
systems (Arcasoy et al., 1997; Grubb et al., 1994) the transduction method was optimized. 
With a modified infection method, like spinoculation and the addition of polybrene, 
transduction could be significantly improved and reached infection rates up to 90%. The 
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spinoculation procedure was also shown in other studies to increase transduction rates from 
40 to >90% for primary keratinocytes without influencing cell viability (Gagnoux-Palacios et 
al., 2005). The addition of 8µg/ml polybrene increased the infection rate by 20-30% (Figure 
1), confirming previous works (Nanba et al., 2013). However, Nanba et al. showed a 
reduction of keratinocyte proliferation at polybrene concentrations higher than 5μg/ml (Nanba 
et al., 2013). Notably, in these studies keratinocytes were exposed to polybrene over night, 
which could have negative effects. With our infection method NHEKs were incubated with the 
virus and polybrene for only 90 minutes and we could not observe any toxicity on the cells. 
This was in agreement with studies from Kuhn et al. where the cells were exposed to 
polybrene for 4 hours and no toxic effects were reported (Kuhn et al., 2002).  
 
To perform pulse-chase experiments with this reporter system, it is important to reliably turn 
off the GFP expression in keratinocytes. Therefore, the responsiveness of the reporter to 
Dox is crucial. For the detection of LRCs in OTCs, H2B-GFP is expressed in all cells for the 
first 2 weeks in the absence of Dox (pulse period). Subsequently, Dox is added to the culture 
medium and thus the expression of the reporter is turned off. The H2B-GFP is diluted in all 
proliferating cells (chase period), only slow-cycling cells are able to keep the label and can 
be detected as LRCs. If the reporter is not reliably turned off in all cells after addition of Dox, 
H2B-GFP positive cells could be identified as false positive LRCs after the chase period. 
NHEKs in 2D cultures showed a tight regulation of the reporter without toxicity. This was 
consistent with studies done in human malignant keratinocytes (HaCaT-ras II4) (Falkowska-
Hansen et al., 2010). The tight control of the vector could be also demonstrated in 3D 
cultures, showing that GFP expression after the chase period is a result of a long-lived, 
stable protein and not de novo expression in the presence of Dox (Figure 12).  
 
However, when analyzing OTCs with H2B-GFP NHEK in the absence of Dox, we detected a 
decline of H2B-GFP positive cells (10-30%) already after 2 weeks of cultivation even though 
the culture contained 100% GFP positive cells at the beginning of the experiment. Notably, 
long-term transgene expression was still sustained in most of the cells even after 8 weeks in 
the absence of Dox. This demonstrated that the H2B-GFP expression is not turned off in all 
cells over time (in the absence of Dox) and there was no growth advantage of the H2B-GFP 
negative cells. The decline of H2B-GFP cells could be due to transcriptional silencing which 
can occur with lentiviral infection (He et al., 2005). Other studies did not observe such 
findings, only aberrant expression of H2B-GFP reporter in transgenic mice was reported 
(Challen and Goodell, 2008) or possible insertion of the H2B-GFP transgene into sites of 
permanently silenced chromatin (Fuchs E., 2005, Patent WO2005054445A8).  
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Moreover, we wanted to ensure that the expression of the H2B-GFP protein in NHEKs does 
not influence the epidermal homeostasis. It was shown that tissue homeostasis is maintained 
by the interplay between stem cells and its surrounding cells (Moore and Lemischka, 2006). 
Therefore it was of major importance to achieve tissue integrity and long-term epidermal 
regeneration with H2B-GFP transduced NHEKs. BrdU can be toxic for human skin 
keratinocytes (Muffler et al., 2008). Interestingly, treatment of HSCs with BrdU caused an 
injury response leading to increased proliferation of HSCs (Wilson et al., 2008). In our study 
we could not detect any influence of H2B-GFP on the proliferation of NHEKs neither in 2D 
nor in 3D (Figure 9 and 11). Keratinocytes transduced with the H2B-GFP lentiviral vector 
were capable of generating a well-organized epithelium positive for epidermal differentiation 
markers and markers for a mature basement membrane and cell-cell contacts (Figure 13 and 
14). In summary, the Tet-Off-H2B-GFP lentiviral vector can maintain long-term gene 
expression without toxicity in NHEK grown on OTCs. 
 
4.2 OTCs to study stem cells in the human epidermis 
To test if there are differences in the growth of H2B-GFP keratinocytes between different 3D 
models we used two types of OTCs, scaffold-based OTCs (sca OTCs) and fibroblast-derived 
matrix OTCs (fdm OTCs) in our studies. Sca OTCs can support epidermal tissue 
regeneration of NHEKs for 15 weeks or longer (Boehnke et al., 2007; Stark et al., 2004) and 
are therefore a suitable tool to study LRCs. Moreover, LRCs labeled with IdU could be 
identified in sca OTCs (Muffler et al., 2008). For fdm OTCs, normal human dermal fibroblasts 
(NHDF) were used to generate a fibroblast-derived matrix as dermal equivalent, called 
fdmDE. By using fdm OTCs, an epidermis with normal tissue morphology was maintained for 
up to 24 weeks (Berning et al., 2015). Furthermore, an improved matrix with a high density of 
assembled collagen fibrils and a dermal ECM which largely displays the dermal ECM 
architecture in the human skin was demonstrated (Berning et al., 2015). There is growing 
evidence that the ECM is crucial for the establishment of the stem cell niche by directly or 
indirectly regulating the maintenance, proliferation, self-renewal and differentiation of cells 
(Lu et al., 2012). We therefore also used fdm OTCs. Histological stainings and analysis of 
typical epidermal marker proteins, like Desmoglein, E-Cadherin, Keratin 14 or α6 integrin did 
not reveal any differences between H2B-GFP NHEKs grown on sca OTCs or fdm OTCs. In 
both culture approaches, the cells followed a normal differentiation process and established 
a basement. Thus, there was no evidence for an advantage of the fdm OTCs compared to 
sca OTCs. Since the precultivation time is significantly shorter in sca OTCs compared to fdm 
OTCs, we used sca OTCs for all further co-culture experiments. 
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4.3 Influence of the Rho kinase inhibitor Y-27632 on NHEKs 
It was shown that treatment with Y-27632 successfully immortalized human foreskin 
keratinocytes, human ectocervical keratinocyte and human vaginal keratinocytes (Chapman 
et al., 2010). Gene expression analysis performed by Chapman et al. revealed 
downregulation of many genes which are expressed during keratinocyte differentiation as an 
effect of rho kinase inhibition. It is believed that inhibition of differentiation and stratification is 
one of the key causes for the long-term keratinocytes proliferation mediated by ROCK 
inhibition (Chapman et al., 2014). Supporting this, Notch1, an inducer of keratinocyte 
differentiation (Watt et al., 2008), was suggested as upstream regulator for ROCK1. 
Interestingly, it was suggested that the activation of ROCK is mediated by signal transduction 
and not on transcriptional level (Yugawa et al., 2013). Rho kinases are targeting the 
phosphoproteome rather than the transcriptome (Chapman et al., 2014). Nonetheless, the 
precise mechanism of Y-27632–mediated long-term proliferation of keratinocytes is still 
elusive. With the addition of Y-27632, we were able to passage NHEKs for several months 
(Figure 16). Moreover, we showed that cocultivation with feeder fibroblasts is indispensable 
for long-term subculturing of NHEK in the presence of Y-27632 (Figure 16) as described by 
Chapman et al. (Chapman et al., 2010). As demonstrated by several other studies (Chapman 
et al., 2010; McMullan et al., 2003; Terunuma et al., 2010) proliferation of NHEKs in the 
presence of Y-27632 was increased in our experiments. Previous studies have also shown 
that keratinocytes that had been cultured with Y-27632 for up to 18 passages kept their 
ability to differentiate after removal of Y-27632 and formed a stratified epithelium in 
organotypic cultures after 17 days (Chapman et al., 2010). Here, we found that NHEKs, 
precultivated in Y-27632, maintained their capacity to form a stratified epithelium. However, 
H2B-GFP transduced NHEKs retained their proliferation potential over several passages in 
the presence of Y-27632 in 2D, but did not form a stratified epidermis long-term in OTCs. In 
contrast to our results, van den Bogaard et al. showed even enhanced epidermal 
morphology of OTCs generated from transduced, Y-27632- treated keratinocytes with Y-
27632 present during the submerged phase of the OTCs (van den Bogaard et al., 2012). 
However, this study did not consider long-term regeneration since the OTCs were harvested 
after 10 days (van den Bogaard et al., 2012). Therefore, we suggest that long-term 
regeneration cannot be achieved with transduced NHEKs precultivated in the presence of Y-
27632 grown on OTCs. Consequently, we could not perform repeated FACSoring in order to 
select for a stable H2B-GFP population. Such approaches are under normal culture 
conditions restricted owed to the limited life span of NHEKs. All subsequent studies were 
done with H2B-GFP NHEKs, which were not expanded in Y-27632 and a decline of H2B-
GFP expression during the pulse period has to be taken into account with the possible 
consequence, that less LRCs than present could be detected after the chase period. 
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4.4 Detection and Isolation of LRCs in OTCs 
One assay to study epidermal stem cells in the absence of distinct cell surface markers is to 
functionally identify stem cells as label-retaining cells. Stem cells are believed to divide rarely 
and can therefore be identified as label-retaining cells (LRCs) (Arai and Suda, 2007; 
Bickenbach, 1981; Bickenbach et al., 1986; Cotsarelis et al., 1990; Morris and Potten, 1999; 
Orford and Scadden, 2008). Evidence for this could be also found in the interfollicular 
epidermis where it was shown that slow cycling cells in vivo are those cells with the highest 
self-renewal capacity in vitro (Jones et al., 1995). LRCs could also be detected in the in the 
HF bulge (Braun et al., 2003; Cotsarelis et al., 1990). The way in which stem cells balance 
tissue maintenance in the IFE is still elusive and is controversially debated. Therefore, there 
is a strong need to isolate and characterize LRCs of the human IFE in order to investigate 
the role of LRCs in tissue homeostasis and to find new markers for their identification. In our 
studies, we were able to detect LRCs after chase periods up to 11 weeks (Figure 20). 
Intriguingly, LRCs were detected mostly in clusters. This clustered distribution was also 
reported for the permanent portion of the hair follicle and cornea limbus (Braun et al., 2003). 
In OTCs of human skin LRCs were observed more individual, nonclustered cells (Muffler et 
al., 2008). Accordingly in the interfollicular epidermis of mouse back and tail skin (Braun et 
al., 2003) and in the sweat gland of mice LRCs were also detected in a scattered pattern. 
However, we could not detect any uniform pattern of the LRC distribution which would 
indicate the presence of epidermal proliferative units suggested by previous studies 
(Mackenzie, 1970; Morris et al., 1985; Potten, 1974). Different patterns of LRCs could be due 
to differences in mouse and human skin and different labeling methods. Notably, LRC 
detection in OTCs was done by labeling with IdU (Muffler et al., 2008). A main disadvantage 
of labeling with IdU is the harsh condition to visualize the label which could degrade the 
structure of tissue (Salic and Mitchison, 2008). Moreover, the antibody detection of IdU could 
be less sensitive than the detection of GFP without any fixation or antibody staining.  This 
could explain different patterns of LRCs in OTCs. The LRC cluster could be a result of 
differences in the proliferative manner of individual LRCs. It was reported that individual 
quiescent LRCs were able to proliferate and could be detected as Ki67-positive in OTCs at 
all time points, even after 10-week chase (Muffler et al., 2008). Additionally Ki67- positive 
cells were detected close to LRCs (Muffler et al., 2008). Clusters of LRCs could indicate that 
not only LRCs are occasionally proliferating, but also the progeny of these LRCs are slow- 
cycling cells.   
 
In our study, we were able to isolate LRCs in a range between 1% and 7.4% of basal cells 
(Figure 21 B). The results are in agreement with in vivo experiments of the murine 
interfollicular epidermis (Morris et al., 1985; Morris and Potten, 1994). In another study 
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performing limiting dilutions experiments, different ratios of GFP-positive keratinocytes and 
GFP-negative keratinocytes of the murine IFE were mixed in order to study long-term 
repopulating cells transplanted on the fascia of mice. The results proposed that only 0.01% 
of the basal cells are stem cells (Schneider et al., 2003). However, it is likely that the 
suggested stem cell numbers could differ depending on the methodology of detection (in vivo 
vs. in vitro vs. transplantation studies) and model system (murine vs. human IFE).  
 
4.5 Molecular characterization of LRCs 
With the aim to find different gene expression patterns and new markers to identify LRCs we 
performed global gene expression analysis of the isolated LRCs.  
The previously suggested epidermal stem cell marker of the human IFE, such as expression 
of β1 integrinhigh, the Notch-ligand delta-like 1 (DLL1), the melanoma chondroitin sulfate 
proteoglycan (MCSP), the transmembrane protein LRIG1 and the transmembrane 
glycoprotein CD46 (Jensen and Watt, 2006; Jones and Watt, 1993; Legg et al., 2003; Lowell 
et al., 2000; Tan et al., 2013), could not be recapitulated in our analysis. Notably, single cell 
expression profiling of human keratinocytes did not always show an overlap of expression of 
these suggested marker (Jensen and Watt, 2006). Moreover, although cells isolated on the 
basis of these markers had a greater colony forming efficiency in 2D (Tan et al., 2013), little 
is known about the contribution of these cells to the homeostasis of the IFE due to the lack of 
further characterization by transplantation assays. Furthermore, it was already shown that in 
OTCs grown from NHEKs some but not all LRCs co-expressed MCSP, and some MCSP-
positive clusters lacked LRCs altogether (Muffler et al., 2008). Other suggested markers are 
high expression of α6 integrin and low expression of the transferrin receptor CD71 in 
quiescent keratinocytes (Li et al., 1998). These cells showed in transplantation studies 
greater intrinsic tissue-regenerative capacity (Li et al., 2004; Schluter et al., 2011). 
Interestingly, cells with α6bri and CD71dim expression were detected at the bottom part of the 
rete ridges in human IFE, whereas cells expressing MCSP, DLL1 and β1 integrinhigh were 
located at the opposite site (Muffler et al., 2008). The Wnt inhibitor WIF1 was also suggested 
as marker for quiescent stem cell in the IFE and LRCs in OTCs showed co-expression of 
WIF1 (Schluter et al., 2013). The heterogeneous expression of stem cell markers could 
display a functional heterogeneity of stem cells in the IFE. Heterogenic expression could be 
also due to body-site specific variances in the structure of the IFE, for example there are rete 
ridge-poor parts in human skin, like e.g. human breast skin. However, in our microarray 
analysis of isolated LRCs we did not detect any upregulation of the suggested marker. 
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In our study, differential analysis of the gene expression profiles clearly showed a high 
correlation of gene expression within the isolated LRCs and basal cells, reflecting a 
homogeneous population of analyzed cells (basal keratinocytes) (Figure 23 B). However, the 
transcriptional profiling of isolated LRCs revealed a group of 102 genes which were 
differentially expressed (Table 2, and Table 6 in the appendix). The microarray analysis 
unexpectedly revealed that especially ECM genes were highly upregulated in LRCs. There is 
growing evidence that particularly the ECM provides an essential niche component for stem 
cells in various tissues (Hall and Watt, 1989; Scadden, 2006; Spradling et al., 2001; Watt and 
Hogan, 2000). Also in the human skin several hints can be found for the important role of the 
ECM in the regulation of epidermal stem cells. Strikingly, ECM and integrin expression 
seems to differ among different regions of the human skin (Watt, 2002). Furthermore, 
variations of ECM components and integrins play a role during development. For example, it 
was suggested that neonatal keratinocytes and neonatal fibroblasts maintain a higher 
integrin expression (Cho et al., 2004; Choi et al., 2015). Moreover, the differential expression 
of ECM components can modulate tissue specificity (Votteler et al., 2010; Watt and Fujiwara, 
2011). It was also suggested that increased level of integrin expression, which mediates cell 
binding to the ECM, can be used as marker to enrich epidermal stem cells (Jones et al., 
1995; Jones and Watt, 1993; Stingl et al., 2006; Wagers and Weissman, 2006; Watt and 
Jones, 1993) and make them more adhesive to the ECM (Jones et al., 1995). Accordingly, 
the loss of contact with the ECM or reduced integrin expression leads to the differentiation of 
epidermal cells (Grose et al., 2002; Watt, 2002). Importantly, microarray analysis of 
epidermal mouse label-retaining cells and Keratin-15-positive mouse hair follicle stem cells 
revealed that these cells also showed increased expression of ECM genes (Morris et al., 
2004; Tumbar et al., 2004).  
Our findings support a functional role for ECM components for stem cell regulation. We could 
show increased expression in LRCs for collagen, type I, decorin, fibronectin-1, fibulin 1, 
fibulin 2 and lumican, which are all important members of the ECM. Decorin, a small leucine 
rich proteoglycan, is abundant in the ECM of the human skin (Carrino et al., 2011; Seidler, 
2012). Decorin is binding to type 1 collagen which is necessary for proper collagen fibril 
assembly and prevents the cleavage by MMPs (Ruhland et al., 2007; Stuart et al., 2011). 
Interestingly, decorin and collagen, type 1 were identified as quiescins. Quiescins are genes 
which were found to be upregulated in quiescent cells, for example W138 human embryo 
lung fibroblasts, compared to actively cycling cells (Coppock et al., 1993). Decorin was also 
shown to influence the induction of quiescence. Transfected CHO cells, which overproduce 
decorin, had a decrease in their growth rate (Ruoslahti, 1989). Moreover, decorin might play 
a role in the regulatation of cell growth since it can bind and sequester TGFβ, demonstrated 
in chinese hamster ovary cells (Yamaguchi et al., 1990). Thus, decorin could be also 
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involved in TGFβ binding and sequestering in the microenvironment of LRCs.  Other 
components of the ECM that seem to play a role were Fibulin 1 and Fibulin 2. Both were 
shown here to be upregulated in LRCs.  Fibulin 1 and Fibulin 2 are secreted glycoproteins 
and support ECM stability (Lau et al., 2010). They build a tight connection with fibronectin 
and a number of other ECM proteins like laminin and fibrinogen (Tran et al., 1997). In 
addition, Fibulin 2 is an important factor for the basement membrane integrity (Longmate et 
al., 2014). Fibulin 1 was also enriched in the stem cell niche of the bulge (Fujiwara et al., 
2011) and also upregulated in hair follicle stem cells (Morris et al., 2004). Our findings 
suggest that these ECM components could be important for the integrity and regulation of 
LRCs. 
 
Notably, not only ECM components were upregulated, but also the tissue inhibitor of 
metalloproteinase, TIMP2, was upregulated. This is a hint towards a decreased degradation 
of ECM molecules. An upregulation of TIMP2 was also shown in label-retaining cells of the 
hair follicle (Tumbar et al., 2004) and Keratin-15-positive mouse hair follicle stem cells 
(Morris et al., 2004), thus confirming that TIMP2 could play a role in stem cells. 
 
Interestingly, we did not find any downregulation of genes which are related to cell cycle 
progression, suggesting that slow cycling of the LRCs is not necessarily regulated on 
transcriptional level. The expression profile, as mentioned above, could indicate a different 
regulation of quiescence of the LRCs. A hint for a quiescent phenotype of the isolated LRCs 
was the downregulation of histone clusters. Histone clusters are upregulated in actively 
cycling cells which progress from G1 to S phase (Harris et al., 1991; Marzluff and Duronio, 
2002). The downregulation of histone clusters confirmed may therefore represent the G0 
status of the LRCs. Other indications came from the downregulation of Keratin 14 in LRCs. 
Keratin 14 is a marker of basal keratinocytes (Alam et al., 2011; Byrne et al., 1994; 
Coulombe et al., 1989). Keratin 14 knockdown in HaCaT cells was shown to lead to 
decreased cell proliferation and to a delay in cell cycle progression, but also to the induction 
of keratinocyte differentiation (Alam et al., 2011). Since we saw a downregulation in LRCs, it 
is conceivably that moderate downregulation of Keratin 14 also leads to decreased 
proliferation in LRCs.  
 
Surprisingly, vimentin, an intermediate filament protein which is usually expressed in 
mesenchymal cells and a marker for fibroblasts was also upregulated in LRCs. Vimentin can 
be detected transiently in non-mesenchymal cells, like epithelial cells, during embryonic 
development, especially during cell migration processes (Bignami et al., 1982; Kasper et al., 
1989; Lane et al., 1983). Moreover, vimentin is upregulated in keratinocytes at the migratory 
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tongue during wound healing in the skin (Yan et al., 2010). Vimentin was found to be also 
expressed in NHEKs cultivated in 2D under low-calcium conditions (Franke et al., 1979a; 
Franke et al., 1979b). A different study showed a vimentin-expressing population located at 
the migratory/proliferative rim of growing colonies also under normal calcium growth 
conditions. A small fraction of these vimentin positive NHEKs showed high levels  of α5β1 
integrin and integrin α6 (Castro-Munozledo et al., 2015), which were suggested as epidermal 
stem cell markers (Hotchin et al., 1993; Jones et al., 1995). Silencing of vimentin in 
keratinocytes leads to smaller colonies, suggesting a role for vimentin for a migratory 
phenotype of NHEKs and colony growth (Castro-Munozledo et al., 2015). Interestingly, β1 
integrin, a suggested epidermal stem cell marker, was also shown to be involved in migration 
(Grose et al., 2002); since β1 integrin-null keratinocytes showed not only impaired adhesion 
but also to a less migratory phenotype (Grose et al., 2002). Therefore, the unexpected 
upregulation of vimentin in LRCs could indicate a more motile phenotype.  
 
In summary, we could show that LRCs in the IFE express unique ECM genes different from 
those of the bulk of the basal cells. Supporting this, the molecular characterization of Keratin-
15-positive mouse hair follicle stem cells revealed also an upregulation of ECM genes, like 
different collagens, fibulin 1, Tenascin C, TIMP2 among others. Similar results were revealed 
by expression analysis of mouse epidermal label-retaining cells. The functional importance of 
the different ECM is still elusive. There are indications that increased levels of ECM 
components not only allow for better adherence of the stem cells in the niche, it may also 
play a role for the binding, distribution and activity of polypeptide growth factors (Mooradian 
et al., 1989). This is also known from other cell types, like endothelial cells which produce 
bFGF and incorporate it into the local niche where it may regulate autocrine endothelial cell 
growth (Gordon et al., 1987; Vlodavsky et al., 1987). Studies from Mooradian et al. and 
others demonstrated that TGFβ can interact with different ECM proteins and may be 
released by extracellular matrices as consequence (Mooradian et al., 1989; Streuli et al., 
1993). Thereby the ECM could serve as a reservoir for growth factors, such as TGFβs, and 
could generate stable gradients of these (reviewed in (Fuchs, 2008), (Zhu and Clark, 2014)). 
The expression of different ECM components could also lead to different responses to the 
same growth factor (reviewed in (Zhu and Clark, 2014)). We propose that LRCs might retain 
at least in part their stem cell character by expressing differential ECM components that 
influence the immediate surroundings of LRCs. 
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4.6 A role for TGFβ signaling in LRC regulation? 
 
Transforming growth factor (TGF)-β family signaling has been reported to be involved in the 
development and maintenance of stem cells in various organs. For example it was shown 
that TGFβ plays an important role in the maintenance of embryonic stem cell identity 
(summarized in (Mishina et al., 2002; Sirard et al., 1998; Watabe and Miyazono, 2009)). 
Molecular characterization of LRCs of the bulge in the hair follicle also showed involvement 
of TGFβ. It was shown that LRCs had elevated transcripts for Latent TGF-beta binding 
protein (LTBP-1), which activates latent TGFβ (Unsold et al., 2001), and TGFβ target genes 
as well as Smad interacting genes (Tumbar et al., 2004). TGFβ activation was also indicated 
by increased phospho-Smad2 expression in the bulge compared to the progeny (Tumbar et 
al., 2004). Moreover, studies revealed that the proliferation of keratinocytes is inhibited by 
TGFβ signaling (Massague and Weinberg, 1992), which could be also involved in regulating 
the slow cycling of LRCs. However, in hair follicle stem cells loss of TGFβ receptor type II 
does not influence the quiescent state (Guasch et al., 2007). Studies performed in OTCs with 
human adult HaCaT variants, like Smad7-overexpressing HaCaT, demonstrated that active 
TGFβ/Smad signaling is essential for epidermal differentiation (Buschke et al., 2011). 
Notably, it was demonstrated that diminished TGFβ signaling in the anal epithelium of mice 
result in increased proliferation but epidermal homeostasis was maintained regulated by 
increased apoptosis (Guasch et al., 2007). In our study, the results of the IAP analysis from 
isolated LRCs indicated that TGFβ could be involved in the regulation of LRCs, though direct 
evidence is still elusive. We could not detect differences in expression levels of TGFβ, 
Smad3, Smad7 and the TGFβ receptor type I and II determined by qRT-PCR. Since we 
hypothesize that the concentration of TGFβ in the local environment of LRCs is increased 
similar mRNA expression levels of TGFβ between LRCs and basal cells were not surprising. 
However, we did not test the activation of TGFβ/phopho-Smad proteins in LRCs. Hints for 
enhanced TGFβ activation in isolated LRCs could be shown by higher expression of TGFβ 
receptor type III. The TGFβ receptor type III, Betaglycan, can also serve as reservoir for 
TGFβ and regulate access of TGFβ to the cell (Blobe et al., 2001; Lopez-Casillas et al., 
1991). This could indicate a higher availability of TGFβ in LRCs. 
 
4.7 Induction of LRC-like phenotype by TGFβ-1 
To further analyze the role of TGFβ signaling in LRCs we tested if we can induce the 
expression of different target genes through TGFβ-1 stimulation of keratinocytes in 2D 
monoculture. TGFβ was shown to induce higher vimentin, fibronectin and collagen 
expression and promote their incorporation into the ECM (Ignotz and Massague, 1986; 
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Miettinen et al., 1994). It was also reported that the expression of collagens, tenascin, 
proteoglycans and their transmembrane receptor integrins is controlled by TGFβ (Pearson et 
al., 1988; Roberts et al., 2006). In addition, it was suggested that TGFβ might be an 
important regulator of IL6 production in fibroblasts (Elias et al., 1991). Therefore, we asked if 
TGFβ stimulation can also upregulate IL6 in keratinocytes. In a first attempt we could detect 
an upregulation of fibronectin (20 fold) and IL6 (22.6 fold) and vimentin (5.4 fold) in the 
presence of higher TGFβ-1 concentrations (5ng/ml). Our results indicate that high 
concentrations are required, since we could detect only a slight upregulation of TGFβ- 
associated genes, like vimentin, THBS1, fibronectin, IL6, COL1A1 and tenascin C with low 
TGFβ-1 concentrations (10pg-1ng/ml). However, the activation of the TGFβ pathway in the 
treated keratinocytes is questionable since the expression of the endogenous Smad pathway 
inhibitor, Smad7, which is induced by TGFβ (Itoh et al., 2000; Massague and Chen, 2000; 
Moustakas et al., 2001) was only slightly upregulated. This was also the case for the cyclin-
dependent kinase inhibitor p21, which is rapidly induced by TGFβ-1 (Datto et al., 1995; 
Hannon and Beach, 1994; Reynisdottir et al., 1995). Phospho-Smad3 stainings from NHEKs 
treated with 5ng/ml TGFβ-1 for 3 days showed phosphorylation of Smad3 only in few cells 
(Figure 28 A); whereas upon treatment with 10ng/ml TGFβ-1 phosphorylation of Smad3 was 
observed in all cells (Figure 28 A). This confirmed that activation of TGFβ pathway in 
NHEKs, cultured in low-calcium medium, requires high concentrations of TGFβ-1 and further 
experiments should be performed with such concentrations. This was also shown in other 
studies where high TGFβ-1 concentrations (20ng/ml) were used to induce e.g. higher 
fibronectin secretion in keratinocytes (Hashiro et al., 1991). 
 
Confirming this, inhibition of proliferation was only observed with TGFβ-1 concentrations of 
5ng/ml or higher. Interestingly, the long-term treatment over several passages with low 
concentrations led to decreased proliferation (Figure 29 C). It is important to note that the 
growth inhibitory effect in adult human HaCaT keratinocytes, cultivated in serum and calcium 
containing medium ((Yang et al., 1996), Dissertation Susanne Buschke 2008) was much 
more apparent than in our studies with human keratinocytes cultivated in low-calcium 
medium. It was shown that high Ca2+ can inhibit keratinocyte growth similar to TGFβ by 
activating p21 (Sakaguchi et al., 2004). Studies have shown that S100C/A11, a Ca2+-binding 
protein, is mediating a pathway which is crucial for the growth inhibition of keratinoctyes 
induced by high Ca2+ and TGFβ (Figure 32) (Sakaguchi et al., 2004). It was demonstrated in 
keratinocytes that the protein kinase PKCα phosphorylates the protein S100C/A11 after 
stimulation with TGFβ or Ca2+. This in turn induces the activation of Sp1, which is regulating 
together with activated Smads the induction of p21 (Figure 32) (Sakaguchi et al., 2004; 
Sakaguchi et al., 2003). The activation of Sp1 was shown to be important for the growth 
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inhibition of keratinocytes (Sakaguchi et al., 2004). In another study, it was also suggested 
that for TGFβ activation physiological concentrations of Ca2+ are necessary. It was shown 
that under low-calcium conditions in conditioned media of growing keratinocytes TGFβ was 
present in the latent form in contrast to conditioned medium with physiological Ca2+ 
concentrations where the active form was restored (Kato et al., 1995). Therefore, it is 
conceivable that the presence of TGFβ together with calcium is enhancing the growth 
inhibitory effect.  
 
The increased expression of ECM proteins determined by immunostaining, like fibronectin 
and decorin, in NHEKs after TGFβ-1 stimulation in 2D could indicate a role for TGFβ in 
LRCs. Interestingly, increased fibronectin secretion was suggested to be a specific result of 
TGFβ-1 stimulation, since stimulation with other growth inhibitory substances did not lead to 
a change in fibronection secretion (Hashiro et al., 1991). However, we have to carefully 
evaluate further experiments before making a definite statement on the role of TGFβ in 
LRCs. 
 
  
 
 
 
Figure 32: Suggested Signaling pathways for high Ca2+ and TGFβ 1-induced inhibition of proliferation in 
keratinoctyes. Blue arrows, known from the results of studies by others; black arrows, shown in  
(Sakaguchi et al., 2003); red arrows, shown in (Sakaguchi et al., 2004). Figure from (Sakaguchi et al., 
2004). Activtion of PKCα through calcium or TGFβ 1 leads to the phosphorylation of S100C which is 
translocated to the nucleus and is releasing Sp1 which can transcriptional activate p21, like TGFβ via 
Smad signaling. 
 
Taken together the transcriptional profiling of the isolated LRCs revealed that LRCs are 
characterized by a unique set of expressed genes. Our data suggest that LRCs might be 
able to create their own niche by the autocrine secretion of ECM proteins. This could not only 
serve for better adherence of the cells but rather it may play a role in regulating signaling 
pathways, for example to increase the local bioavailability of growth factors and therefore 
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control the quiescent state of LRCs. It is tempting to speculate that especially TGFβ is 
involved in the regulation of LRCs. However, one can assume that TGFβ signaling alone is 
certainly not sufficient to regulate the maintenance of LRCs. Also other signaling pathways 
could be involved. It was shown that activation of the mitogen-activated protein kinase 
(MAPK) cascade mediated by the epidermal growth factor receptor (EGFR) is critical for 
epidermal homeostasis in order to balance proliferation and differentiation (Sotiropoulou and 
Blanpain, 2012; Zhu et al., 1999). Interestingly, the microarray analysis revealed 
downregulation of dual specificity phosphatase 6, DUSP6, which is known to negatively 
regulate members of the mitogen-activated protein (MAP) kinase superfamily (Li et al., 2007; 
Ramos, 2008). This aspect needs to be addressed in future studies. The functional 
significance of the individual ECM composition of LRCs is still elusive and further 
investigations are needed. Moreover, the functional role of LRCs in epidermal homeostasis 
cannot be sufficient determined from the data presented here. Whether the isolated LRCs 
possess stem cell properties remains an open question for further studies. 
4.8 Clonal kinetics in the IFE 
To study the clonal kinetics of H2B-GFP NHEKs grown on fdm OTCs we performed linear 
amplification-mediated (LAM)-PCR from the epithelium at different time points. Lentiviral 
vector integration in the cellular genome can be used as unique molecular marker for each 
transduced cell and allows tracking the distinct clonal progeny (Schmidt et al., 2009). Starting 
from week 2, we detected 186 individual clones, after 6 weeks the clone number fell to 22 
clones and to 4 clones after 9 weeks. Only one clone persisted after 3 months. Notably the 
analyzed cells contained both basal and suprabasal cells. Thus, we could show that the 
number of surviving clones gradually diminished as was demonstrated in experiments 
performed in mouse tail epidermis (Blanpain and Simons, 2013; Clayton et al., 2007). To 
prove that a constant clone number is approached at later time points, experiments 
exceeding 12 weeks need to be performed. So far, we observed that as little as 1 clone is 
able to maintain epidermal regeneration of the entire OTC. The stem/TA cell hypothesis 
implies that epidermal stem cells divide asymmetrically into a stem cell and a differentiated 
transit-amplifying (TA) cell which divides for several rounds until exiting the cell cycle thereby 
creating epidermal proliferating units (EPU). Consequently, in the EPU model each 
compartment is maintained by a single slow cycling stem cell surrounded by transit-
amplifying cells (Mackenzie, 1970; Potten, 1974; Potten, 1981). The stem/TA cell model 
would predict that the clone-size distribution has to become constant at some average value 
over time (Blanpain and Simons, 2013; Clayton et al., 2007). In contrast, it was shown by 
inducible genetic labeling in tail mouse skin that the average clone size was increasing 
(Blanpain and Simons, 2013; Clayton et al., 2007) which suggests a single-proliferative 
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compartment during IFE homeostasis correlating with the so called stochastic model. This 
model predicts that all basal cells follow a stochastically balanced fate, generating either two 
cycling daughters, or two non-cycling daughters or one of each (Blanpain and Simons, 2013; 
Clayton et al., 2007; Doupe and Jones, 2012). However, with our approach, we cannot draw 
any conclusions regarding the stem cell hierarchy prevalent in human IFE. From the LAM-
PCR results we can derive the clone number but not the average clone size. Both 
parameters are required to gain deeper insights into the question how tissue homeostasis is 
maintained.  
4.9 Conclusion 
In this study we investigated label-retaining cells, the potential stem cells, in OTCs of human 
epidermis. It was possible to effectivly transduce normal human keratinocytes with a tet-off 
controlled H2B-GFP lentiviral vector. Moreover, we were able to expand a stable H2B- GFP 
positive keratinocyte population in the presence of the rho-kinase inhibitor Y-27632, which 
prolongs the life span of adult human keratinocytes. However, Y-27632 treated H2B-GFP 
NHEKs lost their ability for long-term regeneration in 3D, rendering this method unsuitable to 
detect LRCs. Therefore, non-treated H2B-GFP NHEKs were used in long-term OTCs. 
Although we observed a decline of GFP positive cells during the 2 weeks of pulse period, 
LRCs could be detected after chase periods of up to 11 weeks. Subsequently, we were able 
to isolate LRCs from OTCs. Microarray analysis of LRCs compared to basal cells of the 
same OTC revealed 102 genes which were differentially regulated. Several genes of those 
genes were highly upregulated; particularly ECM components were upregulated which could 
be confirmed by qRT-PCR for most of the genes. To verify differential ECM protein 
expression in LRCs, further characterization on protein level is necessary. However, the 
results indicate that LRCs influence their local microenvironment by the autocrine secretion 
of unique ECM components. Thereby, the ECM could serve not only as anchor for LRCs in 
the niche but also as a reservoir for growth factors and by that regulate cell signaling. LRCs 
could be kept in a quiescent state indirectly by local availability of growth factors in their 
environment. Our studies suggest that TGFβ signaling could be involved in the regulation of 
LRCs. We have first hints which show the upregulation of genes upon TGFβ stimulation of 
NHEKs in 2D cultures which were also highly upregulated in LRCs. This was confirmed also 
on protein level in 2D. Moreover, the proliferation inhibiting capacity of TGFβ was also shown 
in NHEKs in 2D at least with high TGFβ-1 concentrations (10ng/ml) or long-term stimulation. 
 
Interestingly, the range of isolated LRCs compared to the cell number of isolated basal cells 
was between 1-7,4% after 6-8 weeks of chase as suggested in the literature (Morris et al., 
1985; Morris and Potten, 1994). The detection of individual clones via LAM-PCR revealed 
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that the epithelium is maintained by 3-11% of individual clones after 6 to 9 weeks, compared 
to the initial number of clones. At present, it remains elusive if LRCs reflect these clones and 
are responsible for maintaining tissue homeostasis in OTCs.  
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6 Appendix 
Table 6: Complete list of differentially expressed genes revealed by the microarray analysis analyzed with 
chipster. 
 
  
gene 
symbol gene 
Fold 
change 
1 DCN decorin 22,40631251 
2 IL6 interleukin 6 (interferon, beta 2) 19,27065005 
3 FBLN2 fibulin 2 16,42134054 
4 FN1 fibronectin 1 9,741653484 
5 IGFBP4 insulin-like growth factor binding protein 4 9,285631315 
6 TIMP2 TIMP metallopeptidase inhibitor 2 8,534657944 
7 COL6A1 collagen, type VI, alpha 1 8,0556444 
8 COL1A1 collagen, type I, alpha 1 7,981537412 
9 C1S complement component 1, s subcomponent 7,754318535 
10 RASD1 RAS, dexamethasone-induced 1 7,498835972 
11 AEBP1 AE binding protein 1 7,34451216 
12 FBLN1 fibulin 1 7,279749911 
13 PTGS2 prostaglandin-endoperoxide synthase 2 6,700025873 
14 CTSK cathepsin K 6,415966756 
15 LUM lumican 6,190259974 
16 THBS1 thrombospondin 1 5,958709852 
17 VASN vasorin 5,769048265 
18 NPTX2 neuronal pentraxin II 5,540437872 
19 DPYSL3 dihydropyrimidinase-like 3 5,502167273 
20 VIM vimentin 5,256733755 
21 SERPINE2 
serpin peptidase inhibitor, clade E 
 (nexin, plasminogen activator inhibitor type 1), 
member 2 5,58 
22 LEP leptin 5,55 
23 C11orf96 chromosome 11 open reading frame 96 5,43 
24 IL1RL1 interleukin 1 receptor-like 1 5,41 
25 CDR1 cerebellar degeneration-related protein 1, 34kDa 5,14 
26 MMP1 matrix metallopeptidase 1 (interstitial collagenase) 5,05 
27 COL6A3 collagen, type VI, alpha 3 4,91 
28 APOD apolipoprotein D 4,88 
29 HMOX1 heme oxygenase (decycling) 1 4,67 
30 SFRP2 secreted frizzled-related protein 2 4,67 
31 COL1A2 collagen, type I, alpha 2 4,13 
32 MFAP4 microfibrillar-associated protein 4 4,12 
33 NDN necdin, melanoma antigen (MAGE) family member 4,07 
34 DPT dermatopontin 3,93 
35 STC1 stanniocalcin 1 3,92 
36 RGS2 regulator of G-protein signaling 2, 24kDa 3,87 
37 TNFAIP6 tumor necrosis factor, alpha-induced protein 6 3,65 
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38 KIAA1199 KIAA1199 3,62 
39 CNFN cornifelin 3,57 
40 RARRES2 
retinoic acid receptor responder (tazarotene 
induced) 2 3,53 
41 COL3A1 collagen, type III, alpha 1 3,32 
42 MEDAG mesenteric estrogen-dependent adipogenesis 3,24 
43 PDGFRA 
platelet-derived growth factor receptor, alpha 
polypeptide 3,20 
44 ATP8B2 
ATPase, aminophospholipid transporter, class I, 
type 8B, member 2 3,15 
45 PTX3 pentraxin 3, long 3,11 
46 METTL7A methyltransferase like 7A 2,97 
47 OLFML3 olfactomedin-like 3 2,96 
48 S100P S100 calcium binding protein P 2,95 
49 CRISPLD2 
cysteine-rich secretory protein LCCL domain 
containing 2 2,90 
50 LGALS1 lectin, galactoside-binding, soluble, 1 2,86 
51 NID1 nidogen 1 2,85 
52 CXCL12 chemokine (C-X-C motif) ligand 12 2,84 
53 CRCT1 cysteine-rich C-terminal 1 2,79 
54 CXCL5 chemokine (C-X-C motif) ligand 5 2,77 
55 TNC tenascin C 2,77 
56 KLK7 kallikrein-related peptidase 7 2,74 
57 HSPB8 heat shock 22kDa protein 8 2,73 
58 APCDD1 adenomatosis polyposis coli down-regulated 1 2,64 
59 S100A4 S100 calcium binding protein A4 2,64 
60 FLNC filamin C, gamma 2,53 
61 GEM 
GTP binding protein overexpressed in skeletal 
muscle 2,50 
62 SAA1 serum amyloid A1 2,49 
63 THY1 Thy-1 cell surface antigen 2,35 
64 FST follistatin 2,33 
65 CFD complement factor D (adipsin) 2,32 
66 TMEM119 transmembrane protein 119 2,32 
67 COL4A1 collagen, type IV, alpha 1 2,31 
68 CIDEA cell death-inducing DFFA-like effector a 2,26 
69 STMN2 stathmin-like 2 2,25 
70 PPARGC1A 
peroxisome proliferator-activated receptor gamma,  
coactivator 1 alpha 2,25 
71 SVEP1 
sushi, von Willebrand factor type A, EGF  
and pentraxin domain containing 1 2,21 
72 CLDN11 claudin 11 2,18 
73 LCN2 lipocalin 2 2,16 
74 NNMT nicotinamide N-methyltransferase 2,15 
75 CTHRC1 collagen triple helix repeat containing 1 2,14 
76 PRRX1 paired related homeobox 1 2,13 
77 LOXL4 lysyl oxidase-like 4 2,04 
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78 CRYAB crystallin, alpha B 2,04 
79 GREM1 gremlin 1, DAN family BMP antagonist 2,00 
80 EDNRB endothelin receptor type B 1,98 
81 COL5A1 collagen, type V, alpha 1 1,96 
82 TNFRSF11B 
tumor necrosis factor receptor superfamily, 
member 11b 1,96 
83 SLC39A14 
solute carrier family 39 (zinc transporter), member 
14 1,91 
84 CXCL6 chemokine (C-X-C motif) ligand 6 1,90 
85 PODN podocan 1,86 
86 AP1S2 adaptor-related protein complex 1, sigma 2 subunit 1,83 
87 NCCRP1 
non-specific cytotoxic cell receptor protein 1 
homolog (zebrafish) 1,81 
88 ISLR 
immunoglobulin superfamily containing leucine-rich 
repeat 1,80 
89 RCAN2 regulator of calcineurin 2 1,80 
90 LOR loricrin 1,79 
91 CPE carboxypeptidase E 1,77 
92 SCNN1D sodium channel, non-voltage-gated 1, delta subunit 1,77 
93 DIO2 deiodinase, iodothyronine, type II 1,76 
94 DUSP6 dual specificity phosphatase 6 0,40 
95 HIST1H2BG histone cluster 1, H2bg 0,39 
96 HIST1H4H histone cluster 1, H4h 0,39 
97 GOLGA7B golgin A7 family, member B 0,38 
98 CXCL14 chemokine (C-X-C motif) ligand 14 0,38 
99 KRT14 keratin 14 0,37 
100 MCM3 
minichromosome maintenance complex 
component 3 0,36 
101 HIST1H2BK histone cluster 1, H2bk 0,36 
102 ITGB4 integrin, beta 4 0,33 
 
 
 
